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Acute salicylate poisoning has become increasingly
more common in recent years. It is, at present, the third
most frequent cause of acute intoxication and depending on age,
the mortality rate varies from 1.0 to 7#0 per cent. Aspirin
overdosage, therefore, constitutes a serious problem of
management for all practising doctors.
The diagnosis and assessment of patients with this
condition are discussed in the light of the clinical features
and biochemical results found in 84 patients (39 males and
45 females) with moderate and severe acute salicylate
poisoning admitted to the Poisoning Treatment Centre, Edinburgh
Royal Infirmary. Measurement of the plasma level of salicylate
is considered to be the best single investigation, both to
confirm the diagnosis and to provide an index of the severity of
the poisoning. The important clinical features and assessment
of acid-base status are also discussed.
In addition to supportive measures to maintain vital functions
it is generally agreed that rapid removal of salicylate from the
body is the most important objective of treatment. This may
be achieved by gastric aspiration and lavage to minimise the
amount of drug absorbed from the gastro-intestinal tract. As
all the patients in this series had ingested the overdosage,
gastric aspiration and lavage was performed in every case.
The value of this procedure in this poisoning is discussed.
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After absorption has occurred, increased removal of
salicylate from the body may be achieved in adults by many
methods, including forced oral fluids, forced water diuresis,
forced alkaline diuresis, peritoneal dialysis and haemodialysis.
The use of the artificial kidney is the most efficient method,
but the great demands on this form of treatment for other
conditions, has prompted a search for alternative forms of
treatment. The most suitable method for general use is forced
diuresis using intravenous infusions, but there is much
controversy regarding the most appropriate regime. Forced
alkaline diuresis therapy, described by Dukes and his colleagues
in 1963» is the most effective of these regimes. Several
authorities, however, on theoretical grounds, stress that the
administration of large amounts of alkali may cause severe
metabolic alkalosis and potentially fatal tetany. The need for
potassium supplements with this treatment, also remains undecided.
The purpose of this investigation was to develop the safest
regime of forced diuresis in adults, consistent with effective
removal of salicylate.
Of the 84 patients with moderate or severe poisoning,
9 were treated with forced oral fluids, 11 with forced saline-
laevulose, 51 with forced alkaline and 13 with forced "cocktail"
diuresis, which is a modification of the Dukes' method. One
patient died giving a mortality of 1.19 per cent. The
effectiveness of these forms of treatment in increasing removal
of salicylate are assessed. Detailed studies of changes in
acid-base status, and in plasma and urinary levels of potassium,
sodium, magnesium and calcium were done, both during and after
the main diuresis period. Despite significant and at times,
alarming falls in these plasma cations and associated rises in
arterial pH, tetany was rarely found. The significance of
these changes are discussed.
The need for substantial potassium supplements is
demonstrated and forced "cocktail" diuresis with standardised
potassium administration is shown to be highly effective; it
is also a safer and technically simpler regime of treatment
than forced alkaline diuresis.
INTRODUCTION
In keeping with the steady increase in hospital admissions
due to acute poisoning (H.M.S.O. report 1966; Matthew & Lawson,
1966), the incidence of acute salicylate overdosage has also
risen and now accounts for approximately 16 per cent of all acute
poisonings admitted to hospital (Graham, 1967). In the case of
infants and toddlers, salicylates are almost as common causes
of accidental overdosage as iron preparations. Young children
are also peculiarly sensitive to the effects of aspirin and even
relatively small doses of the drug, which would otherwise be
regarded as therapeutic levels, may result in poisoning, (Craig,
Ferguson and Syme, 1966).
Salicylate overdosage usually arises from an overdosage
of aspirin itself or one of the bewildering variety of
pharmaceutical preparations containing both mixtures of different
salts of salicylic acid and also featuring aspirin as a constituent
of compound analgesic tablets. When compound tablets containing
aspirin, phenacetin and codeine are taken in overdosage, the most
important toxic features are those of salicylism (Matthew and
Lawson, 1967). Methyl salicylate, "Oil of Wintergreen", is
occasionally taken by the inquisitive child as an accidental
poisoning. This is very toxic since it is readily absorbed and
has a high salicylate content; one teaspoonful is equivalent to
twelve standard 300 mg. tablets of acetylsalicylate.
In Edinburgh, since the late 19th century, a ward has been
developed to provide special facilities for the management,
toxicological investigation and psychiatric assessment of patients
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Figure 1.
Total annual admission rate to the Poisoning Treatment
Centre, Edinburgh Royal Infirmary.
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however, this is not a major cause of the general rise in this
condition, as at the present time it still only accounts for
about 10 per cent of the patients admitted. Similarly suicidal
poisoning where the patient is truly intent on self-destruction
is present in only a further 10 per cent. There is no doubt
that the main cause of the increase of patients admitted with
acute poisoning is a remarkable rise in the incidence of self-
poisoning. This is a term instituted by Kessel (1965) to
describe a conscious, often impulsive manipulative act by which
patients seek to achieve a change in their environment. Such
patients do not genuinely wish to die. Their motives for
taking an overdosage of poison may be very varied. Confusion
arises, however, as self-poisoning is in practice what many
others refer to as attempted suicide. The latter term is
preferably restricted to those patients who appear to have
a very determined desire to end their life. Self-poisoning is
responsible for up to 80 per cent of all admissions to the
Poisoning Treatment Centre. So common is it nowadays that it
appears to have replaced the Victorian vapours as a means of
registering distress.
An important factor in the increase of self-poisoning is
the ready availability of drugs. It is significant that the
sharp rise in incidence of acute poisoning occurred apparently
(Fig. 1) simultaneous to the start of the National Health Service.
The natural inclination is to blame the ready availability of
drugs on the abandon with which drugs are prescribed on the
health service. There is no doubt that this is a major factor
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as there must be few households in this country today who do not
possess potentially lethal quantities of various drugs including
barbiturates and salicylates. On the other hand the incidence
of acute salicylate poisoning has also increased in keeping with
the other poisonings (fig. 2) and over half of the vast quantities
of salicylates, if,000,000,000 tablets, which are consumed in
Britain every year are bought over the counter or from slot
machines and not on prescription.
With this enormous annual consumption of salicylate
containing tablets it is no surprise that acute salicylate
poisoning is a common cause of admission. In the Poisoning
Treatment Centre in Edinburgh over a two-year period (fig. 3)
acute salicylate overdosage was the second most common individual
poisoning.
Acute poisoning is therefore nowadays a very real medical
and social problem in developed countries. -*-t is not isolated
to any ethnic or social group and so it must concern every
practising doctor.
Comparison between hospital and national death rates have
indicated (fig. 4) that infants have been sent to hospital in
the great majority of cases but in the olderage groups, where
intentional self-administration is the major cause of poisoning,
this has in the past been far from the case. It may be that
doctors have mistakenly given their patients the "benefit of the
doubt* in order to avoid the stigma of suicide. In recent years,
with a greater awareness of the problems of acute poisoning,
general practitioners are becoming quite rightly much more inclined
- 9 -
YEARLY ADMISSIONS OF PATIENTS ADMITTED













•Annual admission rate of patients with acute salicylate
poisoning to the Poisoning Treatment Centre, Edinburgh
Royal Infirmazy.
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TYPES OF POISONING ADMITTED TO POISONING TREATMENT CENTRE
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Relative frequency of different types of poisoning
admitted to the Poisoning Treatment Centre, Edinburgh
Royal Infirmary in a two year period.
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CASE FATALITY RATE FROM SALICYLATE POISONING IN
ENGLAND AND WALES, 1958 - 1960
Figure 4-.
Comparison between the case fatality rate in hospital
and the total number of deaths due to salicylate poisoning
in England and Wales (1958 - 1960).
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to refer these patients to hospital. It is inevitable, therefore
that many hospitals, including peripheral hospitals, will have to
accept an increased load of patients with acute poisoning and
many will be seriously ill. In the absence of effective
treatment a number of these patients will die and many more
will be 'near misses*.
Good medicine, therefore, demands a constant search for
standardised, improved and safer methods of treatment in order
that this considerable group of patients may be saved. Simplicity
of method is of great importance, as it is essential that all
doctors, even those working in hospitals where technical
facilities and biochemical support are limited, may be able to
use the regimes with safety. The purpose of this thesis is to
review the general management and assessment of patients with acute
salicylate poisoning and to describe detailed metabolic and acid-
base studies carried out during four different regimes of forced
diuresis. By suitable monitoring of the metabolic changes
occurring during these different types of forced diuresis,
a regime has been developed which is highly effective, technically




In the last twenty years there has been an explosive
increase in the incidence of acute poisoning in this country,
and indeed in all the developed countries of the world, (Berman,
Jeghers, Schreiner and Pallotta, 1956; Clemineson and Nilsson,
1961; Ministry of Health Report, 1962; Montani and Perret,
1963; Matthew and Lawson, 1966). This is now a problem of
the first magnitude not only from the point of view of management
but also in the field of preventive medicine, and is an exacting
challenge both to the general practitioner and also to the
hospital doctor.
Each year from the 10 per cent sample survey of hospital
in-patients the number of patients admitted to the hospital is
increasing (Table I), and approximately 10 per cent of all acute
admissions to general medical hospitals in Britain are suffering
from this condition (Curry, 1965)• More recent figures indicate
that, in certain general medical hospitals, this proportion of
acute emergency admissions due to poisoning has risen to as much
as 25 per cent.
World Health Organisation statistics indicate that
Scotland is in the disturbing position of having the highest
incidence (Pig. 5) in fatal domestic accidents, the main cause
of which is poisoning. Also the crude death rates due to
poisoning (Table I) for England and Wales and (Table II) for
Scotland, England and Wales are very high compared with other
developed countries. Only Denmark with a death rate of 12.7
per 100,000 population has a similarly high rate. In Japan,
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Pagig m :
feii% due to poisoning and gassing
Figure 5.
Comparison between the percentage of fatal domestic
accidents due to poisoning in Canada, U.S.A., England
and Wales and Scotland.
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TABLE I
Poisoning figures (Registrar &eneral)
1957-1964» England and Wales
All poisoning
Admissions to Deaths in Deaths Crude death
hospital hospital per rate per
(estimated (estimated 1,000 100,000
total) total) admissions persons
1957 15,900 523 32.9 10.9
1958 17,500 563 32.4 11.2
1959 20,200 477 23.6 11.3
1960 23,300 445 19.1 11.3
1961 27,900 540 19.4 11.5
1962 33,400 645 19.3 13.0
1963 45,942 887 19.3 1 4.1






Rates per 100,000 population
1963
Country- Persons Males Females
Canada 5.2 6.5 4.1
Japan 7.4 8.9 6.1
Belgium 5.9 5.9 5.8
Bulgaria 2.6 5.4 1.9
Denmark 12.9 15.1 10.8
France 5.2 5.5 4.9
Italy 2.1 2.4 1.9
Norway- 5.7 4.9 2.4
Portugal 1.7 2.2 1.3
England and Wales 14.1 14.6 13.7
Northern Ireland 7.5 8.2 6.5
Scotland 12.7 15.5 10.0
Source: World Health Statistics Annual, 1963, Vol. I, p. 441.
Northern Ireland, Belgium, Canada and France rates lie between
5.2 and 7.4 per 100,000 persons and in Norway, Bulgaria, Italy
and Portugal between 1.1 and 3*7. It is difficult to under¬
stand why the incidence of death due to accidental poisoning,
in which carelessness is the most important factor, should be so
different in countries which are otherwise relatively comparable.
Variations in the method of registration and coding of causes
of death may be a significant factor. Whatever the reason,
these figures serve to emphasise the gravity of the situation in
this country today in regard to the problem of acute poisoning.
Scottish deaths from poisoning reached a peak in 1962 and
have declined since (Table III). A similar fall has occurred
in England and Wales since 1963 (Table IV). Analysis of the
place of death in 1963 and 1965 (Table IV) shows that the
majority of patients die from acute poisoning at home.
Examination of age specific death rates for England and
Wales for all forms of poisoning (Table V) shows that increases
have occurred in children under 5 years of age. In patients
between 5 and 25 years of age there has been little change in
rates and at the present time, in the age group 25-34 years acute
poisoning is the cause of 1 in 10 of all deaths. The greatest
reductions in rates have been in the older patients in both sexes.
The probable explanation for the reduction in death rate is that
more patients are being referred to hospital and at an earlier
stage. This is reflected in the increase in hospital admissions
and the slight fall in the proportion of deaths occurring 'at



























Deaths from poisoning, Scotland, 1955—1965
., . , . . , Suicide and Self-Accidental poisoning by Inflicted Injury,solids, liquids, gases Poisoning by solids,^ Tapoura liquids and gases
Males Females Males Females
Numbers
112 134 133 118
102 122 139 113
130 129 160 114
132 166 162 113
136 143 170 121
126 147 140 113
170 164 162 120
215 185 203 145
184 139 185 121
145 155 137 138
161 132 151 138
Rates per million living
46 50 54 hbr
42 46 57 42
53 48 65 43
54 62 66 42
55 53 69 45
51 55 56 42
68 61 65 44
86 68 81 54
74 51 74 45
58 57 55 51
64 49 60 51
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TABLE IV
Deaths from poisoning in England and Wales by place of death
Proportions per cent of deaths at particular sites
All causes of poisoning
1963 1965
Males Females Males Females
Total deaths 3,341 3,313 2,868 2,842
In hospitals 17.7 21.5 18.6 23.6
In institutions 0.5 0.5 0.5 0.5
At own home 65.2 67.8 61.0 64.8
At other place* 17.0 10.4 20.2 11.1
"At other place" includes in private houses other than





Age specific death rates per 100,000 persons
1963-1965, England and Wales
MALES FEMALES
Age
1963 1964 1965 1963 1964 1965
All Poisons
0- 26 30 30 12 29 29
1- 36 36 41 21 32 23
5- 4 6 5 4 4 5
15- 71 57 62 36 36 51
25- 115 112 96 86 68 69
35- 150 140 144 121 111 112
45- 184 190 170 168 157 153
55- 285 239 217 221 228 199
65- 333 297 256 295 281 246
75- 564 448 440 496 402 327
85 and over 795 728 542 614 535 460
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death rates is probably an improvement in methods and skills
of treatment of those admitted.
There are two main sources of information concerning the
national trends of acute salicylate intoxication. The first is
the time honoured method of death certification which is, however,
a relatively insensitive method and takes no account of non-fatal
cases. The second is the ten per cent sample of all hospital
in-patient records, which has been an effective statistical
analysis since 1958.
In England and Wales, in the period 1951-1960 the mortality
due to acute salicylate overdosage increased (Fig. 6). In the
quinquennium 1951-55it ™as 3.9 per million whereas in the next five
years it was 4»7 per million, an increase of 20 per cent. From
1955 to 1960 the total mortality remained over two hundred per
annum. The mortality rate for hospital admissions of acute
salicylate poisoning is about one per cent, whereas for all casesit
is in the region of seven per cent. The mortality due to acute
salicylate poisoning also has increased in Scotland (Table VI).
The relation of the hospital fatality rate for the three years
1958-1960 to a calculated national fatality rate is shown in
Figure 4. It was not possible to obtain any figures for non¬
fatal cases not admitted to hospital and so the national fatality
rate was calculated on the basis of registered deaths plus
hospital discharges as giving the total number of cases to be
considered. The ratio of registered deaths to this total of
cases provided an estimate of the national fatality rate.
There was a striking difference between the hospital and national
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DEATH RATE FROM SALICYLATE POISONING IN ENGLAND AND WALES, 19E1-1960
Figure 6.
Trends in mortality due to acute salicylate poisoning in
England and Wales (1951 - 1960).
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TABLE 71
Deaths from acute poisoning
due to aspirin and salicylate
in Scotland (1962-66)
1962 1963 1964 1965 1966
Sex
M F M F M F M F M F
Accidental 3 1 5 1 3 2 7 3 6 3
Intentional 2 4 CM 3 7 2 3 1 6
Total 55 7 4 69 96 79
10 11 15 15 16
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figures. This suggested that in 1960 there was a very large
number of people, particularly in patients over the age of
fifteen, who died due to aspirin poisoning and did not have the
benefit of hospital care. The remarkable contrast in the above
figures would almost certainly be accentuated if information
was also available for the total number of non-fatal incidents.
Deaths from salicylate poisoning are accidental, the resulu
of self-poisoning episodes or genuinely suicidal. Twenty per
cent of all such deaths are due to accidents and the remainder
result from the other two causes. The differences for sex and
age in patients dying from acute salicylate overdosage are
shown in (Fig. 7). The figures for self-poisoning and true
suicide have been added together and are referred to as 'suicide'.
Infants and toddlers are at risk from accidental poisoning and
these deaths are all the more tragic as they are all preventable.
Death due to this cause is uncommon during school age, but after
adolescence the mortality in both sexes rises steadily up to the
age of sixty-five years. In these older groups intentional
self-administration is by far the main cause of poisoning*
Morbidity statistics give much more detailed information
regarding the true incidence of poisoning from salicylates.
Different forms of poisoning predominate in each age group.
Salicylate is the choice of the teenager, which is in contrast
to coal gassing which is commonest in older patients (Matthew
and Lawson, 1967). This is reflected in the Figure for the
mean annual Hospital In-Patient Rate per million population in
England and Wales for 1958-1960 (Fig. 8). These figures show aone
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Differencesfbr sex, age and cause of poisoning in
patients dying from salicylate poisoning in England
and Wales (1951 - 1960).
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SALICYLATE POISONING IN ENGLAND AND WALES, 1958 -1960
HOSPITAL DISCHARGE RATE, INCLUDING DEATHS
Figure 8.
Mean hospital in-patient rate per million population
in England and Wales $958 - 1960).
interesting differences from those shown in (Fig. 7) for death
rates according to age and cause of intoxication. The peak for
infants and toddlers is much more prominent and boys remain more
frequent than girls. The second peak in terms of hospital
admissions occurs in the adolescent and early adult period for
both sexes although females seem much more at risk. In the
older age groups there is a steady decline in incidence which is
in contrast to the corresponding death rate.
Acute salicylate poisoning is likely to present as a medical
anergency wherever aspirin is readily available. The high
incidence of this "type of overdosage is therefore not surprising,
when one considers the vast quantities of aspirin consumed in
this country every year and the fact that over half of these
tablets are bought without prescription in a wide variety of
shops and even from slot machines. An interesting experiment
regarding this ready availability of aspirins was carried out
by the Edinburgh University Department of Psychological Medicine.
This young girl volunteer (Fig. 9) was sent out into the city
maintaining the expression and general manner shown. She
was to visit any chemist shop she encountered and to ask for one
hundred aspirin tablets. In half an hour she visited five shops
and in (Fig. 10) is shown the number of tablets she bought. In
only one was any comment made about her obvious state of distress.
In none of the shops was any objection or even hesitancy shown
to the giving of the tablets. In one chemist's she was offered
a cup of tea and if one was being facetious it might be suggested
that this was given simply to wash down her tablets1
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Figure 9.
Appearance of volunteer maintained during the experiment.
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Number of tablets acquired in 50 minutes.
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This type of poisoning remains dangerous with a significantly
high mortality,, In addition to those who die there are many who
are seriously ill. Serious complications may arise with little
or no warning, even when patients are being carefully monitored
both for their clinical and biochemical progress. The main
reason for this is that, despite numerous studies of the subject,
the metabolic and acid-base upsets associated with acute salicylate
poisoning remain incompletely understood. Also there have been
many different types of treatment advocated for these patients,
including extracorporeal haemodialysis, peritoneal dialysis,
exchange transfusion, anion exchange resins and various types of
forced diuresis. All have advantages and disadvantages and the
indications for the correct use of these treatments remains
largely a matter for conjecture.
The development and standardisation of an effective yet
simple form of treatment, which was sufficiently safe to make its
use appropriate in all medical units would be an important
contribution to a reduction not only in the mortality but,
perhaps more important, in the morbidity resulting from acute
salicylate poisoning.
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DIAGNOSIS OF ACUTE SALICYLATE POISONING
Acute salicylate intoxication may result from a number of
different preparations of salicylic acid and by a number of
different routes. Acetyl salicylic acid was first introduced
to medicine in 1899 by Dreser and marketed by Bayer under the
trade name of aspirin as a palatable and non-irritant form of
salicylic acid. ASpirin is now sold by the ton and, quite apart
from its wide therapeutic use by the medical profession, the
lay public take it with great frequency and all too often with
gay abandon for every conceivable complaint. It is no surprise,
therefore, that this preparation of salicylate is by far the most
commonly taken in overdosage. Sodium salicylate, although an
older fashioned preparation, is still prescribed and occasionally
may be taken in excessive amounts. Methyl salicylate (Oil of
Wintergreen, Gaultheria Oil, Betula Oil, Sweet Birch Oil), which
is the main ingredient of many counter-irritant liniments, also
maybe the cause of acute salicylate poisoning. Preparations
containing methyl salicylate are usually taken accidentally by
the inquisitive toddler but are occasionally intentionally
self-administered by adults. This is a particularly dangerous
form of poisoning as methyl salicylate is the most toxic of the
salicylates weight for weight. For example, one teaspoonful
(5 ml.) of methyl salicylate mixture is equivalent to twelve
300 mg. tablets of acetyl salicylate.
Acute salicylate poisoning occurs not only by ingestion of
the drug. It may follow the over-enthusiastic skin application
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of ointments containing salicylic acid, such as salicylic acid
ointment, B.P. and benzoic and salicylic acid ointment, N.F.
This is especially the case when extensive areas are being treated
and when the skin surface is broken, (von Weiss and Lever, 1964).
Doctors must be aware of all these possible routes of entry
if the diagnosis of acute salicylate poisoning is not to be
overlooked.
It is a common misconception amongst doctors generally
that patients with acute salicylate overdosage are unconscious.
Impairment of level of consciousness can certainly occur in
young children. In older children and adults with poisoning due
to salicylate alone, this only happens in the most severe types
of intoxication and is a rare occurrence in clinical practice
(Matthew and Lawson, 19^7). On the contrary, such patients are
characteristically very alert and hyperkinetic. So unusual
is impairment of level of consciousness that, if it occurs, the
presence of concomitant poisoning with some other toxic substance,
particularly sedative or tranquillising drugs, should be carefully
considered.
In practice, as the great majority of patients are fully
conscious, there is seldom much difficulty in diagnosis. Patients,
especially those with self-poisoning, frequently either exaggerate
or understate the dose which they have taken; but only a few
deny having taken the tablets. In these, provided the diagnosis
is considered, the clinical features are usually sufficiently




The effects on the nervous system function are numerous.
Headache, dizziness, tinnitus, deafness, dimness of vision,
apprehension and mental confusion may all be present in moderately
severe or even mild acute salicylate poisoning (Robin, Davis and
Rees, 1959; Done 1965; Goodman and G-ilman, 1965). In young
children, drowsiness, convulsions and frank coma are not uncommon
even when relatively small quantities of salicylate have been
ingested. In older children and adults in severe overdosage
effects on the central nervous system may become more pronounced
and include delirium, mania, hallucinations, generalised
convulsions and loss of consciousness. This fully developed
syndrome has been called the "salicylate jag" (Goodman and
Gilman, 19^5)• The toxic effects of salicylate on the central
nervous system may result in a clinical presentation very similar
to hysteria. Unless the possibility of acute salicylate over¬
dosage is considered serious errors in diagnosis may be made.
Cardiovascular
The circulation is generally hyperactive with tachycardia
and a full bounding pulse. Sustained 'shock' may occur but is
an unusual complication. On the other hand sudden cardiovascular
collapse is a well recognised mode of death, (Done, 1965).
Respiratory
Hyperpnoea is a veiy common feature of salicylism. This
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effect is probably mediated by the anterior hypothalamus, since
lesions in this area may reduce or totally abolish the stimulatory
effect of salicylate on ventilation (Robin and Hume, 19^5). Acute
pulmonary oedema may occasionally occur (Granville-Grossman and
Sergeant, 1960) and is considered to be due to sodium retention.
Acute respiratory arrest may occur and is the usual terminal
event resulting in death, (Done, 1965)*
i
G-astro-intestinal
Toxic effects on gastro-intestinal function are usually
prominent. Epigastric tenderness and actual pain, nausea,
vomiting and anorexia are all common. According to Goodman and
Gilman (1965)> more than half of the individuals with even moderate
salicylate poisoning have nausea. It is fortunate, indeed, that
so many patients do in fact vomit shortly after having taken the
tablets, as, by doing so, they may lose a considerable number of
the aspirins taken and not infrequently save themselves from very
severe salicylate poisoning. Haematemesis due either to the
local irritant effect on the gastric mucosa or else to the bleeding
tendency which some patients develop as a toxic effect of the
absorbed salicylate may occur but is less frequent than many
authors suggest.
Renal
Oliguria is commonly found as the great majority of patients
are dehydrated to a greater or lesser degree. The effects on
renal function of acute overdosage of salicylates varies, depending
on whether or not the patient has been taking regular therapeutic
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doses of the drug in the period immediately before the acute
poisoning. If the patient has not recently been exposed to the
drug, albuminuria, urinary casts and a sharp increase in the urine
cell count will be found. The cells are predominantly renal
tubular cells (Scott, Penman and Dorling, 1963; Prescott, 1965)»
but red cells and leucocytes are also present in considerable
numbers. The presence of albuminuria and celluria does not
necessarily indicate serious renal damage (Smith and Smith, 1966).
According to Scott et al., (1963)* the rise in urine cell count
is a transient finding and there is a refractory period of about
a month during which further salicylate insult to the kidneys
produces only a diminished response.
Gross and Greenberg (1948) concluded that salicylates in
acute overdosage could cause nephritis and acute tubular necrosis
has been described by Bracey (1951 )> locket (1957)> Campbell an<^
Maclaurin (1958) and Granville-Grossman and Sergeant (i960).
Further evidence of tubular damage due to large doses of salicylate
was presented by Ben-Ishay (1964) who reported aminoaciduria in
adult males. From these findings there is little doubt that acute
overdosage of salicylates can result in renal damage but Ghose and
Joekes (1964) and Smith and Smith (1966) regard the incidence of
acute renal failure in this condition to be rare.
Haematological
These changes are seldom marked and only occasionally cause
problems in management. The most frequently reported blood disorder
which occurs is a bleeding tendency due to hypoprothrombinaemia.
■iuick and Clesceri (i960) demonstrated that this was due to
decrease of Factor VII. They also found that the dose of
salicylate required to cause even a slight prolongation of the
prothrombin time was relatively large (6.0 g. per 70 kg.).
This would require the ingestion of approximately 20 standard
tablets of aspirin. Bleeding tendency during acute salicylate
poisoning may also result from increased capillary fragility
(Frick, 1966; Smith and Mackinnon, 1951)* thrombocytopenia
(Rappaport, Nixon and Barker, 1945) or impaired platelet
stickiness (Beaumont, Willie and Lenegre, 1955)*
Intravascular haemolysis occasionally may occur to
a significant degree.
Metabolic
Hyperthermia is a common feature of acute salicylate
poisoning. In older children and adults this is usually mild
and seldom gives rise to a serious problem of management (Smith
and Smith, 196$). In young children, however, there is frequently
severe pyrexia and fatalities may occur (Segar and Holliday, 1958).
Hie mechanism of the hyperthermia is increased heat production
at tissue level due to the uncoupling action of salicylate on
oxidative phosphorylation. This allows the energy produced to
be dissipated as heat rather than stored, as is normally the case.
As a result of hyperthermia, sweating is a common finding. This
may be profuse and contributes to the development of dehydration,
which may be severe.
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-^ute salicylate poisoning is almost invariably associated
with an abnormality of acid-base equilibrium and the severity nnd
complexity of the upset is closely related to the severity of the
overdosage. The mechanism of this abnormality has interested
many but is still not completely understood. Until quite recently
it was generally accepted (Singer, 1954; Segar and Holliday, 1958;
and Winters, White, Hughes and Ordway, 1959; Eichenholz,
Mulhausen and Redleaf, 1963) that the general sequence of events
was an initial respiratory alkalosis which progressed to metabolic
acidosis. However more recently (Winters, 19&3; McLaughlin,
1965; and Smith, 1966) have supported a somewhat more rational
approach in so far as they suggest that there is always a mixed
disturbance with multiple simultaneous independent actions each of
which may result in imbalance of acid-base equilibrium in one
direction or another. The net result in any one patient will
depend on the individual response to the poisoning and also to
other factors such as age. It is well known for example that
infants and toddlers are peculiarly sensitive to acid-base
shifts in acute salicylate poisoning. They characteristically
develop a severe metabolic acidosis whereas in older children
and in adults, the usual finding is predominantly that of
respiratory alkalosis. The exact mechanism of these abnormalities
remains highly controversial and reports in the literature may at
times be remarkably contradictory. On the other hand, it is
very important to recognise that whatever the mechanism the net
result is a complex disturbance.
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Smith (1966) has summarised the situation as far as is
known at the present time. He points out that the acid-base
disturbance of the acute salicylate poisoning may be described





The respiratory alkalosis results from the stimulation of
the medullary respiratory centre by salicylate itself. It is
generally agreed that at least a partial explanation of this
stimulation is that salicylate increases the sensitivity of the
respiratory centre to relative changes in the partial pressure of
COg and the pH of arterial blood (Alexander, Spalter and West,
1955; Tenney and Miller, 1955)« Williams, Winters, Clapp,
Hollander and Welt (1958) suggested that this effect of salicylate
may be mediated by its effect in stimulating metabolic oxidative
reactions. '^his, however, has not been established. The
ability of salicylate to produce hyperventilation appears to
be mediated by the anterior hypothalamus since damage in this area
may reduce or totally abolish the stimulatory effect of salicylate
on ventilation, (Robin, et al., 1959)-
As a result of the increased alveolar ventilation, which may
be sustained for long periods of time during the poisoning, there
is a consequent fall in the partial pressure of carbon dioxide
(pCOg) in the alveolar air and also in the arterial blood.
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Initially, this disturbance results in a rise in the arterial
blood pH, which is limited by compensatory buffer mechanisms
including haemoglobin/oxyhaemoglobin and the secretion of an
alkaline urine containing bicarbonate together with an exchange
of intracellular hydrogen ions for extracellular cations. An
actual alkalaemia only occurs if the compensatory mechanisms do
not operate sufficiently adequately to prevent a significant
change in blood pH. The degree to which alterations in blood
pH occur by this mechanism, therefore depends on the integrity of
these buffer mechanisms. It therefore, depends on the severity
and duration of the poisoning and amongst other functions on the
integrity of kidney function.
Some authors have reported their experience in the use of
various measures to reduce the increased respiratory exchange
in salicylate intoxication. Harvie and Singer (1955) attempted
to do this by administering a gas mixture with a high carbon
dioxide content. Eichenholz, Mulhausen and Redleaf (1963)
claimed that they were able to prevent the onset of the subsequent
metabolic acidosis by administering a mixture of 4 per cent
carbon dioxide in air, thereby preventing any reduction in blood
pCO^ level. There are, however, objections to this form of
treatment. The respiratory centre is already more sensitive to
the effect of changes in pCC^ and administered carbon dioxide
would ultimately produce depression of the respiratory centre.
Ereier, Real, Misbet, Rees, and Wilson (1957) concluded that the
inhalation of carbon dioxide in acute salicylate poisoning was
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effective only at the expense of accentuated respiratory dysfunction
and that its use required very skilled administrations together
with close control and monitoring of respiratory function involving
highly developed techniques.
Respiratory depressant drugs such as barbiturates and other
sedatives have also been used by Rapaport and Guest (1945) to
eliminate the hyperpnoea of the poisoning. It was found, however
that salicylates seemed in some curious way to increase the
sensitivity of the subjects to these drugs. Even average doses
of barbiturates resulted in prolonged coma and in some experimental
animals in death. On the whole, no specific treatment for the
respiratory alkalosis need or should be given (G-hose and Joekes,
1964).
Respiratory Acidosis
A now well known metabolic effect of salicylates is their
uncoupling action on oxidative phosphorylation reactions. The
degree to which this occurs is proportional to the severity of
the overdosage. As a result of this uncoupling action there is
an increased metabolic production of carbon dioxide at tissue
level due to increased substrate oxidation. Direct experimental
evidence in favour of this mechanism has been provided in the
dog by Tenney and Millar (1955) and in the rat by Smith (1959).
This effect must also occur in humans as it has been demonstrated
that salicylate will increase the basal oxygen consumption,
(Hetzel, Charnock and Lander, 1959). Respiratory acidosis will \
therefore result in a rise in pCOg.
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There are therefore two apparently opposing effects on the
pCOg levels and the net result will depend upon the relative
intensity of the two mechanisms. In practice increase in alveolar
ventilation as a result of the intense hyperpnoea of acute
salicylate overdosage is so marked that the pCOg falls, resulting
in a net respiratory alkalosis.
Metabolic Acidosis
The metabolic acidosis of acute salicylate intoxication is
as yet incompletely understood. However, Winters et al. (1959)
demonstrated that the plasma of these patients contained
a significant fraction of undefined anions. They considered that
these anions of organic acids were the main reason for the fall
in buffer bicarbonate. Other factors including the salicylate
itself, have been suggested as being contributory towards the
metabolic acidosis. Winters and his associates (1959), however,
have demonstrated that the contribution of the salicylate is
relatively small. For example, a plasma salicylate concentration
of 70 mg. per 100 ml. is equivalent to only 5 mM* Hyperchloraemia
has also been suggested as a contributory factor in the acidosis.
Winters and his colleagues rejected this concept and considered
that any rise in plasma chloride was only the result of secondary
compensatory changes and not the primary cause of the acidosis.
Eichenholz et al. (19^3) reported that there was an increase
in the concentrations in the blood of pyruvate and lactate in dogs
poisoned with salicylate, but Done (19&3) found that the plasma
lactate level was normal in patients with this type of overdosage.
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On the other hand, he agreed that pyruvate levels were elevated
in the plasma of children with salicylate poisoning, but he did
not feel that they were sufficiently high to account for the
overall acidosis which was present. Increases in the levels of
the acidic ketone bodies, aceto-acetic acid and p-hydroxy-butyric
acid both in plasma and in urine have been recognised for some
considerable time, (Barnett, Powers, Benward and Hartmann, 1942
and Erganian, Forbes and Case, 1947).
In a detailed study of organic acids in salicylate
intoxication Schwartz and Landy (1965) concluded from their data
that the major factor in the development of metabolic acidosis
in salicylate poisoning was the excessive production of organic
acids. In addition to acidic ketones there was also a considerable
increase in organic acid production from the Kreb's cycle. Since
all these acids have pK's below those of the major physiological
buffers, the latter are displaced isohydrically by the organic
acids until these are metabolised or excreted in the urine. An
accumulation of organic anions in the plasma may result from two
separate actions. Firstly, the increase in substrate oxidation
as a result of the uncoupling action of salicylates leads to an
increased formation of pyruvate. Secondly, salicylate has been
shown to inhibit several Kreb's cycle enzymes including <y-Keto-
butyric dehydrogenase and succinic dehydrogenase (Kaplan, Kennedy
and Davis, 1954). Results of such an inhibition would result
in interference with the Tricarboxylic acid cycGe. Smith (1966)
has suggested that salicylate also affects glutamate metabolism
via inhibition of glutamic-pyruvic transamination. As a result
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of these enzyme inhibitions there will be a reduction in the
conversion of pyruvate to either lactate or alanine. So pyruvate
ion will accumulate and its conversion to acetyl coenzyme A will
be increased. The acetyl coenzyme A formed will not completely
enter the tricarboxylic acid cyle because of the above enzyme
inhibitions and there will result an accumulation of organic
acids such as malate, fumarate and citrate. Also much of the
acetyl coenzyme A which fails to enter the tricarboxylic acid
cycle, will be converted to aceto-acetyl coenzyme A and this would
lead to an increased production of aceto-acetic acid and B-
hydroxy-butyric acid with resultant ketosis. Yoshida, Metcoff
and Kaiser (l96i) have confirmed the defects in the above enzymes
in in-vitro studies on tissues and in addition they have demonstrated
numerous other enzymes defects but the significance of these
remains rather uncertain and will require further research.
The effects of the metabolic acidosis in patients with
acute salicylate intoxication varies very markedly with age.
Infants and toddlers have been shown to be remarkably sensitive to
the development of metabolic acidosis, and Done (19&3) reported
that there was a direct age relationship to the increase in plasma
anions noted, but this was not found to be the case when the
relationship was examined for pC02 in the blood. In regard to
the respiratory components of the acid-base upset there appears
to be little or no age relationship and all patients would appear
to be equally prone to these abnormalities.
The metabolic effects of salicylate in interfering with
tissue enzyme actions is not confined to the carbohydrate metabolism
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and Bodie in 1956 demonstrated that there was also an impairment
of fatty acid metabolism which would also tend to promote keto¬
acidosis.
Summary
The total sequence of events which might lead to the
acid-base disequilibrium, which occurs in acute salicylate over¬
dosage may be summarised (Fig. 11:). The phase of respiratory
centre stimulation results in a decrease in carbon dioxide tension,
a rise in blood pH and the excretion of bicarbonate buffer in the
urine. According to the isohydric principle all other buffers
are affected so that a redistribution between haemoglobin and
bicarbonate occurs in the blood. At this stage an increase in
pyruvate and lactate production together with the excretion of
bicarbonate results also in some depletion of buffer although
respiratory alkalosis is present. As the other effects of
salicylate become manifest in diverse tissues, such as muscle,
liver, kidney and brain, related production of organic acids
increases and exceeds the rate of metabolism and/or excretion of
these via the urine. Under such circumstances a metabolic
acidosis rapidly supervenes because these endogenous acids are
inadequately buffered. The excretion of these metabolic acids
does not restore displaced buffer completely since they are
relatively stronger acids. When the urinary pH exceeds 5> more
than 50% of the organic acids must be excreted in the ionised
form, rather than an unassociated acid. To the extent that the




Sequence of events leading to acid-base imbalance in acute
salicylate poisoning.
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homeostatic mechanismsfor restoration of this buffer loss are
the excretion of ammonia and of additional titratable acid as
phosphate. Both of these mechanismsare limited in such a rapidly
developing acidosis.
Electrolyte Changes
It must be remembered that when the rapid changes in
hydrogen ion concentration in the blood occur as described
above the compensatory buffer mechanism are stretched to the full
and as these mechanisms take place, particularly those of the
kidney, secondary effects may occur. Appreciable amounts of
sodium and potassium may be lost in the urine and if this is
associated with other losses of these ions to the body for
example by vomiting and by sweating then body stores of sodium
and potassium may become depleted. The importance of the hypo¬
kalemia which results from the respiratory alkalosis from acute
salicylate poisoning has been stressed by Robin, Davis and Rees
in 1959. The occurrence of hypokalaemia with metabolic alkalosis
is well known. The development of this problem in respiratory
alkalosis is, however, less well recognised. In 1955* ELkington,
Singer, Barker and Clark reported studies on the acute metabolic
effects of respiratory alkalosis under experimental conditions.
They failed to demonstrate any marked cellular or renal potassium
shifts during voluntary hyperventilation. The studies however
were carried out over a very short period of time and the
stimulus to hyperventilation was a mild one. In salicylate
intoxication on the other hand there is a very high respiratory
minute volume which may bp maintained for many hours (Robin et al.,
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1959)• As a result of this the alkalosis may be severe and
prolonged.
There are several factors responsible for the development
of hypokalaemia during alkalosis. An alkaline pH tends to shift
potassium out of the extracellular and into the intracellular
compartment in exchange for hydrogen ions. This shift may
produce hypokalaemia without total body potassium depletion and
hypokalaemia itself may produce electrocardiographic and neuro¬
muscular changes independent of changes in the total body
potassium stores (Robin et al., 1959). A second factor is that
alkalosis may produce hypokalaemia and ultimately potassium
depletion because of excessive renal loss. thirdly salicylates
themselves have been shown to have a direct effect on the renal
tubular mechanisms involved in potassium excretion resulting in
a further increased loss of potassium in the urine.
The primary renal mechanism for the development of potassium
depletion in alkalosis is related to the ion exchange mechanism
for the distal tubular reabsorption of sodium whereby potassium
is secreted into the urine and is closely involved in the
mechanism for the acidification of the urine, (Berliner, Kennedy
and Orloff, 1951). There is a competition between potassium
and hydrogen ions during the distal tubular reabsorption of
sodium. In alkalosis the deficit of hydrogen ions favours the
exchange of potassium for sodium leading to significant depletion
of potassium ion from both the intracellular and extracellular
spaces.
A further significant factor undoubtedly operative in
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patients with salicylate intoxication is the mutual aggravation
of alkalosis and potassium depletion. With a stimulus for the
renal secretion of potassium, the entrance of hydrogen ion into
the intracellular compartment will aggravate the extracellular
alkalosis providing further stimulus for potassium depletion.
The secretion of an alkaline urine is not an invariable
finding in respiratory alkalosis and it is well known that in
other forms of alkalosis a 'paradoxical' aciduria may occur
(Gamble and Ross, 1925 and Robin et al., 1959). The exact
cause of this is not entirely clear. It has been suggested that
it is due to the potassium depletion primarily and to the
consequent decrease in relative availability of potassium ion in
competition for hydrogen ion in the distal reabsorption of sodium,
(Berliner and Kennedy, 1948). Another explanation, which has
been offered, is that it may be due to the relative cellular
acidosis following the exchange between the extracellular and the
intracellular spaces of hydrogen ion for potassium ion during the
development of potassium depletion and alkalosis (Cooke, Segar,
Cheek, ^orille and Barrow, 1952). Whatever the cause the result
in either case is the production of an acid urine despite a severe
systemic alkalosis.
Alterations in plasma sodium are quite frequently found but
the significance of this in itself is rather difficult to assess.
Granville-G-rossman and Sergeant, (19^0) suggested that acute
pulmonary oedema may occur as a result of sodium retention. The
evidence for this however is rather incomplete. Plasma electrolyte
patterns encountered in patients with acute salicylate poisoning
particularly in infants and children are often those of dehydration
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and there is no doubt that plasma electrolyte patterns in
themselves may be difficult to interpret. It is therefore
important to consider every facet of an individual case in order
that appropriate treatment may be given.
On the whole the diagnosis of acute salicylate poisoning
on clinical grounds is not difficult as the features of salicylism
are familiar to all practising doctors. There is no doubt, however
that in a minority of patients especially those who deny having
taken the poisoning, the features may not be characteristic.
Further difficulties arise as the clinical features may sometimes be
present at very low levels of plasma salicylate or they may be
absent even when the patient is severely poisoned. In addition,
particularly in patients who indulge in self-poisoning, the
classical features of salicylate intoxication may be obscured by
the patient having taken some other preparation, in particular
sedative and hypnotic drugs.
In terms of clinical presentation acute salicylate overdosage
may mimic a number of other well-recognised clinical presentations.
These include frank hysteria and organic delirium. The patient
may be thought to be suffering also from diabetic ketosis as
glycosuria and ketonuria may be found in acute salicylate poisoning.
Also as papilloedema may be a feature of this particular poisoning,
a diagnosis of intracranial space occupying lesion may be
mistakenly made, and the patient exposed to all manner of unpleasant
and even dangerous procedures.
For all these reasons it is clear that clinical diagnosis
alone may be very uncertain. A more certain proof of salicylate
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overdosage is required and is provided by measurement of the plasma
salicylate level. There are a number of commonly used means of
analysis of salicylate in biological fluids. These include the
colorimetric methods of Brodie, Udenfriend and Coburn, (1944),
and more recently described by Routhand Jkyer, (1961.) Other methods
include those of Smith and Talbot (1950) and of Trinder (1954)
as described by Macdonald (1965). The first of these is perhaps
the most sensitive and specific but the second is subject to
interference from a number of other drugs notably phenacetin and
phenolphthalein. Trinder'snethod is the least sensitive of those
mentioned and it also has the disadvantage that the absorption
spectrum of the ferric salicylate complex may be rather ill
defined and is subject to changes in external factors such as
temperature, pH and ionic strength. If phosphates are also
present in the mixture they interfere by preferentially kelating
with the reagent. These limitations are particularly troublesome
in measuring salicylate in urine, but in the case of plasma the
results can be obtained with adequate reproducibility and accuracy
in the range from 25 to 75 per "100 ml., which for clinical
purposes is the most important. A great advantage of Trinder's
method is that it is technically very simple and can be carried
out in approximately 10 minutes. for these reasons Trinder's
method is the most suitable for clinical purposes and may even,
with relative ease, be set up as a side room procedure. The
technique has been described in some detail by MacDonald (1965).
The reaction is carried out on specimens of heparinised venous
blood and the equipment required consists simply of disposable
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tubes (10 ml. plain bottles, Stayne Laboratories Ltd.). The
absorbance is measured in standard cuvettes (Eel spectra).
REGIME
Principle




2. Standard salicylate solution 40 mg./lOO ml.
which is kept in a refrigerator.
Procedure
1. Centrifuge 5 ml. heparinised blood and separate
the plasma.
2. Set the Eel spectrophotometer to a wavelength (520 myt).





Trinder's reagent 4.5 ml. 4.5 ml. 4.5 ml.
4. Mix well and allow to stand for five minutes.
5. Centrifuge and remove the clear supernatant carefully with
a pasteur pipette and transfer to a clean dry tube for
measurement.
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6. When the machine is sufficiently heated for stable recording
the three solutions Blank, Test and Standard are transferred
in rotation to the flow cell and the measurements made.
The scale reading gives mg. of salicylate per 100 ml. plasma
directly.
7. After use wash out flow cell with 1 N BEL and allow to drain
then rinse with water and allow to drain.
8. If more than one 'unknovai' is being read rinse the flow
cell with reagent blank.
In practice, this very simple and rapid technique will
provide a definitive confirmation or exclusion of the diagnosis
of acute salicylate poisoning. The plasma salicylate level
should always be done whenever this poisoning is suspected. In
particular it is wise to perform this simple test in any patient
with otherwise unexplained pyrexia, hyperpnoea, nausea or vomiting.
Also a diagnosis of hysteria or delirium should be made only after
due consideration of the possibility that the patient is suffering
from an overdosage of salicylates.
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ASSESSMENT OF THE SEVERITY OF ACUTE
SALICYLATE POISONING-
The intensity of treatment given to any individual patient
depends upon the severity of poisoning. The assessment of the
severity of the intoxication in acute salicylate overdosage is
unfortunately not a simple matter. There are three basic
approaches to the problem. These are,
Clinical Assessment of the Patient
Measurement of Plasma Salicylate Level
Estimation of the Acid-Base Upset.
In the two periods 1st October, 1963 to 1st October, 1964
and from 1st October, 1965 to 1st June, 1967 there were 307
patients (127 males and 180 females) admitted with acute salicylate
poisoning to the Poisoning Treatment Centre, Royal Infirmary,
Edinburgh. Of these 84 patients (39 males and 45 females) were
considered to have moderate or severe poisoning (Pig. 1?). From
this histogram it will be seen that, although these 84 patients
were selected in terms of severity of poisoning, their age and
sex distribution was very similar to that of the total group of
patients. The remaining patients were mildly poisoned and
presented no problem of treatment. For these reasons, the
assessment of patients with acute salicylate overdosage will be
discussed tinder the above three headings with specific reference
to the 84 patients with moderate or severe poisoning.
Clinical Assessment of the Patient
There is general agreement that clinical assessment of the
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Histogram of the Age and Sex distribution for 307 patients with
Acute Salicylate Poisoning. Inset - Corresponding histogram for
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Comparison between the age and sex distribution of the
patients with moderate or severe poisoning compared with
the total number of admissions due to acute salicylate
poisoning.
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patient alone not only is not very satisfactory in this condition,
but may befrankly misleading (Done, I960; Rea and Robertson,
1963; Beveridge, Forshall, Ivfunro, Owen and Weston, 1964; Brown,
Cameron and Matthew, 1967 and Smith, 1967)• The clinical
assessment is complicated by variable sensitivity of individuals
to the drug, (Smith 1966) and also by the time which has elapsed
since moment of ingestion of the salicylate. Clinical features
of acute salicylate intoxication are well known (Goodman and
Gilman, 1965) and have been described in some detail in the
previous chapter. The clinical features of acute salicylism are
sufficiently characteristic, when they are present, to be of
assistance in diagnosing that the patient is suffering from
salicylate overdosage, but will give little indication of the
severity of the poisoning. It is true that some features, part¬
icularly severe and sustained hyperpnoea, impaired level of
consciousness, and cardiovascular depression are indications
of severe poisoning. On the other hand several authors (Done,
1960 and 1965; Rea and Robertson, 1963? Brown et al, 1967 and
Smith, 1967) have reported patients, who present with few or no
clinical signs or symptoms and who have nevertheless ingested
a large amount of salicylate. In short most authorities would
agree with Cumming, Dukes and Widdowson (1964), who stated that
in general the clinical features of acute salicylate poisoning
in older children and adults provide little information, which
may be regarded of prognostic value.
Complex acid-base disturbances may occur and are influenced
by the dose of salicylate taken, the duration of poisoning,
antecedent illness, and most importantly, the age of the patient.
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The net result of these disturbances may be either alkalosis,
particularly in adults, or acidosis, especially in young children.
It might be expected that such gross disturbances would lead to
fairly typical patterns of clinical presentation. Robin et al.
(1959) were, however, at pains to stress that the clinical
features of both alkalosis and acidosis in acute aspirin poisoning
are to all intents and purposes identical. Hyperventilation is
regarded by many as being a feature of acidosis as a result of the
increased hydrogen ion concentration stimulating the respiratory
centre. Hyperpnoea, however,my also be present and is
frequently of the Kussmaul type in salicylate poisoning even in
the presence of severe alkalosis. This results from the primaiy
effects of the salicylate in stimulating the respiratory centre.
Also patients may be flushed due to marked vasodilatation,
and will have a high cardiac output with bounding pulse, tachycardia
and marked apical impulse both in the presence of respiratory
alkalosis or metabolic acidosis. These facts are not widely
appreciated and as a result many have been misled into a wrongful
interpretation of the clinical features in terms of acid-base
status (McLaughlin, 1965)• The clinical features found in the
84 patients with severe acute salicylate intoxication admitted to
the Poisoning Treatment Centre, Edinburgh Royal Infirmary are
shown in Table VII.
Tinnitus and Deafness
These are frequently regarded as cardinal symptoms of acute
salicylate poisoning. It is therefore of interest to note that
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TABLE VII
















Renal Impairment 1 1.2
No Symptoms 8 9*8
The clinical features found in 84 patients with severe acute
salicylate poisoning.
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in this series these features were present in only a proportion of
the patients studied. Also no close relationship between the
plasma level of salicylate and these features was noted. Indeed
many of the patients with the highest plasma levels did not suffer
from any auditory disturbance. fcjyers, Bernstein and Fostiropolous
in 1965 reported a clinical study on salicylate ototoxicity and
found that in overdoses of this drug the presence of ototoxicity
was directly dose related and was not commonly found in patients
who had blood salicylate levels below 30 mg. per 100 ml. It is
a reasonable assumption, therefore, that if tinnitus and deafness
are present in a patient, who has recently taken an overdosage
of aspirins, that patient is likely to have a plasma level of
salicylate of 30 mg. per 100 ml. or above. These features will,
however, give no more precise indication of the severity of the
poisoning in an individual case.
Sweating and Pyrexia
Sweating was a fairly common feature in this group of
patients and was a contributory factor in the development of
dehydration. It is interesting, however, to note that twice as
many patients had severe sweating as those who were found to have
significant pyrexia. Significant pyrexia was regarded as any
patient having a recorded rectal temperature consistently in
excess of374°G. None of the patients had marked fever and it
presented no serious problems of therapy. The highest temperature
recorded in any patient was -6 ar>h. it rapidly returned to
within normal limits during the course of treatment.
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Hyper-reflexia
Exaggeration of the limb reflexes was present in
approximately one in five of the patients studied and when present
it was a rather striking feature. It usually occurred in
patients in whom generalised agitation and restlessness was
a marked feature. None of the patients on admission showed any
features of tetany and all the patients had normal plantar responses.
Agitation and restlessness
Hyperkinesis and general agitation was a prominent feature
in about a third of the patients. In itself it did not cause
any serious problems of management and it settled down fairly
rapidly after specific treatment for the poisoning was given.
Its main importance was that it could resemble a hysterical
syndrome very closely and in these patients, unless salicylate
overdosage is considered, there is a danger that the correct
diagnosis may be overlooked. None of the patients in this series
showed any evidence on admission of impaired level of consciousness.
Hyperpnoea
Hyperventilation was a very prominent and common sign.
It may he readily overlooked particularly in patients who have
features of agitation and so the significance of this valuable
feature may not be appreciated. It tended to occur particularly
in patients who were very severely poisoned and this would confirm
the suggestion of G-hose (1967) who suggested that hyperpnoea
could be used as a useful index of the severity of the poisoning.
This index of severity of poisoning must be used with some caution,
Ly
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however, especially in patients who have indulged in self poisoning,
as these patients may be very anxious and excited and these states
in themselves may result in overbreathing. Another interesting
feature of the hyperpnoea observed subsequently in these patients
was that it tended to persist for many hours, even when the plasma
salicylate had fallen to what would be otherwise regarded as a non¬
toxic level.
Tachycardia
As with hyperpnoea, tachycardia was a prominent and common
feature in these patients. Also, on the whole, the degree of
tachycardia was related to the severity of the overdosage. It
is, on the other hand, a very non-specific clinical sign and the
reservations and precautions stressed regarding the use of
hyperpnoea in the assessment of the severity of the poisoning, are
even more pertinent in the case of tachycardia.
Hypotension
This was present in three of the patients studied.
Hypotension was regarded as being present when the systolic blood
pressure fell below 90 mm. of mercury in a patient over the age
of 50 and below 80 mm. of mercury in younger patients. This
was not a very serious complication in the three patients, as in
each case the fall in blood pressure was not marked and was
relatively transient. In all cases the hypotension responded
to simple elevation of the foot of the bed and required no more
active therapy. So mild was it that all of the patients
subsequently had a successful form of forceddiuresis treatment.
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Nausea and Vomiting
These are commonly considered to be frequent and marked
features of acute salicylate poisoning. In this series nausea
was a prominent feature in only about one third of the patients
and actual vomiting occurred in only one patient in four. None
of the patients developed haematemesis, but four patients,
during gastric aspiration and lavage were noted to have slight
bleeding in the recovered fluid. This was regarded as probably
traumatic in origin rather than the result of a primary effect
of the drug overdosage.
Renal Impairment
Mild impairment of renal function was demonstrated in only
one patient. This developed subsequent to forced diuresis
therapy and simply took the form of a mild rise in the plasma urea
level to 60 mg./lOO ml. This subsequently returned to within
normal limits quite spontaneously and no further action was
required. Renal impairment is generally reported to be a very
uncommon finding in acute salicylate poisoning, (Robin et al.,
1959; Beveridge et al., 19^4 and Done, 1965)• It is however
very important to remain always vigilant for the development of
impairment of renal function in this overdosage, as forced diuresis
therapy, which is dependant on good kidney function, is frequently
used.
No Symptoms
Eight of the patients had no symptoms or signs of acute
salicylate poisoning, despite the fact that they had all ingested
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large amounts of aspirin and all had high levels of plasma
salicylate. Even the rather non-specific but commonly found
signs of hyperpnoea and tachycardia were absent. This serves
to emphasise the possible difficulties of assessing patients with
acute salicylate toxicity on a clinical basis and confirms
similar findings in several other reports (Schreiner, Berman,
G-riffin and Eeys, 1955; Rea and Robertson, 1961 j and Beveridge
et al., 1964). absence of symptoms and signs of salicylism
in no way excludes the possibility that an overdosage of aspirin
has been taken. None of the patients in the total group showed
any significant features of haemorrhagic disorder.
Hypoprothrombinaemia
In almost every textbook in which the treatment of acute
salicylate poisoning is discussed doctors are advised that vitamin
Kj should be given to counteract the development of hypo¬
prothrombinaemia in acute salicylate overdosage. In Table VIII
results are shown for prothrombin ratios which were carried out
on 25 consecutive patients suffering from severe salicylate
poisoning. Significant impairment of the prothrombin time was
considered to be present when the prothrombin ratio was higher
than 1.25. On this basis only five of the 25 patients studied
had any real impairment of prothrombin time. The highest
prothrombin ratio measured was 1.5. This occurred in a patient
with the relatively low peak salicylate level of 44 mg. per
100 ml. Three other patients had prothrombin ratios of 1.4 and
the corresponding peak plasma salicylate levels were 5&» 60 and 50
mg. per 100 ml. respectively. In the fifth patient who had
TABLE VIII
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PLASMA SALICYLATE (mg. per 100 ml.)




Relationship between peak plasma salicylate level and prothrombin
ratio (prothrombin time ^JJ^f^trol^ in 25 Patients vd-th-
acute salicylate poisoning.
- 64 -
a prothrombin ratio of 1.3 the peak plasma salicylate level was
63 nig. per 100 ml. Prom these figures, therefore, hypo-
prothrombinaemia is seldom likely to be a serious hazard in acute
salicylate poisoning. Also there was little relationship
between the degree of prolongation of the prothrombin time and
the peak level of plasma salicylate. None of the patients showed
any bleeding tendency. Quick and Clesceri (i960) discovered
that the increased prothrombin time caused by salicylates in man
was due to a decrease in the stable factor, Factor VII. They
also found that in normal subjects a dosage of acetylsalicylic
acid of 6 g. per 70 kg. of body weight was required to demonstrate
even a slight prolongation of the prothrombin time.
In acute salicylate poisoning there are several other factors
which may promote a bleeding tendency. These include capillary
fragility (Prick, 1956); thrombocytopenia (Rappaport, Nixon and
Barker, 1945) and decreased adhesiveness of blood platelets
(Beaumont, Willie and Lenegre, 1955). There is considerable
doubt, therefore, (Smith, 1966) that hypoprothrombinaemia is the
main causative factor in haemorrhage in acute salicylate poisoning
and its importance as a serious toxic effect of this drug has
almost certainly been overstated. The results of the prothrombin
ratios, admittedly on only 25 patients, supported Smith's
reservations. For these reasons and as haemorrhage is in fact
an uncommon complication of acute salicylate overdosage, it was
decided that vitamin K. supplements would not be given in a routine
manner to any of the patients subsequently studied in this
investigation.
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In conclusion, from the point of view of clinical assessment,
in any patient suspected of suffering from acute salicylate
poisoning, the presence of prominent signs and symptoms particularly
tinnitus, deafness, hyperpnoea, tachycardia and sweating, indicates
that the patient is probably suffering from a significant overdosage
of the drug. These features however, will give no indication
beyond this of the actual severity of the poisoning. It must
always be remembered that the familiar clinical symptoms or signs
of salicylism may be absent even when the patient is very severely
poisoned.
Plasma Salicylate Levels
Measurement of the plasma salicylate level is an essential
part in the investigation of any patient suspected of having
this poisoning. In addition to confirming the diagnosis
admission levels of blood salicylate have been advocated as
a very valuable means of assessing the severity of the intoxication
(Beveridge et al., 1964; Brown et al., 1967)# ^he use of
isolated observations of blood salicylate levels as a means of
assessing the poisoning, has been criticised by several authorities
including Done (i960), Rea and Robertson (1963), Cumming et al.,
(1964) and Smith (1966). They point out that a random sample
of the plasma salicylate level provides only a measure of the
c*.
resultant effect of elementary absorption, renal excretion and
biotransformation of the ingested salicylate. There is therefore
always the possibility that subsequent measurements of the plasma
salicylate may show very considerable rises compared with the
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initial admission level and so may not provide accurate
information of the actual severity of poisoning. This fact
has been accepted by Brown et al. (19^7) who pointed out that
serial estimations may be required in order that a full and
adequate assessment of the situation may be made.
As with many other poisonings there is also the problem
of individual variation of response to salicylate, which in
certain instances may be quite striking. Riley and Worley (1956)
reported five deaths occurring in children who had maximum
salicylate levels of from only 20-40 mg. per 100 ml, despite the
fact that some authorities have quoted 35-40 mg. per 100 ml. as
a relatively safe range (Spector, 1958).
Done (1960) in particular, has produced evidence that
isolated and random levels of the plasma salicylate may be
extremely misleading. In 38 patients he found that there was
little correlation between the salicylate levels measured and
the severity of poisoning as assessed on a clinical basis.
In an effort to correct this discrepancy, therefore, he reported
a method which allows the serum salicylate level to be considered
as a function of time. It is known that once absorption from
acute ingestion is complete, the rise in serum salicylate
concentration both in experimental animals and in humans assumes
the characteristics of a first-order reaction. He demonstrated
that after six hours, absorption of an ingested dose was usually
fairly complete and thereafter the serum salicylate level fell
at a relatively constant rate, which did not change appreciably
over the following 24 hours. In the 38 patients with acute
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salicylate overdosage, whom he investigated, Done then
extrapolated back and determined salicylate values to time 0 for
the highest salicylate level attained. He called these
theoretical values Sq. He then claimed that these theoretical
values correlated well with severity of toxic symptoms. He
also calculated the "half-life" of plasma salicylate and this
averaged 20 hours under normal conditions of metabolism, bio¬
transformation and excretion. The correlation which he
obtained between the magnitude of Sq and severity of symptoms
was considerably better than that obtained with the measured
salicylate value itself. Sq was calculated from the following
formula,
log Sq = log S + 0.015t
where
So = 0 time serum salicylate level,
S = the serum salicylate level in the random
blood sample,
0.015 = the mean slope of regression curve for the
serum salicylate level and
t = the time in hours between the ingestion of
salicylate and the collection of the random
blood specimen.
This calculation of Sq is subject to a number of theoretical
and practical objections. It ignores several variables governing
salicylate metabolism including protein binding, intracellular
dispersion and urinary pH. It is also based on the assumption
that a single dose of salicylate has been ingested and that the
rate of removal of circulating salicylate does not appreciably
differ from the mean "half-life" of 20 hours. The calculation
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itself also depends upon accurate information regarding the
time since ingestion of the poisoning. Many of the patients
have indulged in self poisoning and frequently exaggerate or
minimise the size of dose taken and also the time interval
which may have elapsed. For this reason the information
regarding the time interval may be extremely unreliable.
Nevertheless there is a considerable weight of evidence that
calculation of Sq has provided a useful means of clarifying
apparent discrepancies between an observed serum salicylate
level and the patient's clinical condition.
In considering the different reports regarding the value
of serum salicylate levels in the assessment of patients, it is
important to recognise that both in the series reported by
Beveridge et al. (1964) and by Brown et al. (1967) the majority
of the patients were admitted within a short period of time
after the actual ingestion of the asprin. In other reports,
including Done (1960) and Rea and Robertson (1963), the time
interval since ingestion was on the whole considerably longer
and so time factors were of much greater importance. Therefore
if the patient is admitted within six hours of ingestion
calculation of Sq is probably unnecessary and as absorption
is unlikely to be complete the Done formula is not theoretically
applicable. Under these circumstances it is more appropriate
to follow the advice of Brown et al. (1967) who suggested that
not only the actual measured level of the serum salicylate be
considered, but also the rate of change of plasma salicylate in
the period immediately following admission. They also pointed
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out that subsequent to gastric lavage being carried out there
may well be an increase in plasma salicylate level of between
5 and 10 mg. per 100 ml. in the immediate post lavage period.
All these considerations are important in the accurate assessment
of the poisoning by means of measurement of plasma salicylate
levels.
An alternative calculation of Sq has been suggested by
Cumming et al. (1964). This involves retrospective measurement
of the total absorption of salicylate which is calculated from
the total quantity recovered in the urine plus assessment of the
quantity remaining in the body after clinical recovery. This
total absorption of salicylate is then divided by a calculated
salicylate space, which is defined as the body fluid compartment
in which salicylate is uniformly distributed after intravenous
injection and for which the mean value has been found to be
0.22 1. per kg. body weight. From the point of view of assessment
of the poisoning with a view to therapy, however, this method of
Cumming et al. (1964) is unsuitable as it is of a retrospective
nature.
Most currently available methods for measuring plasma
salicylate measure total plasma salicylate, which includes both
free and protein bound salicylate. The toxic effects of this
drug are related to the amount of free salicylate present in the
circulation, Chose (1967). It may be that even greater accuracy
may be achieved by measuring the free rather than the total
fraction of salicylate. This has the very considerable
disadvantage, however, that it requires more advanced biochemical
- 70 -
technique such as equilibrium dialysis or ultra-filtration
methods (Goldstein, 1949 and Smith, Gleason, Stoll and Ogorzalek,
1946).
The relationship between the measured plasma salicylate
levels and the clinical features of salicylate toxicity present
in the patients with severe salicylate overdosage is shown in
Figure 1<3« As a result of the admission arrangements to the
Poisoning Treatment Centre at the fioyal Infirmary in Edinburgh the
great majority of patients were admitted within a short time of
having ingested the poison. In this group of 84 patients the
mean time following ingestion of the poison was 5«5 hours with
a standard error of the mean (S.E.M.) O.69. As therefore the
great majority of patients were admitted within six hours of
having taken the salicylate, the actual measured value of the plasma
salicylate was used as an index of the severity of poisoning and
Sq was not calculated. With few exceptions, patients with plasma
salicylate levels in excess of 40 mg. per 100 ml. were suffering
from definite features of acute salicylism. There were six
patients, however, who had plasma salicylates which were above what
is generally regarded as toxic levels, yet had no clinical
features which could be detected. This serves to emphasise
what has been stated previously that in a small but important
percentage of the patients significant and sometimes serious
salicylate poisoning may be present in the absence of any
characteristic clinical features of this condition. Nevertheless,
in general, it may be said that in this series there was found to
be relatively good correlation between the measured plasma
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Relationship between plasma salicylate and clinical
features in 84 patients with moderate and severe
poisoning.
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salicylate and the presence of toxic features of acute salicylate
poisoning. It can also be claimed that the measured level of
plasma salicylate provided useful additional evidence of actual
severity of the poisoning.
Measurement of Acid-Base Status
The complex nature of the metabolic upset resulting from
acute salicylate overdosage has been already described and the
importance of assessing the acid-base status in all patients
with severe salicylate poisoning has been stressed by Singer
(1954), Winters et al. (1963) and McLaughlin (1965). Metabolic
acidosis is usually the predominant upset seen in children.
Adults are more likely to be found in a state of respiratory
alkalosis or to have a mixed disturbancej a few others may also
present with metabolic acidosis. The time-honoured concept of
salicylate pathophysiology in which initial respiratory alkalosis
progresses to metabolic acidosis does not appear as rational as
the mixed disturbance which was described by Winters et al. (1963).
In this view a tripartite action of salicylate simultaneously
produces ketosis, stimulation of respiration and increase in
metabolic rate. Complex interaction of these metabolic effects
may result in respiratory alkalosis, metabolic acidosis or mixed
acid-base disturbance.
The only satisfactory way to investigate this upset is
the measurement of arterial blood gases. The importance of
arterial blood studies is now well established (Winters et al.,
1963; Forland and Pullman, 1963; Ghose and Joekes, 1964;
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McLaughlin, 1965; Ghose, 1967).
The results of acid-base studies in 56 consecutive patients
with severe salicylate overdosage are shown in Figure 14. The
great majority of patients had values of arterial pH with the
range 7-40 to 7-48 and so were either normal or only mildly
alkalotic. However there were a number, who had more severe
acid-base upsets. Some were distinctly alkalotic in terms of
pH and a few were considerably acidotic. The fact that the pH
lay within normal limits did not mean that therewas no acid-base
upset present. It merely represented a compensated phase and
was still compatable with a severe degree of poisoning. Therefore,
from the point of view of assessment of patients, when the pH is
outwith the normal range, it must be assumed that the normal
compensatory mechanisms in the kidney and in the body buffer
systems have been overcome. In these cases the acid-base upset
is marked which indicates that the toxic effects of the drug are
severe, irrespective of the plasma salicylate level. Apart from
its very considerable value in the general assessment of the patient
measurement of the acid-base upset may be of important prognostic
significance.
The relationship of the peak plasma salicylate level and
the associated arterial pH in the same 36 patients is shown in
Figure 15. There was no correlation demonstrated as the correlation
co-efficient r was 0.0086. This lack of correlation is not
surprising when one considers that the pH is merely the net result
of what is in this case a very mixed metabolic upset affecting
acid-base status. The relationship between the lowest measured
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Relationship between arterial pH, pC02 and






































Relationship between arterial pH, pC02 and standard
bicarbonate in 36 severely poisoned patients.
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Relationship of peak plasma salicylate levels and
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Figure 15»
Relationship of peak plasma salicylate levels and.
the corresponding arterial pH in 36 patients with
severe salicylate poisoning.
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pCOg and the peak plasma salicylate level in the same group of
patients is shown in Figure 16. Again the correlation was not
very good (r = -0.35) and this did not attain a level of significance
the probability p = 0.10. It was noted, however, that low levels
of the p^Og were closely associated with the clinical presence
of hyperpnoea. Also when the pC02 was initially low this tended
to remain at a low level for many hours, even in the presence of
a falling plasma salicylate. This has been observed by Winters
et al. (1963) and may represent continuance of a degree of metabolic
acidosis with persisting hyperpnoea and low arterial standard
bicarbonate. The relationship between the peak plasma salicylate
level and associated arterial standard bicarbonate levels is shown
in the next Figure 1?. Again there was no significant
correlation between these two measurements (r = 0.287, p = 0.10).
This again may reflect the effects of a mixed metabolic upset
with varying influences on the acid-base status. As with the
arterial pCC>2 the levels of arterial standard bicarbonate were
low and remained so for up to 24 hours even when the plasma
salicylate had fallen to within "non-toxic levels". This may
have resulted in two ways as both respiratory alkalosis and
metabolic acidosis may result in reduction in the standard
bicarbonate levels. In respiratory alkalosis bicarbonate is
excreted in the urine asa compensatory mechanism and in the presence
of metabolic acidosis bicarbonate is utilised as a buffer to
neutralise the excessive amounts of hydrogen ion present.
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Relationship between the arterial pCo2 and the corresponding peak plasma
salicylate level in 36 severely poisoned patients.
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Figure 16.
Relationship of the peak plasma salicylate levels and
the corresponding arterial pCC^ in 36 patients with
severe salicylate poisoning.
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Relationship of peak plasma salicylate levels and
associated arterial standard bicarbonate in 36 patients
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Figure 17«
Relationship of the peak plasma salicylate levels and the
corresponding arterial standard bicarbonate in 36 patients
with severe salicylate poisoning.
- 79 -
Urinary pH
Urinary pH is often used in error to differentiate
respiratory alkalosis from metabolic acidosis (Robin et al., 1959;
G-hose, 1967). This is an unreliable guide to the pH of extra¬
cellular fluid during respiratory alkalosis. Spector and McKhann
(1948) reported the finding of acid reactions in most of the urine
specimens of their cases of acute salicylate intoxication although
the blood pH found was always over 7.45. The presence of an
acid urine pH in the face of severe extracellular alkalosis may
be related to potassium depletion. It is well known that in
other forms of alkalosis a "paradoxical" aciduria may occur.
It may be due to coincident potassium depletion primarily with
consequent decrease in relative availability of potassium ion to
compete for hydrogen ion in "the distal tubular reabsorption of
the sodium in the kidney (Berliner and Kennedy, 1948), or it may
result from the relative cellular acidosis consequent to the
exchange between the extracellular and intracellular spaces of
hydrogen ion for potassium ion during the development of
potassium depletion and alkalosis (Cooke, Segar, Cheek, Corille
and Darrow, 1952). The exact mechanism remains obscure but the
result in either case is the production of an acid urine despite
severe systemic alkalosis. Patients with metabolic acidosis
also produce urine with an acid pH. The urinary pH, therefore,
is not a useful index of the acid-base status of the patient.
Summary
Full assessment of a patient suffering from acute salicylate
poisoning entails due consideration of the clinical features
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present, assessment of the plasma salicylate level and measurements
of the arterial blood gases in order to assess the acid-base
status. None of these three considerations will in themselves
provide a complete assessment of any individual patient.
Measurement of the plasma salicylate is the most valuable index
but should where possible be supported by measurement of the
arterial blood gases.
1. If a patient has marked clinical features compatable
with the diagnosis of acute salicylate poisoning and there is
a clear history of him having taken an overdosage of salicylate
it may be assumed that he is suffering from moderate or severe
salicylate intoxication.
2. When there is any doubt, measurement of the plasma
salicylate must be done to confirm the diagnosis. If the patient
is admitted within 6 hours of having ingested the poison the
measured level of plasma salicylate itself and in appropriate
cases the rate of change of the plasma salicylate measured over
the immediate period after admission to hospital, will provide
a satisfactory index of the severity of the overdosage. If the
patient has been admitted however more than 6 hours after having
taken the salicylate, calculation of Sq should be carried out.
In general, levels of plasma salicylate above 40 mg. per 100 ml.
are found in patients with moderately severe poisoning and levels
above 60 mg. per 100 ml. are in keeping with severe salicylate
poisoning. In a few cases levels above 100mg. per 100 ml. of
the plasma salicylate will be found. ■'•his must be regarded
as very severe poisoning and demands the institution of vigorous
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active therapy to remove the poison as a matter of great
urgency.
3. Measurements of arterial blood gases are necessary
to provide an adequate assessment of the acid-base status of
the patient and if there is a significant deviation of the
arterial pH either towards acidosis or alkalosis, the patient
should be regarded as being severely poisoned, even if the plasma
salicylate level is not very high. On the whole an acid pH is
of more serious import than an alkaline pH (Eichenholz et al.,
1963). Measurements of the PCO2 and arterial standard
bicarbonate will provide useful indications of respiratory
alkalosis and metabolic acidosis in instances where the pH
remains within the normal range.
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TREATMENT OF ACUTE SALICYLATE POISOEING-
i. GENERAL CARE
The successful treatment of patients with acute salicylate
poisoning depends largely on the application of the principles
of good general medicine.
The general care of such patients is in effect the application
of the basic concepts of Intensive Supportive Therapy, which is
a modification of the Scandinavian method of treatment of poisoned
patients, developed in Copenhagen by Clemmesen and Nilsson (1961).
The regime of Intensive Supportive Therapy has been described in
detail by Matthew and Lawson (1966). for clarity general care
will be discussed under headings referring to major system upsets.
Cardiovascular
Cardiogenic shock is a very uncommon complication of acute
salicylate poisoning. It is nevertheless important and may be
serious when it does occur. It is a well recognised mode of
death in this type of intoxication. Therapy simply takes the form
of general principles of treatment of shock resulting from any
other cause of myocardial failure. In addition, however,
hypokalaemia is a common complication of acute salicylate over¬
dosage (Robin et al., 1959) and should any arrhythmia or hypotension
occur, an electrocardiograph should always be done with specific
search for the features of hypokalaemia. This, of course, should
be supported in every case by measurement of the plasma potassium,
tffhen hypokalaemia is present appropriate potassium supplements may
be all that is necessary to correct the cardiovascular upset.
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As has already heen mentioned, tachycardia is a very common
feature of this type of poisoning and usually is a compensatory
mechanism associated with the increased metabolic rate, which is
one of the main toxic effects of this poisoning. Specific
treatment for the tachycardia is therefore seldom required but
occasionally signs of cardiac failure may result if the tachycardia
is severe and prolonged. This complication is more common in
older patients. In this case appropriate digitalization should
be carried out again after suitable precautions have been taken
that the patient does not have significant hypokalaemia.
Respiratory
Hyperventilation is often a marked feature of acute salicylate
overdosage. As with tachycardia, hyperpnoea is frequently
a compensatory mechanism for the stimulation of metabolic activity,
which occurs as a direct effect of salicylates. Treatment to
reduce hyperventilation is, therefore, unnecessary and may even be
harmful. The use of respiratory depressant drugs such as
barbiturates to decrease the hyperpnoea of poisoning has been
advocated (Eichenholz et al., 1963)* Rapoport and Guest (1945)>
however, demonstrated that there was an enhanced toxicity of
salicylates, when patients were treated with such respiratory centre
depressants. Such therapy, therefore, may be dangerous, (Robin
et al., 1959) and the combination of salicylate intoxication and
respiratory centre depressants may lead to irreversible cellular
changes and death.
Many of the patients suffer from respiratory alkalosis.
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A theoretical consequence of this metabolic upset may be
interference with tissue oxygen transport, as alkalosis shifts
the oxyhaemoglobin dissociation curve to the left. For a given
oxygen saturation there is less oxygen available for diffusion
into tissues. -i-his factor would be of greater importance in
salicylate poisoning than in other causes of alkalosis. One of
the main actions of salicylate is to stimulate cellular metabolism.
In the face of an increased oxygen demand and possible diminished
oxygen supply, cellular hypoxia may develop in this disorder.
Robin and his colleagues in 1959 considered this factor to be of
sufficient importance that they routinely administered oxygen to
all their patients with this overdosage in the hope that the
amount of oxygen in physical solution in the blood would thereby
be increased with a greater availability of oxygen to the tissues.
This treatment is not generally accepted and its place in the
routine management of patients with this disorder must remain
undecided.
Occasionally patients with very severe poisoning have such
severe hyperpnoea and respiratory alkalosis may become so profound
that physical exhaustion is produced. This may result in
respiratory depression, which may culminate in acute respiratory
failure. It is generally agreed that respiratory stimulants are
contra-indicated in this situation (Done, 19^5) for two reasons.
Respiratory stimulation is already maximal and stimulatory drugs
may potentiate the convulsant effects of the salicylate. The
management of choice in this situation is artificial respiration
possibly with curarisation of the patient.
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.An uncommon complication of salicylate intoxication is
pulmonary oedema (G-ranville-G-rossman and Sergeant, i960).
Perhaps the most plausible explanation for this type of abnormality
has been suggested by the experiments of Hetzel, Charnock and
Lander (1959). These experiments showed that when salicylates
were given to healthy subjects, sodium and water were retained.
They therefore suggested that the development of oedema in patients
with this poisoning was related to sodium retention. Whatever
the exact aetiology may be the treatment is appropriate diuretic
therapy with, in severe cases, salt restriction.
G-astro-intestinal
Nausea and actual vomiting are of course common features of
salicylate poisoning. Only when these symptoms are severe and
prolonged is any specific treatment required. Treatment with
an anti-emetic such as 50 mg. of cyclizine intramuscularly will
usually be sufficient.
Haematological
The main blood disorder arising from acute salicylate
poisoning is the development of a bleeding tendency. Prank
bleeding most commonly occurs from the gastric mucosa and presents
either as haematemesis or as bleeding into gastric aspiration
fluid. As has been described it may result from a number of
possible factors including hypoprothrombinaemia, capillary fragility
and thrombocytopenia. The time-honoured practice of treating
patients with acute salicylate poisoning routinely with vitamin
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supplements is probably not justified. Vitamin K supplements
should only be given when the patient has been shown to have
hypoprothrombinaemia. Blood transfusion is only occasionally
required.
Central Nervous System
The commonly observed agitation and restlessness seldom
require any specific therapy but occasionally these features
progress to grand mal convulsions. These may be of sufficient
severity to require treatment with barbiturates. These drugs,
however, should be used with caution as their effects tend to be
potentiated by the salicylate group of drugs (Eichenholz et al.,
1963)« The convulsions may be associated with cerebral oedema
and at times papilloedema both of which features probably result
from sodium retention as in the case of pulmonary oedema (Greer,
Ward and Corbin, 1965). If these features are marked, hypertonic
solutions of mannitol (10 or 20 per cent) should be given.
These should be administered rapidly by intravenous infusion,
500 ml. in the first 15 minutes followed by 500 ml. of 5 per cent
dextrose over the subsequent four hours.
Metabolic
Prom the point of view of treatment, one of the commonest
I
complications is pyrexia. It is usually mild and simple tepid
sponging is all that is required. On the other hand, there are
numerous reports in the literature of high pyrexias occurring
particularly in young children. In these cases more active therapy
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to reduce the body temperature, such as the use of damp sheets
and fans, may be necessary.
Both hypo- and hyperglycaemia may occur as side-effects of
salicylate when it has been taken in toxic doses. Treatment
is simply that of hypo- or hyperglycaemia due to other causes.
The carbohydrate upset is usually very transient and seldom
constitutes a serious problem.
Hypernatraemia is reported by numerous workers, and this
may result from relative dehydration, but also in some instances
there is little doubt that true sodium retention will occur.
Marked peripheral oedema may result. When this is severe
a regime of sodium restriction and appropriate diuretic therapy
should be given. The danger of hypokalaemia, which is a common
complication of this poisoning, has been described in detail by
Robin et al. (1959) and by others including Beveridge et al.
(1964). Its treatment is simply by appropriate potassium
supplements.
As a result of vomiting, sweating, hyperpnoea and pyrexia,
dehydration is a common feature of this type of overdosage.
Correction of fluid and electrolyte balance must be regarded
as an integral part of any form of treatment of acute salicylate
poisoning. In mild types oral fluids may be all that is needed
but in more severe overdosages and especially where nausea and
vomiting are prominent features, parenteral treatment must be given
Renal
Renal failure is a most unusual complication of acute
salicylate poisoning (G-hose and Joekes, 1964). The main reason
for this is probably that most of the patients, who take
overdoses of salicylates are in the younger age groups and have
healthy kidneys. It is well known that salicylate will cause
renal irritation with resultant increase in celluria due to
desquamation of the tubular cells. However it tends to be
a rather transient feature and is seldom associated with any
"DC. Utt'.ftiA
significant functional impairment (Scott, Denholm and Dorling,
1963 and Prescott, i965)• -^cute renal failure however can occur
and of course when it does it is of the utmost importance and
must be treated with the usual supportive therapy including fluid
restrictions and dietary measures including low protein intake.
In very severe cases haemodialysis may be necessary.
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TRMTMENT OF ACUTE SALICYLATE POISONING-
ii. SPECIAL CARE
Specific therapy for any internal poisoning consists of
efforts to detoxify the poison substance, to degrade it, or to
remove it from the body. Neither of the first two approaches
is applicable to the management of acute salicylate poisoning, for
no method has been devised which will reduce the toxicity of the
salicyl radicle, and while approximately 20 per cent of salicylate
is normally degraded in humans, no means of augmenting this
process is available. Hence specific therapy has been directed
entirely towards effecting rapid removal of the salicylates from
the body. Recovery of the poison from the patient may be
achieved in two different ways.
1. Prevention of further absorption of the poison by
aspiration and lavage of gastric content.
2. By increasing removal of the poison from the
circulating blood and extra-cellular fluid, after the toxic
substance has already been absorbed from the gastro-intestinal
tract.
As it is the next step in treatment after emergency measures
have been applied to support the vital functions where necessary,
it is appropriate to consider gastric aspiration and lavage, in
the first instance. Spontaneous vomiting is a relatively common
feature of acute salicylate intoxication and there is little doubt
that many patients are saved from having very severe poisoning
as a result of this. There is evidence however, (Arnold, Hodges,
Barta, Spector, ^unshine and Wedgewood, 1959) that spontaneous
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vomiting is an inefficient method of emptying the stomach of
aspirin. Arnold and his colleagues reported the results of
studies on dogs but there is little doubt that the same occurs
in humans (Matthew, Mackintosh, Tompsett and Cameron, 1966).
Rushton (1963) reported that at post mortem examination large
quantities of aspirin are occasionally found in the stomach.
This is probably related to the fact that large doses of salicylate
will promote gastric stasis in humans (Cumming, 1961). Similar
findings have also been demonstrated in experimental animals
(Smith and Irving, 1955)• It is not surprising therefore, that
removal of considerable quantities of salicylate from the gastic
contents may be achieved many hours after ingestion (Thomson and
Alstead, 1960). It is good practice, even when patients have
had spontaneous vomiting either before or immediately after
admission to hospital, to perform gastric aspiration and lavage in
order to achieve the most complete gastric emptying which is
possible. The conclusion of Ghose and Joekes (1964) that gastric
emptying is unlikely to be of great importance in the treatment
by the time the patient has been admitted to hospital with acute
salicylate poisoning is unjustifiable.
Various methods of promoting gastric emptying have been
suggested and the use of syrup of ipecacuanha has been
enthusiastically advocated, particularly in the North American
continent (Done, 1965)* There are a number of serious objections
to the use of this preparation, as the emetic effect is generally
too slow and too uncertain and in addition when vomiting does not
occur the emetine content of the drug may be absorbed and itself
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produce toxicity. Another danger which is common to all
methods of inducing gastric emptying is that if there is any
impairment of conscious level, the patient may inhale vomitus
during the emptying process. In Scandinavia also, copper
preparations have been employed with increasing frequency,
particularly in children, but these are on the whole no more
efficacious than ipecacuanha and have little advantage over other
methods.
Outside hospital there is little doubt that the best method
still of inducing vomiting is the traditional one of irritation
of the pharynx by the finger or a blunt spoon handle, the patient
having been laid on his side with the head dependent. In children
i
they should be placed in the spanking position (Matthew and
Lawson, 1967). In hospital, providing the patient has an
adequate cough and gag reflex or else is sufficiently unconscious
to allow introduction of a cuffed endotracheal tube, the lungs
thereby being protected, gastric aspiration and lavage is the
most efficient method of recovering the salicylate.
A number of objections have been raised to the use of this
method of treatment, the main criticism being the risk of
aspiration pneumonia. In acute salicylate poisoning, however,
.
the great majority of patients when they present in hospital, at
least in older children and adults, are fully conscious and have
efficient cough and gag reflexes. Therefore in this regard there
is little contra-indication to employing the treatment. A further
and perhaps more important objection is that the introduction of
lavage fluid into the stomach may promote the entry of more
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salicylate into the small intestine; thus causing a sharp increase
in the absorption of the poison and thereby defeating the object
of the exercise. It is true that frequently there is a rise
in plasma salicylate in the immediate post-lavage period and
Brown and his colleagues in 1967 estimated that there may be
a rise of between 5 and 10 mg. per 100 ml. following gastric
lavage. This effect, therefore, must be accepted but the rise
is a modest one and perhaps is of less significance than has been
suggested by some. finally it has been claimed that gastric
lavage is not an efficient method of removing solid materials
from the stomach. On the other hand, large amounts of salicylate
have been removed from the stomach by this means both by
Beveridge et al. (1964) and Matthew et al. (1966). Therefore,
provided that the techniques of gastric aspiration and lavage are
performed correctly an efficient recovery of the poison can be
achieved. In general the advantages of gastric aspiration and
lavage far out-weight any possible disadvantages and there is
general agreement that gastric lavage should be undertaken in all
cases (Beveridge et al., 19&f5 Today's Drugs, British Medical
Journal, 1964; Matthew et al., 1966; °mith, 1966 and Matthew
and Lawson, 19^7)•
ftastric aspiration and lavage is a simple technique and
a safe one provided that appropriate precautions are taken. In
the first instance all patients must have an adequate cough
and gag reflex or else be sufficiently unconscious to permit
endotracheal intubation to protect the air-way. To lessen the
risk of aspiration pneumonia all patients must be laid on their
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side with the heaxl dependent. The correct equipment is
absolutely essential if the procedure is to be effective.
It is quite remarkable how often a narrow naso-gastric tube is
used as the lavage tube. This will inevitably fail to recover
any significant gastric content which is of a solid nature. In
older children and adults an adequate size of tube may be regardsd
as a 30 English gauge Jacques tube, which, of course, is passed
through the mouth. This is large enough to permit removal of
semi-solid food material and drugs from the stomach and an
added advantage is that it is also of sufficient size to make it
extremely unlikely that it will enter the trachea. This is
a much more significant hazard when using narrower naso-gastric
tubes. Once the tube is securely in position, gastric aspiration
is carried out using a Dakin's syringe and subsequently lavage is
carried out using 300 ml. portions of warm water at 38°C. The
lavage is then continued until the recovered fluid runs clear.
In children, of course, it is necessary to select appropriate
sizes of tubes and quantities of lavage fluid for the size and
age of patient.
Different authors have suggested different types of lavage
fluid for the procedure. These include isotonic saline (Rentsch
and Marsh, 1959) and dilute sodium bicarbonate solution (Cumming,
1961). The use of sodium bicarbonate solution has been
criticised both by Harvie and Singer in 1955 and Rentsch and
Marsh (1959), who state that this solution should not be used as
it may promote absorption of salicylate from the gastric mucosa.
This criticism of the use of bicarbonate solutions was made also ty Injxian,
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Krasnoff and Schless (194-9) • Sample water alone has been shown
to be a perfectly satisfactory lavage fluid, Beveridge et al.
(1964) and Matthew et al. (1966).
In 1959 Poison suggested that a litre of 5 per cent sodium
bicarbonate should be left in the stomach subsequent to lavage.
This is unnecessaiy and indeed contra-indicated as patients with
salicylate intoxication are frequently nauseated and are liable
to further vomiting. There is a hazard of aspiration pneumonia
in these cases. This danger is even greater than with gastric
lavage as the vomiting may occur without warning and when the
patient is not in the ideal position in which he should be
during the procedure of aspiration and lavage.
Such is the weight of evidence in favour of using these
valuable techniques of gastric aspiration and lavage that it
was the policy in the Poisoning Treatment Centre, Edinburgh
Royal Infirmary to wash out every patient with salicylate
poisoning. All the patients in the present series had this
procedure carried out, quite independently of the time since
ingestion. The view that it is never too late to aspirate in
acute salicylate was taken at all times.
Methods to increase removal of salicylate
Many methods have been used to increase the removal rate
of poisons from the body. Before considering any of these
methods, however, it is essential to consider whether the toxic
substance can be removed in an active form by excretion through
the patient's own kidneys or else by one or other method of
artificial dialysis. In the absence of vomiting, 90 per cent
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of ingested salicylate is excreted by the kidney (Oliver and
I>yer, 1960) and insignificant amounts are excreted either in
the sweat or in the stool (Smith, 1966). it is eliminated in
three forms; free salicylate, combined with glycine as
salicyluric acid and with glucuronic acid as salicyl acyl and
phenolic glucuronides (T'Sai Fan Yu and G-utman, 1959 )• The
remaining 10 per cent of ingested salicylate can not be recovered
in the urine as salicyl compounds because of metabolic conversion
to gentisic acid and other degradation products. When the
urine is acid, only about 20 per cent of the salicylate is
excreted as free salicylate. This is of considerable
importance as it is the concentration of free salicylate in the
unbound fraction of plasma salicylate which probably determines
clinical toxicity (Ghose, 1967). A considerable proportion of
the circulating plasma salicylate (between 50 and 80 per cent) is
bound to plasma albumen. The percentage binding falls when the
plasma salicylate concentration rises, suggesting saturation of
binding sites. The unbound blood salicylate may exist in the
free form or as a conjugate. Two hours after salicylate ingestion
the ratio of free to conjugated salicylate in the blood is 70:1
but 24 hours later the ratio is 15:1 (Milne, 1963). Free
salicylate is excreted mainly in the urine by processes which
depend on glomerular filtration, proximal tubular secretion, urine
volume and urinary pH. Salicylate conjugates are excreted also
by glomerular filtration and tubular secretion but are not
apparently influenced by urine volume or pH.
The influence of urine volume on excretion of free salicylate
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was reported in 1955 by MacPherson, Milne, and Evans. Since
1951 it has been known that when the urine is alkaline the
rate of renal exoretion of salicylates is accelerated (Morris
and Graham, 1931). As the urine pH rises above 7.0 both the
relative percentage and the total amount of free salicylate
increase progressively (Smith, Gleason, Stall and Ogorzalek,
1946; Hoffman and Nobe, 1950; Davis and Smith, 1951; MacPherson,
Milne and Evans, 1955 and Gutman, 7u and Sirota, 1955). In this
way it has been shown that at a urinary pH 8.0, free salicylate
accounts for from 75 to 80 per cent of the total salicylate
excreted. This amounts to a total salicylate excretion of as
much as four times that occurring at pH 5.0. It follows that
alkalinisation of the urine must be very valuable in the treatment
of acute salicylate overdosage.
Different authorities advocate different measures to
increase removal of absorbed salicylate. These include forced
oral fluids, forced water diuresis, forced alkaline diuresis,
peritoneal dialysis, haemodialysis, exchange transfusion in
children and the use of anion exchange resins. The optima.!
management of patients with acute salicylate overdosage remains
a matter of dispute.
Forced Oral Fluids
Use of forced oral fluids in patients with acute salicylate
poisoning has not met with any great success (Done, 1965). This
is perhaps not surprising as the amounts of fluid which can be
tolerated by a patient, who has recently taken an overdosage of
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aspirins is very often limited by nausea or actual vomiting.
The oral administration of sodium bicarbonate in addition to simple
fluids has been advocated by a few with the idea that the alkali
will be absorbed and assist in the elimination of salicylates
through the urine. Done (1965), however, has pointed out that
this practice is contraindicated as it may enhance the absorption
of more salicylate and in this way do more harm than good. Oral
fluids therefore are of no value in the treatment of patients
with severe poisoning, but on the other hand, it is generally
agreed that in the very mild cases maintenance of a good oral
intake of fluids is all that is necessary.
Forced Water Diuresis
Forced water diuresis using parenteral fluids has been
tried by Doolan, Walsh, Kyle and Wishinsky (1951) and also by
MacPherson, Milne and 2vans (1955). ■'■hey failed to demonstrate
any significant increase in the salicylate clearance by using
these techniques and so they suggested that they were of limited
value. The regimes of fluid therapy, which they used, however,
were somewhat conservative by modern standards and it may be that
their failure to demonstrate any very significant increase in the
recovery of salicylate by their forced diuresis was related to the
limited urinary flow which was achieved. Ghose and Joekes,
(1964) reported good recoveries of salicylate using forced water
diuresis supplemented by hypertonic mannitol solutions. They
commented that it was not clear why osmotic diuresis should
greatly increase salicylate excretion, when a water diuresis is
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relatively ineffective. The probable reason was that the urine
flow which they produced by using this method, was greater than
that achieved by those using a simple water diuresis alone.
The recoveries of salicylate, which they found, were therefore
related to this rather than to any specific effect of the
hypertonic mannitol.
Forced Alkaline Piure3i3
Of jill the regimes of forced diuresis the one which
achieves greatest recovery of free salicylate is that which
produces an alkaline polyuria. Such a method has been widely
used in children poisoned with salicylates. In general, the
serum salicylate level has been halved in between 2-5 hours
following the commencement of the diuresis therapy and the
treatment has not been associated with any untoward side-effects,
(Oliver and %er, 1960; %itten, Kesaree and Goodwin, 1961 and
Summit and Etteldorf, 1964). In children, however, the usual
net metabolic upset of acute salicylate poisoning is metabolic
acidosis and there is, therefore, no real objection to administer¬
ing alkali to them. Winters in 1959, however, pointed out
that alkalinisation of the urine even in children requires much
larger quantities of sodium bicarbonate than are required to
correct the acidosis. He therefore, expressed reservations about
alkalinisation of the urine because of the hazards from the
metabolic alkalosis provoked by the administration of the sodium
bicarbonate. The dangers, which concerned him, were largely
theoretical and included the development of acute hypokalaemia
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end severe tetany« In addition to the dangers of promoting
alkalosis as a result of this therapy, Feuerstein, Finberg and
Fleishman, (i960) have also stressed the danger of promoting
hypernatraemia. This, however, can be avoided by appropriate
adjustments of the infusion regime. On the other hand,
Eichenholz, Mulhausen, Anderson and Macdonald (i962) have pointed
out that metabolic acidosis on the whole is less well tolerated
than other types of acid-base upsets, particularly in children*
It would seem, therefore, that despite the possible objections
to this form of therapy the benefits from rapid removal of
salicylate from the patient, outweigh any disadvantages.
Forced alkaline diuresis has not been so widely accepted
for the treatment of older children and adults. The predominant
acid-base upset in these patients is usually respiratory alkalosis.
Several authorities have regarded this respiratory alkalosis as
a contraindication to forced alkaline diuresis (Robin et al.,
1959; &hose and Joekes, 19&4; Done, 1965 and McLaughlin, 19&5).
They point out that a dangerous state of severe alkalosis may
develop and state that the possibility of precipitating severe
and even fatal alkalotie tetany is real. They also stress the
possibility of the development of acute and severe hypokalaemia
in the state of severe alkalosis. Contrary to this opinion
others, including Dukes, Blainey, Cumming and Widdowson (19^3)
and Cumming, Dukes and Widdowson (1964) consider that again, as
in the case of children, the advantages of accelerating the
removal of salicylate from the patient are greater than any
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potential dangers inherent in the therapy. Cumming et al.
(1964) reported the use of a regime of forced alkaline diuresis
in five patients and did not find any serious clinical
complications from the therapy. On the other hand, high levels
of plasma pH were found and the plasma potassium was found also
to fall considerably during the course of this treatment.
There are two other methods, which will produce
alkalinisation of the urine. The first is the use of acetazol-
amide ("Diamox") which is an inhibitor of carbonic anhydrase
activity. MacPherson et al. (1955) have demonstrated a marked
salicyluria following the administration of this drug to adult
volunteers. There are however serious objections to its
clinical use. Winters (1959) ha3 pointed out that if itis used
in patients who are already acidotic, or who have a mixed acid-
base disturbance, it may fail to produce an alkaline urine and
it may even produce a systemic metabolic acidosis, which would
accentuate the pre-existing acidosis. This is particularly
likely in small children (Oliver and %er, i960). Kaplan and
del Carmen (1958) demonstrated a much higher mortality in rats
who received acetazolamide than in animals who were given
bicarbonate after the administration of toxic doses of salicylate.
Further, in a clinical study, Schwartz, tellers, Knapp and Yaffe
(1959) reported detailed investigations in three children with
acute salicylate poisoning, who were treated with acetazolamide.
From the point of view of salicylate recovery, the therapy was
successful but there were very severe changes in the pattern of
urinary electrolytes and the administration of large quantities
- 101 -
of intravenous bicarbonate was necessary to control the systemic
acidosis, which developed in these three patients. As evidence
of the severity of these changes, they described the occurrence
of convulsions in two of the children and papilloedema was
found on ophthalmoscopy. Feurstein et al. (1960) reported more
favourably on the use of this drug as a form of treatment in
this poisoning but on the whole they have failed to convince
others and this method has therefore fallen into general disrepute.
The other method of alkalinising the urine, is the
administration of the organic buffer tris (2-amino-2-hydroxy-
methylpropane-1 ,3-diol) which is now commonly referred to as
THAM. The early reports of Nahas and Ligou, (1959) indicated
that THAM increased urinary output and also achieved
alkalinisation of the urine. These effects have led to the use
of this substance in the treatment of acute salicylate poisoning.
(I9fcl)
Israels and Davies^have reported favourably on the use of this
form of treatment both in rabbits and dogs and also in five
children suffering from this poisoning and similar results were
also found in rats in experiments carried out by Strauss and
Nahas (i960). Further clinical studies have been done by
Strauss, Nahas and Clark, (1961), by Duval and Leveau, (1962) and
by Rangno, Gourley and Israels (1962). Gaultier, Fournier,
Gervais, Bignon, (1963) discussed the use of THAM to produce
an alkaline diuresis and it may be that this agent will prove
a valuable addition to present regimes of therapy. There is
as yet, however, insufficient evidence of a clinical nature to
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substantiate that TEAM has any real advantages over other forms
of alkalinisation.
Gaultier and his colleagues also point out a number
of hazards in using THAM. They state that the agent may in
some instances both modify or even potentiate the action of
certain toxic substances. Thi3 statement is based largely on
experimental animal work and whether it is the case with
salicylates remains to be seen. There are, however, more
definite dangers of the treatment. Careful and close monitoring
of the arterial pH is essential, as rapid and severe changes in
acid-base state may occur during the course of this treatment
and dangerous and even lethal levels of alkalosis may be
reached. THAM may also produce hypokalaemia by a mechanism
similar to that of bicarbonate infusions. It has also an
important depressant effect on respiration and diminution of
arterial oxygen saturation may be of such severity that the
patient may require assisted respiration. Severe hypo-
glycaemia has also been recorded and this treatment may cause
quite severe hypotension, which may be of sudden onset.
Lastly THAM itself is a very alkaline substance and therefore
must be given in a large vein by means of a polythene catheter.
Exudation outside the vein will cause severe pain locally and
possibly necrosis of tissues. How significant all these
complications are, remains to be fully evaluated, but it would
seem likely that the use of THAM is at least as hazardous, if
not more so, than treatment with bicarbonate infusions.
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Peritoneal dialysis
Etteldorf, Montcalvo, Kaplan and Sheffield (i960)
described the results of the use of intermittent peritoneal
lavage as a means of treating salicylate intoxication in dogs.
They found that it was necessary to add 5 per cent human
albumen in order to obtain satisfactory recovery of salicylate.
In 1959 Doolan, Murphy, Wiggins, Carter, Cooper, Watten and
Alpen found that considerable amounts of salicylate could be
removed by intermittent peritoneal dialysis. Elliot and
Crichton (i960) found this in three patients with severe
salicylate intoxication. These results were confirmed in
a further three patients, on this occasion in infants, by
Segar, Gib son and Rhemy (1961). Peritoneal dialysis has also
been reported to be a successful form of treatment in children
(Etteldorf, bobbins, Summit, Rainwater and Fischer, 1961) and
more recently by Summit and Etteldorf (1964).
The disadvantages of the technique are that it is more
complex than forced alkaline diuresis and that it requires more
skilled nursing care. There is also a very considerable danger
of infection in the peritoneal cavity: as the great majority
of patients, particularly older children and adults, are
conscious, they frequently complain of considerable discomfort
and some find great difficulty in tolerating it. This can
only partially be overcome by the addition of local anaesthetics
to the dialysis fluid.
In terms of recovery it is only about 25-50 per cent as
effective as extracorporeal dialysis using an artificial kidney.
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Its main value is perhaps in situations, where the patient
is not suitable for forced diuresis therapy and yet an
artificial kidney is not readily available. In these instances
peritoneal dialysis provides a useful alternative form of
treatment.
Exchange transfusion
Since Heymann, Javett and Rudolph (1954) first reported
the successful treatment by exchange transfusion of an infant,
who had ingested an overdose of acetylsalicylic acid, numerous
other reports of the use of this technique in infants have been
published including those of Done and Otterness, (1956);
Radebaugh and Emery (1957); Bruton, (1958) and Leikin and
Emmanouilides (1960). This has been used almost exclusively
in the treatment of small children; partly because it is
technically simpler than other methods, such as haemodialysis,
in these patients. Cumming (1961), however suggested that it
may be of some value in adults also. It is not as effective
in recovering salicylate from the circulation as forced alkaline
diuresis, however, and would therefore not seem appropriate for
the treatment of older children or adults.
Anion Exchange Resin
The removal of salicylate ion from the blood by passage
through a column of anion exchange resin has been reported by
Clark, Finley, Davis and Finley (1961). It is suggested that
up to 90 per cent of the salicylate is removed in a single
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passage of a sample of blood through the column containing
the resin* These studies were done on dogs and suggested
that the serum salicylate concentration could be halved
between 2 and £ hours after starting treatment. There are no
reports as yet, however, of a clinical application of this
method and so its place in the treatment of patients must await
further study.
Haemodialysi3
There is no doubt that this form of therapy is the most
effective means of removing salicylate from the blood
(Schreiner, Berman, G-riffin and Feys, 1955; James, Kimbell and
Read, 1962; Parson, 1963 and Jorgensen and Wieth, 1963) •
There have been various studies comparing the effectiveness of
haemodialysis with other means of increasing removal of
salicylate. Doolan, Walsh, Kyle and Wishinsky (1951) reported
that the recovery of salicylate with haemodialysis was 5-7 times
greater than that achieved with normal renal excretion. In
studies on dogs, James, Kimbell and Barham (1961 ) compared the
effects of exchanged transfusion, peritoneal dialysis,
haemodialysis and various forms of forced alkaline diuresis.
Their results indicated that haemodialysis was the most effective
method and forced alkaline diuresis using sodium bicarbonate
as the alkalinising agent was second in effectiveness. Exchange
transfusion and peritoneal dialysis with added albumen in the
lavage fluid were approximately half as effective as haemodialysis.
In clinical studies in humans, James et al. (1962) showed that
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haemodialysis using an artificial kidney was about four times
as rapid in recovering salicylate as peritoneal dialysis and,
according to Jorgensen and Wieth (1963), was between two and
five times as efficient as osmotic diuresis. humming, Dukes
and Widdowson (1964) found that haemodialysis was approximately
twice as effective as either exchange transfusion or forced
alkaline diuresis.
Haemodialysis is nowadays a safe technique in older
children and adults. In young children, its use is more
debatable.. A number of authors including Breakey, Woodruff
and Reus (1961); Moorehead, Edwards and Goldsmith (1965);
Hickman and Scribner (1962) and Anderson, Lee and Stroud (1965)
have reported successful treatments of small children by this
method. ^hey all, however, note that there are dangers
involved in the procedure particularly regarding the maintenance
of the circulation, body weight and appropriate levels of
hydration. Moorehead et al. (1965)* for example, have reported
deaths following acute haemodialysis in infants due to cerebral
oedema and brain stem compression. This tends to become more
likely the more intensely the dialysis is applied and it is
thought that the cerebral oedema may be the result of osmotic
gradients between vascular and extravascular compartments.
Kennedy, Linton, Luke, Renfrew and Dinwoodie (1964) suggested
that this complication may be avoided if extra glucose is
added to the dialysing fluid. Mackay (1961) and Seegar (1961)
have emphasised the importance of parenteral fluid therapy and
the hazards of other procedures particularly in children.
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Many methods of treatment therefore have been usedfbr
patients with acute salicylate poisoning and there seems little
argument that salicylate intoxication is a potentially fatal
condition which demands active management. The therapeutic
aim should be to accelerate the removal of salicylate from the
patient, as rapidly as possible. Despite numerous reports in
the literature of different techniques of achieving thi
removal of the salicylate in this poisoning there is no
accepted or standardised form of treatment. The reports
provide a bewildering variety of opinions and approaches to
treatment, which are at times paradoxical.
In view of the efficiency of haemodialysis in recovering
salicylates, a number of authors have suggested that this
method is without any doubt the treatment of choice in patients
with very severe salicylate poisoning (Beveridge et al., 1964
and Smith, 1966). In theory this suggestion cannot be
challenged. However in practice there are a number of serious
criticisms, which may be made. Dukes et al. (1963)> for
example, pointed out quite rightly that there was a delay in
making haemodialysis available. The artificial kidney machine
must first of all be 'primed' with compatable blood. If one
takes into account this delay the effect of forced alkaline
diuresis ab initio will achieve almost comparable recoveries in
a given interval of time. This criticism is perhaps less
valid today as the artificial kidney machine can be prepared
with much greater speed but a certain delay is inevitable still.
A far greater and more important criticism is one purely of
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availability of apparatus and skilled medical and nursing
staff. Throughout this country artificial kidney units are
working to absolute capacity. All doctors working in these
units find themselves in the distressing situation of having to
refuse treatment to patients with severe renal failure, due to
renal disease itself, purely on the grounds of limitation of
facilities, equipment and staff. It is therefore unjustifiable
to add to this burden, a request for artificial kidney time for
the treatment of patients, who might be treated effectively and
safely by other methods.
As patients with acute salicylate poisoning are in "the
main in the younger age groups, it is a relatively rare
occurrence to find a patient who has severe cardiovascular or
respiratory disorder, or impairment of renal function, which
would prevent the safe and successful use of one or other method
of forced diuresis. This opinion has been presented by Ghose
and Joekes (1964) and experience in treating patients with
acute salicylate poisoning in the Poisoning Treatment Centre
at Edinburgh Royal Infirmary would lend support to this viewpoint
It was therefore decided to study the effects of different
forced diuresis regimes on blood salicylate and urinary
salicylate excretion. The effects on the serum and urinary
potassium, sodium, magnesium and calcium were also monitored
together with changes in acid-base status.
As a result of these studies there has been devised a safe,
simple yet highly effective method of treatment which is suitable
for use in even small hospitals with limited biochemical support.
This type of treatment has also been shown to be effective in
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the great majority of patients with acute salicylate overdosage.
Therefore, except in a very few patients who suffer from
complications which make forced diuresis unsuitable, referral
of these patients to an artificial kidney unit for haemodialysis
is unnecessary. The study was carried out on 84 patients
admitted with acute salicylate poisoning to the Poisoning
Treatment Centre at Edinburgh Royal Infirmary and who were
judged to be suffering from moderate or severe salicylate
overdosage.
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POTASSIUM SUPPLEMENTS IN FORCED ALKALINE DIURESIS
The basic regime of therapy, which was selected for use in
the Poisoning Treatment Centre at Edinburgh Royal Infirmary for
patients with moderate or severe acute salicylate poisoning, was
adapted from that of Dukes, Blainey, Cumming and Widdowson
(1963)» In a later paper, Cumming et al. (1964) reported on
the biochemical changes induced by forced alkaline diuresis.
Although they found falls in the levels of plasma potassium,
they did not consider it necessary to administer potassium
supplements with the bicarbonate to prevent intracellular
potassium loss, since the urinary excretion of potassium
over the trial period was not large and of the order of
80 mEq. They did, however, conclude by stating that further
work might indicate the place of potassium supplenents in
therapy.
From the work of Robin et al. (1959) changes in the
extracellular potassium during forced alkaline diuresis, cannot
be regarded as without significance, as electrocardiographic
changes and abnormalities of nerve conduction may occur in the
presence of hypokalaemia, even when the total body potassium
remains unchanged. Also ^inters et al. (19&3)> ®hose and
Joekes, (1964) and McLaughlin, (1965) have all stressed the
possibility of precipitating severe and even fatal alkalotic
tetany by rapid infusions of alkali. In theory, therefore,
the development of dangerous hypokalaemia was considered to be
a significant hazard with this regime. In the absence of any
clear guidance as to which patients would require potassium
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supplements and how much should be given, potassium replacements
were initially administered in a somewhat arbitrary manner
depending upon the levels of plasma potassium in each patient.
Much depended upon intelligent guess work. Ab an initial
part of the study, therefore, it was decided to assess whether
in fact potassium supplements were necessary.
Patients and Methods
The investigation took the form of two studies, the first
was a retrospective study of 15 patients, 7 males and 8 females
(Group A), who had been treated with the full infusion regime
of forced alkaline diuresis and who had also been given
potassium supplements during the main period of diuresis.
These supplements varied from 2.0 g. of potassium chloride
(26.0 mEq.K.) intravenously every hour in some patients to
0.5 g. of potassium chloride (6.5 mEq.K.) intravenously every
hour in others. For comparison, a prospective study was
carried out in 25 patients, 9 male and 16 females (Group B),
who were treated with the full infusion regime of forced
alkaline diuresis but no potassium supplements were given in the
first six hours of the diuresis treatment. The regime of
forced alkaline diuresis used was:
0.9% sodium chloride - 500 ml.
5% dextrose - 500 ml.
1.26% sodium bicarbonate - 500 ml.
These solutions were infused in rotation at a rate of
2.0 litres per hour for the first three hours, thereafter the
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rate was reduced to 1.0 litre per hour. This regime was
continued subject to the patient maintaining a normal jugular
venous pressure and to the absence of signs of pulmonary
congestion. The pulse, respiration and blood pressure were
charted every half hour and careful note was taken of the fluid
intake and output.
Specimens of blood were withdrawn for measurement of plasma
salicylate in all patients immediately before starting treatment
and at two-hourly intervals thereafter until six hours after
starting diuresis therapy. Five patients in Group A had plasma
salicylate levels measured also eight hours following starting
treatment and in Group B the plasma salicylate was measured in
eight patients, 12-hours after starting treatment.
Measurements of the plasma potassium were carried out
in all the patients in Group A immediately before starting
treatment and six hours later. In all the patients in Group B,
plasma potassium levels were measured immediately before
starting treatment and at two-hourly intervals up to the end of
the six hour period. Also in the latter group measurements of
the urinary salicylate and the urinary potassium were made in
three consecutive four-hour collections of urine, the collections
commencing at the beginning of the forced diuresis therapy.
Salicylate levels in plasma and urine were measured
photometrically by the method of Trinder (1954) • Plasma and
urinary potassium levels were measured by manual methods with
a standard technique using an Eel flame photometer.
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Results
Although there were more patients in Group B, than in
Group A, the two groups could be regarded as comparable in terms
of age, numbers of tablets taken, time since ingestion and peak
plasma salicylate levels (Tables IX and X). The range of age
in Group A was from 14-59 years and in Group B from 14-56 years.
The means respectively were 30 and 29 years. The peak plasma
salicylate levels, which were used as an index of the severity
of the poisoning, ranged in Group A from 35 to 110 mg. per 100 ml.
In Group B the range was 41 to 95 mg. per 100 ml. The respective
means were 62 and 59 mg. per 100 ml. There was no great
discrepency also in the time between ingestion of the tablets
and the measurement of the peak plasma salicylate level. The
mean time in Group A was five hours and in Group B, seven hours.
The numbers of tablets taken also were relatively comparable
although this was of less importance than the other parameters
mentioned as the information regarding numbers of tablets
tends to be unreliable and there was little relationship between
the number of tablets said to have been taken and the resulting
peak plasma salicylate level. For example in patient 11,
100 tablets were supposedly ingested and the peak plasma salicylate
level reached only 35 mg. per 100 ml. In patients 1 and 2, how¬
ever, in whom there was said to be the same number of tablets
\
taken, the peak plasma salicylate level was almost double at
65 and 62 mg. per 100 ml., despite the fact that patient 1 had

















Number of Time since Peak Plasma
/Yff® \ tablets ingestion Salicylate level
ingested. (Hours) (mg. per 100 ml.)
18 100 10 65
28 100 4 62
18 50 1 37
45 150 4 47
21 80 8 58
k2 80 4 79
55 200 6 110
17 20 8 39
54 60 4 81
59 130 5 63
38 100 2 35
17 60 5 83
15 40 1 35
41 150 6 58
14 70 4 67
* Vomited after ingestion and before
admission.
Characteristics of 15 patients admitted
with acute salicylate poisoning who were
subsequently treated with forced alkaline





Number of Time since Peak Plasma
PATIENTS tablets ingestion Salicylate level
ingested (Hours) (mg. per 100 ml.)
16 56 150 1 95
M *17 24 200 2 90
A 18 18 100 1 43
19 36 67 7 57
L 20 22 60 2 50
21
E 22
42 150 5 82
21 65 4 51
S 25 21 120 24 79
*24 18 80 9 70
25 25 75 2 45
26 36 60 6 60
27 56 50 12 44
F *28 22 120 4 60
F 29 27 40 6 60E
30 33 50 10 57
M 31 43 75 5 63
A 32 17 75 3 61
33 31 60 5 52
L 34 21 60 6 63
35 51 200 12 74
E 36 23 60 6 61
S 37 14 20 24 54
38 18 50 7 53
39 30 100 2 41
40 45 90 3 46
* Vomited after ingestion and before admission.
Characteristics of 25 patients admitted with acute
salicylate poisoning who were treated with forced alkaline
diuresis without potassium supplements.
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Clinical Progress
All of the patients were successfully given the full
diuresis regime and none showed any features of excessive
overloading of the circulation. All the patients in both
groups made a full recovery from the poisoning. In Group A,
the clinical progress was entirely satisfactory. In Group B,
however, patient 29 developed frank tetany during the regime,
and patient 17 was found to have electrocardiographic changes of
hypokalaemia (Fig. 18). Both these patients responded
satisfactorily to potassium supplements. The other patients
in Group B showed no untoward clinical features.
Changes in Plaama Salicylate Level
The results are shown in Tables XI a*d XII and also
Fig. 19. All the patients showed a satisfactory reduction in
plasma salicylate on forced alkaline diuresis. The reduction
in plasma salicylate levels was similar in the two groups. In
the six hours of observation the plasma levels fell progressively
and the mean half excretion time of salicylate for the 40 patients
was 6 hours. One patient, 31, showed a rise in plasma
salicylate level in the first two hours after starting treatment
but thereafter the fall in plasma salicylate was similar to the
other patients. This rise was presumably associated with
further absorption of the drug from the gastro-intestinal tract.
Urinary Recovery of Salicylate
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Figure 18.
Electrocardiograph carried out in Patient 17 six hours
after starting forced diuresis.
- 118 -
TABLE XI





1 65 45 34 20
M 2 62 50 40
A 3 37 36 24 15
L 4 47 43.5 35 30
E 5 51 40 33 24
S 6 79 59 38 32 16.5
7 110 76 55 40
8 37 36 22 19
9 81 53 33 25
10 61 42 36 28
11 53 44 37 31
12 83 65 35 28
13 35 33 25 16
14 58 38 32
15 67 59 50 37 24
Changes in plasma salicylate during forced alkaline diuresis
with potassium supplements in the 15 patients in Group A.
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TABLE XII
PLASMA SALICYLATE LEVELS (mg. per 100 ml.)
PAUBWS Ti*e <Itours>
Pretreatment
0 2 4 6 12
16 95 49 36 24
17 90 74 53.5
M 18 40 43 36 33 12
A 19 51 57 57 49
L 20 42 38 36 30 26
E 21 82 59 47 33
S 22 51 47 43 39
23 59 38 26
24 70 51 45 44 25
25 45 38 35
26 60 55 38
27 44 14
28 60 29




30 57 50 48 34
31 52 63 48 37
32 61 36 30 15
ii
T, 33 52 39 27 20Jj
E
Q
34 49 43 39
35 74 67 45 36
O
36 61 43 36
37 54 43 34
38 53 45 24
39 43 41 32 28
40 46 42 27
Changes in plasma salicylate in the patients in Group B
treated with forced alkaline diuresis without potassium
supplements.
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Effect on Plasma Salicylate and Potassium of A) Forced
Alkaline Diuresis without Potassium Supplements, and B)




Changes in the mean plasma salicylate standard error
°f the mean S.E.M.) and in the mean plasma potassium
(- S.E.M.) in the patients in Croup A and Group B
treated with forced alkaline diuresis.
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patients in Group B are shown in Table XIII and Figure 20.
During the main period of the diuresis the amount of salicylate
recovered in the urine was relatively high. Thereafter the
amounts excreted decreased as the diuretic regime was relaxed.
In a period of 12 hours after starting infusion therapy the mean
recovery of urinary salicylate was approximately 7.0 g. There
was a considerable variation in the recoveries of salicylate.
This in large measure depended upon the initial peak salicylate
level. For example, patient 17, who had a high initial level
of plasma salicylate and who showed a very satisfactory response
to treatment, had a recovery of salicylate in the urine of
13.5 g. On the other hand, patient 18, who had a muoh lower
initial level and who showed a much slower fall during the course
of treatment was found to have a total recovery of only 3.6 g.
of salicylate.
Changes in Plasma Potassium Level
The changes, which were observed in plasma potassium
during the course of the diuresis regime are shown in Tables XIV
and XV and also in Figure 19. The normal level of plasma
potassium by this method is 3.5-5.0 mEq. per litre. Taking
these levels as the normal range, before treatment three patients,
1,3 and 11, in Group A were relatively hypokalaemic before
starting treatment and in Group B, there were four such patients
16, 32, 35 and 37. None of these patients were severely
hypokalaemic, with the exception of patients 35 and 37> who had






0-4 5-8 9-12 Total
17 6.7 3.1 3.7 13.5
18 2.0 1.0 0.6 3.6
22 6.2 2.2 1.6 10.0
24 3.5 0.7 1.5 5.7
26 6.2 3.5 2.7 12.4
28 4.1 0.5 1.8 6.4
34 4.1 1.7 0.5 6.3
36 0.3 0.7 0.6 1.6
39 3.1 1.7 1.0 5.8
Urinary excretion of salicylate in 9 patients (G-roup B)









M 2 3.6 3.2
A 3 3.4 3.0
L 4 3.6 3.2
E 5 4.3 3.8










Changes in plasma potassium in the patients in Croup A before
and after forced alkaline diuresis with potassium supplements.
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Urinary excretion of Salicylate and Potassium with Forced




















Relationship between the reduction in mean urine volumes
(- S.E.M.) and the mean urinary excretion of salicylate
(- S.E.M.) and of potassium S.E.M.) in 9 patients treated




Plasma potassium (m.Eq. per litre)
PATIENTS Time (Hours)
Pretreatment
0 2 4 6
16 3.4 2.1 2.2
17 5.0 4.1 2.3
M 18 4.9 3.8 2.6 2.8
A 19 4.4 3.6 3.1
L 20 3.6 3.4 3.0 2.8
E 21 4.8 4.0 3.5 2.8
S 22 3.5 3.2 2.5 2.6
23 3.7 3.2 3.0
24 4.7 2.9 2.5 2.4
Changes in plasma potassium in the patients in Group B treated
with forced alkaline diuresis without potassium supplements.
25 4.6 4.2 3.0
26 4.0 3.6 4.0 3.2
27 3.6 2.8 2.5
28 4.6 3.0 3.1
29 4.2 2.7 1.2 2.7
30 3.8 3.5 3.0 2.4
31 4.0 3.6 2.9 2.5
32 3.3 3.1 2.9 2.5
33 4.0 3.2 2.5 2.6
34 3.7 2.5 2.6
35 2.4 1.8 2.0
36 3.9 2.7 2.3 2.4
37 3.1 2.8 2.6 2.7
38 3.7 3.0 2.8
39 3.5 3.6 3.1 3.0
40 4.0 3.8 2.9
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Both these patients were admitted to the unit some considerable
time after having ingested the poisoning. They were also
severely poisoned. It is therefore more likely that the acid-
base disturbance was of a more severe nature in these two patients
than in the others. If this was the case, it would almost
certainly he the reason for them being more hypokalaemic than the
other patients. In neither of these two patients was there any
other obvious cause of a low plasma potassium, such as renal
impairment or gastro-intestinal upset. During the six hours of
observation, 14 of the patients, who had potassium supplements
(Table XIV) showed significant falls in plasma potassium compared
with the pre-treatment level. In only one patient, patient 1,
was there any increase in plasma potassium. In Group B all of
the patients without exception showed hypokalaemia and in 18 of
them this eould be regarded as severe (Table XV). In two patients,
29 and 35, the hypokalaemia was alarming.
Another feature was that in some patients the hypokalaemia
developed very rapidly and six patients were seriously hypokalaemic
two hours after starting treatment. Comparison between Groups
A and B is shown in figure 19- The mean fall in plasma potassium
in Group A was relatively small and severe hypokalaemia was not
demonstrated. In Group B however, the reduction in plasma
potassium was much more marked. It is therefore surprising that
in only two patients were there any obvious features suggestive
of severe hypokalaemia. Patient 17 in whom there was found to be
a fall in plasma potassium from an initial level of 5*0 to 2.3 mEq.
per litre at the 6-hour period was found to have electrocardiographic
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changes of severe hypokalaemia. These responded satisfactorily
to appropriate subsequent potassium administrations. Patient
29 developed clinical tetany four hours after starting treatment
and this was apparently related to a reduction in the plasma
potassium from 4.2 to 1.2 mEq. per litre during the period of
treatment. The tetany continued until after the diuresis regime
had been stopped and until appropriate potassium supplements Had
been given. It is likely that tetany resulted from acute
metabolic alkalosis, which promoted the rapid fall in plasma potassium.
Urinary potassium
The results are shown in Table XVI and also in Figure 20.
As with the urinary salicylate, the urinary excretion pattern of
potassium was maximal during the initial four hours of the diuresis.
Thereafter as the urinary volume fell so the urinary potassium
excretion also fell (Fig. 20). The total losses over the 12-
hour period were considerable and ranged from 80.1 mEq. to
177.0 mEq. with a mean value of 126 mEq. There is little doubt
that the amount of potassium excreted in the urine, to
a considerable degree, was related to the urine flow, but this was
not always the case. The results for the urine volumes for nine
patients in Group B (Table XVII) revealed that there is a considerate
discrepancy between the volumes of urine produced in individual
patients and the amount of potassium excreted. The urinary
volumes produced in patient 17 and patient 36 were low relative to
the whole group. On the other hand, the excretion of potassium
during the same period of time in these two patients was high being





0-4 5-8 9-12 Total
17 93.0 36.0 48.0 177.0
18 56.0 17.7 6.4 80.1
22 7.4 147.3 18.0 172.7
24 69.0 9.7 29.4 108.1
26 87.0 31.0 31.0 149.0
28 57.0 19.7 11.5 88.2
34 82.8 7.2 11.4 101.4
36 59.0 51.0 35.0 145.0
39 30.2 60.0 23.5 113.7
Urinary excretion of potassium in 9 patients in Group B






0 « 4 00iIT\ 9-12 Total
17 1.6 0.7 1.3 3.6
18 3.5 1.4 0.5 5.4
22 2.6 5.3 0.7 8.6
24 2.3 0.5 0.7 3.5
26 2.6 1.7 1.7 6.0
28 3.8 2.1 0.5 6.4
54 2.3 0.5 1.4 4.2
36 0.4 1.2 1.2 2.8
39 4.2 i.1 0.5 5.8
URINE VOLUMES in 9 patients in &roup B during twelve hours
after starting forced alkaline diuresis without potassium
supplements.
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a urinary volume of more than twice that of either patient 17 or
36 and yet his potassium excretion was 172.7 mEq. which, although
high, was not as much as patient 17.
Discussion
Whitten et al. (1961) and Cumming et al. (1964) both agreed that
the most satisfactory measurement to use as an index of efficiency
of treatment is the rate at which the plasma salicylate concentration
falls. On this basis, comparison between these two groups of
patients showed that there was no difference in the relative
effectiveness of the two regimes in the treatment of acute salicylate
poisoning. The mean half excretion time of salicylate in both
groups was approximately 6 hours, which was similar to the results
which have been previously reported by Oliver and Dyer (1960) and
also by Cumming et al. (1964)* who used similar regimes of forced
diuresis. The diuresis treatment in this study, therefore, was
a satisfactory one from the point of view of the removal of salicylate.
When the changes in the plasma potassium occurring during the
treatment were considered, however, there was less reason for
complacency. Even in the group of patients, who were given
potassium supplements, there was a significant number, who
developed hypokalaemia. The reduction in plasma potassium in the
patients who did not receive potassium supplements was striking
and in many cases alarming. A number of patients were relatively
hypokalaemic before the start of the diuresis regime. These
results confirm the reports of Robin et al. (1959) of the importance
of hypokalaemia in acute salicylate poisoning. Admittedly the
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reduction in plasma potassium found in the present series of
patients was less marked than that reported by Robin and his
colleagues. The incidence of clinical complications due to
hypokalaemia was also less. A possible reason for this was
that most of Robin's patients had been admitted to hospital
considerably longer after the time of ingestion than is usually
the case in patients admitted to the Poisoning Treatment Centre
in Edinburgh. It is probable that in addition to the severity
of overdosage the degree and frequency of hypokalaemia in patients
with this condition are related to the duration of the poisoning.
In support of this in the present series the two patients who had
the most severe hypokalaemia before treatment was started were
admitted 12 and 24 hours after taking the tablets. This was
a considerably longer time before admission to hospital than in
the remaining patients.
The reasons for the fall in plasma potassium noted in the
patients during the course of forced alkaline diuresis were
almost certainly the result of a complex series of changes.
Urinary excretion of potassium was considerably increased during
the period of diuresis and there is no doubt that this played some
part in the development of the hypokalaemia. On the other hand,
the changes in plasma potassium occurred very rapidly and it would
seem likely that shifts of potassium ion from the extracellular
to the intracellular compartment were also occurring. During
the first six hours of the diuresis almost 3»000 mEq. of sodium
are administered and approximately 950 mEq. of bicarbonate are
also given. For practical purposes the excretion of potassium
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depends almost exclusively on the tubular secretion of potassium
in exchange for sodium. Filtered potassium plays very little
part. As most of the body potassium is intracellular the
external control of potassium relates to tubular cell content of
the ion. Also since potassium excretion depends upon an exchange
with sodium, it is regulated by the amount of sodium delivered
to the exchange site in the distal tubule, to the avidity with
which sodium is reabsorbed and to the availability of the intra¬
cellular potassium for exchange. Thus the delivery of more
sodium to the distal tubule, during sodium diuresis, increases
the excretion of potassium. It is likely, therefore, that the
excessive load of sodium during this diuresis regime will be
a contributory factor in the production of excessive potassium
loss. In addition to this, the large amount of bicarbonate
administered will both promote the movement of potassium from the
extracellular compartment to the intracellular compartment and in
addition aggravate further potassium loss in the urine. It was
surprising that no more marked clinical features of hypokalaemia
were demonstrated in the patients particularly in Group B.
The possibility of precipitating severe and even fatal
alkalotic tetany using this type of regime of therapy has been
stressed by Winters et al. (19&3)* by Ghose and Joekes, (1964) sxti-
again more recently by McLaughlin in 1965* These possibilities
have largely been on a theoretical basis and the reports of patients
with acute salicylate poisoning who develop actual tetany are
extremely few. The only well documented example was reported by
Freier et al., (1957). Of the two patients in Group B, who were
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found to have definite clinical features of severe alkalosis and
potassium depletion, one had demonstrable changes on ECG of severe
hypokalaemia and this resolved with appropriate replacement of
potassium; the other patient developed clinical tetany. This
was probably due to the induction of metabolic alkalosis resulting
from the infusions of bicarbonate. In addition this patient was
shown to develop severe and rapidly developing hypokalaemia.
Unfortunately there were no measurements of acid-base status done
in any of these patients. However after stopping bicarbonate
therapy and the administration of potassium the tetany subsided.
Prom the results of this study, there seems little
justification for the conclusion of Cumming et al. (1964), in
which they considered it unnecessary to administer potassium with
bicarbonate during the course of forced alkaline diuresis.
Indeed the changes in plasma potassium observed in the patients
Group A who were given intravenous potassium supplements, suggested
that vigorous potassium replacement therapy is required if serious
and rapid changes in the plasma potassium are to be avoided.
The results of this initial study demonstrated that forced
alkaline diuresis, as suggested by Cumming et al. (1964), is an
extremely efficient method in reducing the plasma salicylate in
patients suffering from acute salicylate overdosage. It is
a therapy, however, which has a number of inherent dangers, which
are associated not only with the brisk diuresis produced, but
more particularly, with the large quantities of sodium and
bicarbonate, which are administered in the course of the regime.
The main complication was the high incidence of hypokalaemia.
J
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Few clinical features of potassium deficit were observed but
the rapidity and degree of changes of plasma potassium, which
occurred, were alarming and could only be regarded as potentially
hazardous. Tetany, which was probably related to the rapid
development of alkalosis, occurred in another patient and, although
an uncommon finding, did suggest that this regime of treatment
may provoke harmful changes in acid-base status.
A number of workers including Curaraing et al. (1964) have
acknowledged these complications of the therapy but as they were
unable to demonstrate any serious clinical features resulting from
the changes in acid-base status and in plasma potassium, they
considered that the advantages of rapid reduction in plasma
salicylate more than compensated for any possible hazards, which
might exist. Considerable controversy still exists, regarding the
advantages and disadvantages of forced diuresis in acute salicylate
overdosage and about the exact regimes, which should be used.
It was decided, therefore, to conduct a detailed clinical and
biochemical study of the effects of different regimes of forced




Forced oral fluids were reported to be ineffective in the
treatment of patients with severe salicylate poisoning (Doolan,
et al., 1951). On the other hand, correction of dehydration
and maintenance of fluid balance by this means is widely used in
the treatment of the less severe forms of this poisoning. It
was decided, therefore, in the first instance to gather a group
of patients who were judged to be only moderately poisoned, who
had not vomited and in whom nausea was not a marked feature.
The protocol used for this study was similar to the one employed
for patients who had more severe forms of the overdosage and in
whom more elaborate forms ofdiuresis were used.
Biochemical Methods
The same methods of biochemical measurements were used
throughout the whole study.
The arterial pH, partial pressure of carbon dioxide (pCC^)
and Standard bicarbonate, were determined at 38°C by the micro
Astrup method (radiometer PHM 27) of Siggaard-Andersen (1962).
The urine pH was measured at room temperature using a glass
electrode (radiometer PHM 25)j the pH meters were calibrated with
precision phosphate buffers. The packed cell volume (PCV) was
measured using a micro-haematocrit centrifuge (Hawksley). Plasma
and urinary salicylate was assayed photometrically (EEL Spectra)
by the Method of Trinder (1954). Plasma and urinary sodium and
potassium were measured manually by conventional methods (EEL
flame photometer). Flasma calcium was measured by automated
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colourimetry (Auto Analyzer) according to the method of
G-itelman (19^7) - Plasma and urinary magnesium and urinary
calcium was estimated by atomic absorption spectrophotometry
(Perkin-Elmer 303) by the technique described by Thin and Thomson
(1967). These electrolyte determinations were made using
primary standards (B.D.H., analar), which were themselves checked
against control sera (Hyland or Versatol).
Patients and Methods
Nine patients, 4 males and 5 females were studied whilst
under treatment with forced oral fluids. Characteristics of these
nine patients are shown in Table XVIII. They had all been
admitted to hospital a relatively short time after ingestion
(mean time 4.3 hours). The peak plasma salicylate level found
in these patients ranged from 38 to 62 mg. per 100 ml. On this
basis a number of the patients were fairly severely poisoned but
none of the patients had very severe symptoms and were not unduly
distressed. As they were to be carefully monitored it was,
therefore, considered justifiable to treat them with this form
of therapy alone.
All the patients in this group were encouraged to drink as
much fluid as possible, particularly during the six hours of
treatment. It was found that the fluid intake was considerably
limited by nausea, which was precipitated relatively easily, even
in patients who had not previously spontaneously complained of
this. The fluids used were in the main simply iced water
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given, as they were better tolerated. Fluid intake achieved
ranged from 170 to 210 ml. per hr. with a mean of 190 ml. per hr.
With all the regimes of forced diuresis studied the period chosen
for close observation was the six hours after the start of
treatment. This period represented the phase of maximum diuresis
in the case of the intravenous regimes. Also during these first
six hours the patients were given only the treatment regimes
stated; in particular, there were no complicating factors such
as the need for potassium supplements other than those contained
in the type of treatment under study. Also no food was given to
the patients during the six hour period.
The arterial blood gases were measured in seven of the nine
patients at the time of the peak plasma salicylate level.
Subsequently these measurements were monitored for six hours after
the commencement of treatment. The blood gas measurements were
made on blood taken from the brachial artery by routine arterial
puncture. The usual precautions of collection and preservation
of the samples of arterial blood were made. The blood gas
measurements were all carried out within 30 minutes of the time
of arterial puncture. The plasma salicylate was measured in
all patients at the time of admission to hospital and hourly for
six hours after the beginning of treatment. In a number of
patients, the further measurements of the plasma salicylate were
made at eight hours and in a few up to 24 hours. The plasma
salicylate was carefully monitored incase it would rise
significantly above 60 mg. per 100ml. as this would have required
a more active form of therapy. The urinary salicylate was
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measured, in consecutive hourly specimens of urine and the
urine volumes were also carefully noted. The plasma potassium
was also measured in all patients and monitored at hourly
intervals for six hours, in a number of patients for eight hours
and in a few up to 24 hours. Urinary excretion of potassium
was measured at hourly intervals for six hours after commencement
of treatment. Plasma magnesium levels were estimated in six
patients at hourly intervals from the beginning of treatment up
to the end of the six hour period, and the plasma calcium was
determined in four of the patients in a similar manner. In
each patient the plasma sodium was measured every two hours for
the first six hours and the urinary excretion of sodium was also
measured during the same period.
Results
Clinical Response
All of the nine patients ultimately made a complete and
uneventful recovery, from the poisoning. In each patient, who
had any features of salicylism, however, it was noticeable that
symptoms persisted for up to 24 hours after starting treatment.
None of the patients had to be treated subsequently with any
more active form of therapy to remove salicylate.
Changes in Plasma Salicylate and Acid-Base Status
The results are shown in Table XIX. In five patients
(42, 43, 2j4, 45 and 47) the plasma salicylate was found to rise
somewhat during the first four hours of treatment. In all these
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TABLE XIX
PLASMA SALICYLATE (nig. per 100 ml.)
PATIENTS Time (Hours)
Pretreatment
0 2 4 6 8 12 18 24
41 48 44 43 38 33
42 48 49 53 34
43 42 51 49 35 20
44 44 49 53 34
P
E 45 45 51 62 50 46
M 46 52 52 49 49 47
A 47 46 48 40 36 32 28
L 48 38 38 34 30 30 15
E 49 51 49 46 46 50 48
S
Changes in plasma salicylate in 9 patients with acute salicylate
poisoning treated only with forced oral fluids.
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Acid - base Status of Patients in Relation to Plasma Salicylate
during Forced Oral Fluids.
J I I I I I I
0 1 2 3 C 5 6
HOURS
Figure 21.
The mean values of arterial pH, pCO^ and standard
bicarbonate (- SEM) in relation to changes in the
mean levels of plasma salicylate (- SEM) in 9 patiai ts
treated with forced oral fluids.
-In¬
patients, however, the blood level subsequently fell. The
mean results for the group of nine patients are shown in Figure
21. During the first six hours of treatment there was a fall
of rather less than 10 mg. per 100 ml. on the average. On
extrapolation of this data, the mean half excretion time for
salicylate for this group of patients was between 20 and 24 hours.
In Table XVIII is shown the acid-base status observed in
seven of the patients in relationship to the peak plasma salicylate
levels. Four of these patients had normal pH levels. In three
patients (41, 47 and. 49) a moderate alkalosis was present and the
associated low levels of pC02 and standard bicarbonate suggested
that this was predominantly a respiratory alkalosis.
Mean changes in arterial pH, pCO^ and standard bicarbonate
are shown in Figure 21. The normal range for arterial whole
blood pH in this laboratory is 7.39-7.43. On the whole, the
mean arterial pH remained slightly elevated or in the high range
of normal and overall there was little change in the level
throughout the period of observation. The normal range of
pCO,., for this method is 37-42 mm.Hg. and the results show that
the mean values of pC02 at different times during the six hour
period remained consistently low. As with the arterial pH
there was little fluctuation in the actual levels measured
during the six hour period. In the case of standard bicarbonate,
the normal level ranged from 25-28 mEq./l. and here again the
levels remained steady but generally low.
Relationship Between Changes in Plasma Salicylate and Urinary
Salicylate
The changes in plasma salicylate and the urinary excretion
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of salicylates over the first six-hour period are shown in Tables
XIX and XX. Comparison between the mean values and the appropriate
standard errors for plasma salicylate, urinary salicylate, urinary
pH and urinary volume are shown in Figure 22. As has already
been seen, there was only a modest fall in the plasma salicylate
during the six-hour period. The graph of the urinary salicylate
would indicate that at first there was a high excretion of salicylate.
This quickly fell and after two hours and for the rest of the six
hours remained fairly constant at a relatively low level. These
changes in salicylate excretion corresponded to changes in urinary
volume during the same period of time. The apparently high
initial levels of salicylate excretion were probably false as the
measurements of urinary salicylate and the urinary volume at
0 hours did not represent an accurate one hour collection of urine
and was simply the urine collected when the patient emptied his
bladder immediately at the commencement of treatment. It therefore,
in most cases, reflected several hours urinary excretion and was
not comparable with the remaining part of the graph.
The total urinary outputs of salicylate (Table XX) were
relatively constant, with one exception, patient 44, who showed an
excretion of about two times that of any of the other members of
the group. The urinary volume found in this patient was not
excessive and averaged 300 ml. per hour. Possibly a more
significant factor was that the urinary pH in this patient ranged
between 6.5 and 7.0 which was significantly higher than the levels
found in the other patients studied. Mean values of urinary pH
for the whole group of patients remained relatively low in the
region of 6.25. The average pH before treatment however was
TABLE XX
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0 1 2 3 4 5 6 Total
(mg.)
M
A 41 948 387 387 149 140 154 136 2301
L 43 340 236 240 440 85 185 100 1626
E
S
44 360 720 520 520 520 750 750 4140
P
45 261 230 236 185 160 85 100 1257
46 817 217 225 210 140 132 149 1890
48 909 85 95 76 80 94 84 1423
49 117 320 340 230 222 9 9 1247
S
Urinary excretion of salicylate in 7 patients during diuresis on
forced oral fluids.
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Effects of Forced Oral Fluids on Plasma Salicylate and
Urinary Salicylate, pH and Volume.
HOURS
Figure 22.
Comparison between the mean changes (- S.E.M.) of plasma
salicylate, urinary salicylate, urinary pH and urinary
volume in nine patients treated with forced oral fluids.
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rather higher than subsequent measurements and the urinary pH
tended to fall as the period of observation progressed.
Changes in Plasma Potassium and Urinary Potassium in Relationship
to Arterial pH and Urinary pH
The changes in plasma and urinary excretion of potassium
during the period of observation are shown in Tables XXI and
XXII and the relationship between the changes in the mean values
of plasma potassium and urinary potassium are plotted in
relationship to the mean values of arterial and urinary pH in
Figure 23. One patient, 48, was found to be mildly hypokalaemic
before the commencement of treatment and he remained mildly
hypokalaemic throughout the period of observation. In two
patients, 43 and 44, there was no significant alteration in the
plasma potassium during the period of study. The remaining six
patients all developed a modest degree of hypolcalaemia. In
I
the few measurements taken beyond the eight hour period it seemed
that the nadir of the curve for hypokalaemia occurred between six
and eight hours following the start of treatment.
The urinary excretion of potassium in seven of these
patients is shown in Table XXII. The losses of potassium during
the six hour period were relatively small, with one exception,
patient 44, who as with urinary salicylate losses, excreted
considerably more potassium than any of the other patients
studied. Despite this there was no demonstrable change in his
plasma potassium. The mean losses of the urinary potassium
(Fig. 23) tended to fall as the study progressed. From the graph






0 2 4 6 8 12 18 24
M
A 41 4.3 3.3 3.0 3.1 3.3
L 42 3.7 4.0 3.2
E 43 4.2 4.3
S 44 4.1 4.0 4.2
F
E 45 4.2 3.4 3.3 3.6 3.5
M 46 3.8 3.6 3.6 3.6 2.8
A 47 3.5 3.6 3.5 3.4 3.4
L 48 3.4 3.8 3.4 3.4 3.1
E 49 3.6 3.5 3.1 3.8 3.5
S
Changes in plasma potassium in 9 patients with acute
salicylate poisoning treated only with forced oral
fluids.
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Effects of Forced Oral Fluids on Plasma Potassium,Urinary
Potassium, Arterial pH and Urinary pH.
HOURS
Figure 23,
Changes in the mean values (- S.E.M.) of plasma potassium,
urinary potassium, arterial pH and urinary pH in nine
patients treated with forced oral fluids.
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TABLE XXII
URINARY EXCRETION OF POTASSIUM (m.Eq./hour)
PATIENTS TiM (Bour3)
Pretreatment
0 1 2 3 4 5 6 Total
M
A 41 35.0 15.0 15.0 8.25 8.25 8.25 8.25 63.0
L 43 11.0 7.5 7.5 2.7 4.0 4.0 4.3 41.0
E
S
44 23.0 26.0 26.0 26.0 26.0 17.0 17.0 161.0
F
E
M 45 3.3 2.0 2.3 2.3 2.3 2.3 5.6 20.1M
A 46 21.2 8.1 8.1 8.3 3.8 3.8 3.8 57.1
J±
T, 48 20.0 1.6 1.6 1.6 1.4 1.8 1.3 29.3Jj
E 49 5.0 10.0 9.6 8.5 8.5 0.5 0.5 42.6
S
Urinary excretion of potassium in 7 patients during
diuresis on forced oral fluids.
- 150 -
also demonstrated. Another important factor was that the urinary
output also fell at the same time. It would seem, therefore,
that the tendency for the plasma potassium to fall was not due to
any excessive loss in urine. The mean values of the plasma
potassium reflect the very modest degree of hypokalaemia which was
found in these patients.
Changes in Plasma Potassium. Magnesium and Calcium in Relation to
Arterial pH and P.C.V.
The changes in plasma magnesium in six patients and in plasma
calcium in four patients are shown in Tables XXIII and XXIV. The
relative changes in the mean values within each group over the six
hour period for plasma potassium, magnesium, calcium and arterial
pH and P.C.V. are shown in Figure 24. The normal range of plasma
magnesium for the method used was 1.7 to 2.4 mg. per 100 ml.
All of the patients (Table XXIII) had normal levels of plasma
magnesium throughout the period of study. Similarly for plasma
calcium, none of the patients showed a reduction of plasma calcium
below the lower limit of normal for this technique of measurement
which was 8.5 mg. per 100 ml. (Table XXIV). In Figure 24 there is
shown the slight fall in the packed cell volume from the third to
the sixth hour. This reduction was small and of doubtful
significance, but it may indicate a slight degree of haemodilution.
This may have been a factor in the slight reductions in plasma
potassium and plasma calcium, which were noted also during the
latter three hours of observation.
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TABLE XXIII
PLASMA MAGNESIUM (mg. per 100 ml.)
PATIENTS Time (Hours)
Pretreatment





41 2.24 1.91 1.83 2.16
F
E 45 2.3 2.45 2.25
M 46 2.08 2.04 2.00 2.08
A 47 2.28 2.08 2.24 2.24
L 48 2.08 1.83 1.95 2.04
E 49 2.30 2.25 2.20 2.25
S
Changes in plasma magnesium in 6 patients treated only
with forced oral fluids.
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TABLE XXIV

























Changes in plasma calcium in 4 patients treated only
with forced oral fluids.
- 153 -
Effects of Forced Oral Fluids on Plasma Potassium, Magnesium
and Calcium and on Arterial pH and Packed Cell Volume.
Figure 24.
Changes in the mean values (- S.E.M.) of plasma potassium,
magnesium, calcium, arterial pH and P.C.V. in patients
treated with forced oral fluids.
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Changes in Plasma and Urinary Sodium
Changes in the levels of plasma sodium are shown in
Table XXV. The normal range for plasma sodium was 135-143 m.Eq.
per litre. The plasma levels remained relatively constant
during the six hours and none of the patients developed significant
hyponatraemia. The urinary excretions of sodium in the six hours
varied from 37.0-108 m;Eq. (mean 83 m.Eq.).
Discussion
The fluid intake achieved in this group of patients was
relatively small and only a limited diuresis was achieved.
Assessing the method in terms of reduction in plasma salicylate
there was no difference between the calculated mean half
excretion time for salicylate compared with that which has been
reported in untreated cases (Cumming et al., 1964). This form
of therapy, therefore, was of no value except possibly in the case
of the very mildly poisoned patients in whom simple rehydration
is all that is required. This group of patients however provided
a valuable control group for comparison with the more intensive
forms of diuresis therapy.
In terms of acid-base disturbance, this small group of
patients demonstrated the mixed type of acid-base disturbance,
which occurs in acute salicylate poisoning. In the seven
patients in whom measurements of acid-base status were made four
had arterial pH's within the normal range and three were alkalotic.
All of these patients without exception had consistently low
arterial pCQ^ and standard bicarbonate levels. This suggested
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TABLE XXV
PLASMA SODIUM (ra.Eq. per litre)
PATIENTS Time (Hours)
Pretreatment
0 2 4 6
41 145 142 145 140
42 144 138 138 134
43 140 140 141 141
44 140 144 140 143
F
E 45 137 138 138 137
M 46 137 138 145 138
A 47 140 136 134 134
L 48 135 137 136 138
E 49 144 140 140 142
S
Mean Values 140 1 39 140 1 38
Changes in plasma sodium in 9 patients treated only
with forced oral fluids.
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that there was an element of respiratory alkalosis, which was not
of sufficient severity to prevent the normal buffer mechanisms of
the body from containing the blood pH within the normal level in
four of the patients but was of greater significance in the
remaining three. In two of the patients with alkalosis the
standard bicarbonate levels were relatively high indicating
a degree of compensation for the respiratory alkalosis. In the
last patient however there was no sign of this in that both the
arterial pC02 and standard bicarbonate remained low. The fact
that the arterial pC02 levels remained persistently low in all
the patients was not surprising. The plasma salicylate levels
remained high and so there would be a continued stimulatory effect
on the respiratory centre. This is an effect, which has been
noted by a number of authors including Tenney and Miller, (1955);
Winters, Lowder and Ordway (1958); Oliver and Dyer, (1960) and
Whitten, Kesaree and Goodwin, (1961).
The urinary recoveries of salicylate were rather low with
the one exception mentioned in the results. This patient also
was the one patient, who showed significant losses of potassium
in the urine. It was noted that the pH of this patiaat's urine
was higher than that of the other patients in the group. As the 1
urinaiy flow achieved was limited this was not a major factor.
It is more likely that the increases in excretion of salicylate
and potassium were related to the differences in pH present. The
more alkaline the urinary pH the more salicylate and potassium
will be lost by this route (Robin et al., 1959; Cumming et
al.± 1964). The urinary pH found in the whole group was in the
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acid range throughout the six hour period of observation. This
was reflected in the falling excretion rates of salicylate.
Hypokalaemia, although present in several patients was only
mild in degree and so not considered to be of very great
significance from the therapeutic point of view. The changes in
hypokalaemia may be explained primarily as a result of the salicyHafce
intoxication itself (Robin et al., 1959) rather than any effects
of the therapy, which was given. All patients made a satisfactory
recovery without the need for potassium supplements and no
significant changes in the other three cations investigated,
magnesium, calcium and sodium were demonstrated.
In conclusion, therefore, the changes in plasma salicylate
and particularly the calculated nean half excretion time of
salicylate in patients treated with oral fluids alone were little
different from those found in patients who are given no specific
therapy. This therapy was ineffective in patients with moderate
or severe intoxication and in all but the mildest types of
poisoning, it fails to relieve the symptoms of salicylism which
may persist for many hours after starting therapy.
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FORCED SALINE - LAEVULOSB DIURESIS
In previous reports, Doolan et al. (1951) concluded that,
what they called forced water diuresis, was ineffective in
increasing the removal of salicylate from patients with acute
overdoses of this drug. The rate of infusion given was, however,
considerably less than that used in the forced alkaline diuresis
regime suggested by Cumming et al. (1964). The latter regime
involves a very considerable administration of sodium ion and
.
also of bicarbonate both of which have been incriminated in
causing other severe biochemical and acid-base upsets. It was,
therefore, decided to investigate a group of patients with moderate
and severe acute salicylate poisoning to determine the effective¬
ness of forced saline-laevulose diuresis using the same rate
of infusion as that used in forced alkaline diuresis in reducing
the plasma salicylate. Studies were also made of the biochemical
and acid-base changes which occurred during the course of
this treatment.
Patients and Methods
Eleven patients, 8 male3 and 3 females, were treated by
this method. The regime of infusion used was,
0.9 per cent sodium chloride - 500 ml.
5.0 per cent laevulose - 500 ml.
5.0 per cent laevulose - 500 ml.
These solutions were given in rotation at a rate of 2.0
litres per hour for 3 hours and 1 .0 litre per hour thereafter.
In 4 patients (all of whom were male) (Table XXVI), no potassium
PATIENTS
Age (Years)
Number of Tablets Ingested
Time Since Ingested (Hours)
Peak Plasma Salicylate Level (mg.per 100ml.)




































Characteristicsofifpatienttreatedwi hforcedsaline- laevulosediuresiswithoutpotassi msuppl m nts.
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supplements were added to the regime, but in the remaining
7 patients, 4 males and 3 females (Table XXVII) a standard
administration of 2.0 g. KC1 (26 m.Eq.K+) was given intravenously
in every 500 ml» bottle after the fifth bottle in the regime.
The patients were all moderately or severely poisoned, the
plasma salicylate varying from 46-83 mg. per 100 ml. (mean
64 mg. per 100 ml.). All had been admitted to hospital relatively
soon after having taken the tablets (range 2-9 hours; mean 4.8
hours). As in the group of patients treated with oral fluids
alone, the main period of investigation using forced saline-
laevulose diuresis was the first six hours following the start
of treatment.
In each patient the plasma salicylate was measured
immediately before starting treatment and at hourly intervals
for four hours thereafter and then two hourly up to eight hours.
In two patients further measurements were made up to 24 hours.
Measurements of the arterial pH, pCOg and standard bicarbonate
were made on blood taken from the brachial artery by routine
arterial puncture, immediately before starting treatment and twice
at three hourly intervals after the infusion began. The usual
precautions of collection and preservation of the samples of
arterial blood were made. The blood gas estimations were all
carried out within 30 minutes of the time of arterial puncture.
Measurements of the plasma potassium, calcium and magnesium and
the packed cell volume (P.C.V.) were made on venous blood taken
at the time of the arterial punctures. Levels of plasma sodium
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before treatment and at two hourly intervals for six hours.
The patients emptied their bladders at the start of
treatment and the volumes of this urine and hourly collections
of urine for six hours after starting treatment, were carefully
measured. Aliquots of the pretreatment collection of urine and
also of those made at the third, fifth and sixth hours were
carefully taken into a well fitting syringe, when the urine was
fresh, and capped as with the arterial specimens for blood gases.
The urine pH was estimated on each of these specimens. The
urinary salicylate and potassium levels were measured on each of
the hourly collections of urine and the total six hour urinary
magnesium, calcium and sodium excretions were measured in
8 patients. The plasma osmolality was monitored in 4 patients
using semi-micro osmometer tubes (Advanced Instruments).
Results
A. Forced Saline-Laevulose Diuresis Without Potassium Supplements
Clinical Progress
The acid-base status of the 4 patients is shown in Table
XXVI. Two patients had a normal arterial pH and the other two,
51 and 52, were alkalotic. The corresponding levels of pC02
and standard bicarbonate suggested that this was a partially
compensated respiratory alkalosis. The levels of pC02 and standard
bicarbonate were moderately reduced in all patients.
All of the four patients made a full recovery from the
poisoning. None of them showed any features of tetany or of
hypokalaemia in the form of electrocardiographic changes or
muscle weakness. As with the patients treated with oral fluids,
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the clinical signs and symptoms of salicylism, particularly
tinnitus, deafness, hyperpnoea and sweating, were not relieved
rapidly by this method of treatment. These features when presen
tended to persist for up to 12 hours after starting infusion.
Changes in Plasma Salicylate in Relation to Urinary Salicylate.
Urinary pH and Urinary volumes
Results are shown in Table XXVIII and figure 25. In all
patients there was a steady fall in plasma salicylate during the
period of observation. From these figures the calculated mean
half excretion time for salicylate in these 4 patients was
between 9w "10 hours.
The pattern of urinary excretion of salicylate showed
a steady fall from the second hour of the diuresis until the
end of the period of study. This occurred despite the fact
that a good diuresis was abhieved. Two hours after starting the
infusion a urine flow of 500 ml. per hour or more was achieved
and this was maintained for the remainder of the diuresis. The
urine pH remained acid throughout and there was a tendency for
the acidity to increase as the diuresis proceeded. The total
six-hour recovery of salicylate in the urine for the four patiaits
is shown in Table XXIX. There was a considerable increase
compared with the pretreatment values but the actual recoveries
were of only modest amounts ranging from 2.6-4.5 g. salicylate.
Relationship Between Changes in Plasma Salicylate and Acid-Base
Status
Results are shown in Fig. 26.
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TABLE XXVIII




50 60 54 49 49 49
51 60 53 43 43 33
52 65 60 52 50 47
53 65 51 50 47 36
Changes in plasma salicylate in 4 patients
treated with forced saline-laevulose diuresis
without potassium supplements.
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Effects of Forced Saline-Laevulose Diuresis without Potassium




Changes in the mean values (- S.E.M.) of plasma and
urinary salicylate, urinary pH and urine volumes in four





































































Fluidba anceaurinaryexc etionpatternsofpot ssi m,calci m,magnesiuma dsalicyl tebef rdf er forceddiuresiswithsaline—laevulosewithoutpotassiumsu plements.
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Acid-Base Status of Patients in Relation to Plasma Salicylate
during Forced Saline-Laevulose Diuresis without Potassium
Supplements.
0 1 2 3 (. 5 6
HOURS
Figure 26.
Changes in the mean values (i S.E.M.) of plasma
salicylate in relation to the mean values (- S.E.M.)
of arterial pH, pGO^ and standard bicarbonate in four
patients treated with forced saline-laevulose diuresis
without potassium supplements.
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Despite a fall in mean plasma salicylate from 62.5 to 47 mg.
per 100 ml. in 6 hours no significant changes were noted in the
mean levels of arterial pH, pCO^ or standard bicarbonate. The
mean level of arterial pH remained within normal limits whereas
the arterial pC02 and standard bicarbonate were consistently low.
Changes in Plasma and Urinary Potassium in Relation to Alteration
in Arterial and Urinary pH
The changes in plasma potassium are shown in Table XXX and
the mean values for the four parameters are plotted in Pig. 27.
The general trend of mean values showed that there was a reduction
in plasma potassium over the six hour period. The reduction,
however, was relatively small and only one patient, 53» who was
mildly hypokalaemic before treatment, developed any significant
hypokalaemia. He did not, however, have any clinical features
of potassium deficit.
The curve for urinary potassium showed an initial elevation,
which was probably related to the fact that the pretreatment
collection of urine was not an accurately measured hour collection
and reflected the urinary excretion of potassium for a longer
period of time than the other collections shown. From one hour
to the end of the diuresis period the average hourly excretion of
potassium remained remarkably constant. The total excretion of
potassium for the individual patients is shown in Table XXIX.
Only modest losses of potassium occurred during the six hour
period ranging from 30.0 to 75.0 m.Eq.K* (mean 49.25 m.Eq.).
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TABLE XXL




50 3.8 3.6 3.5
51 4.2 3.8 3.6
52 4.2 3.8 3.6
53 3.2 3.0 2.9
Changes in plasma potassium in 4 patients treated with
forced saline-laevulose diuresis without potassium
supplements.
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Effects of Forced Saline-Laevulose Diuresis without Potassium
Supplements on Plasma Potassium, Urinary Potassium,
Arterial pH and Urinary pH.
0 1 2 3 l 5 6
HOURS
Figure 27.
Changes in the mean values S.E.M.) of plasma and urinary
potassium and the arterial and urinary pH in four patients
treated with forced saline-laevulose diuresis without
potassium supplements.
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There was no significant change noted either in the arterial
or urinary pH and so changes in acid-base probably had little
influence on changes in plasma potassium in these patients.
Changes in Plasma Potassium. Magnesium and Calcium in Relation to
Changes in Arterial pH and P.C.V.
Mean results are plotted in Fig. 28.
The changes in plasma magnesium and calcium in three of
the patients are shown in Tables XXXI and XXXII. Two of the
three patients, 51 and 52, were found to have significant hypo-
magnesaemia and hypocalcaemia towards the end of the six hour
diuresis period. The urinary loss of both magnesium and calcium
over the 6 hour period in these two patients are shown in Table
XXIX. In neither patient was the magnesium loss excessive and
also the calcium loss in patient 52 was not remarkable. In
patient 51, however, the calcium loss in the urine was considerable
and associated with the greater urinary loss, also showed the
most dramatic fall in plasma calcium.
Simultaneous with the reductions in plasma potassium,
magnesium and calcium there was also a 16 per cent reduction in
P.C.V. over the 6 hours. The average fall in plasma potassium
was 13 per cent and in plasma magnesium was 27 per cent. The
mean fall in plasma calcium was 18 per cent.
Fluid Balance
The fluid balance was calculated in all patients from the
time of starting treatment until the end of infusion therapy. This
was determined both by a reduction in plasma salicylate to below
35 mg. per 100 ml. and provided that the patient was able to tolerate
an adequate oral intake of fluids. This time varied considerably
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Effects of Forced Saline-Laevulose Diuresis without Potassium
Supplements on Plasma Potassium .Magnesium and Calcium.
Arterial pH and Packed Cell Volume.
HOURS
Figure 28.
Changes in the mean values (— S.E.M.) of plasma potassium,
magnesium and calcium, arterial pH and P.C.V. in patients









: A 50 2.10 2.20 2.05
L 51 2.25 2.45 1.70
E 52 2.40 2.10 1.75
S
Changes in plasma magnesium in 3 patients treated with






















Changes in plasma calcium in 3 patients treated with
forced saline-laevulose diuresis without potassium
supplements.
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from patient to patient as might be expected. In these four
patients the duration of infusion therapy ranged from 8-14 hours.
It is of interest to note (Table XXIX) that all the patients were
found to have a fluid deficit ranging from 1.5-6.7 litres. This
was in spite of copious fluids intravenously and the fact that all
the patients had a brisk urine flow during the period of diuresis.
None of the patients showed any clinical features of dehydration.
B. Forced Diuresis with Saline-Laevulose with Potassium Supplements
Clinical Progress
All of the patients treated with this regime made a full
recovery from the poisoning. Wone of them showed any clinical
evidence of tetany or hypokalaemia. However, as in the previous
group of patients, clinical features of salicylism tended to
persist for 12 or more hours after the infusion regime was started.
The main features which persisted were nausea, sweating, hyperpnoea
and tachycardia.
Acid-Base Status of the Patients
Results are shown in Table XXVII. Four patients had arterial
pH levels within the normal range. The remaining three patients
(55, 56 and 60) were alkalotic. The levels of arterial pCC>2 and
standard bicarbonate were low in all patients.
Changes in Plasma Salicylate in Relation to Urinary Salicylate.
Urinary pH and Urinary volumes
Results are shown in Table XXXIII and Fig. 29. In all
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TABLE XXXIII
PLASMA SALICYLATE (mg. per 100 ml.)
PATIENTS Time (Hours)
Pretreatment
0 2 4 6 8 12 16 24
54 78 67 62 60 55 42 36
55 65 60 52 50 48
56 60 53 43 43 33
57 60 54 49 51 51 49
E
M 58 83 60 52 49 49 46
A 59 66 50 49 50 47 45
L 60 61 59 53 42 38 33
E
Changes in plasma salicylate in 7 patients treated with












Effects of Forced Saline-Laevulose Diuresis with Potassium


















Changes in the mean values (- S.E.M.) of plasma salicylate,
urinary salicylate, urinary pH and urine volumes in 7 patients
treated with forced saline-laevulose diuresis with potassium
supplements.
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patients there was a steady reduction in plasma salicylate. The
calculated mean half excretion time for plasma salicylate, in this
group of patients, was 11.8 hours. In some patients, 54, 57 and
59, in whom plasma salicylate levels were measured for longer periods
the half excretion time was longer than that calculated.
Despite again a satisfactory urine flow which averaged 600 ml.
per hour throughout the period of observation, the pattern of
urinary excretion of salicylate, after an initial rise in the first
hour, steadily fell as the diuresis proceeded. The total amounts
of salicylate recovered in each patient over the six hour period
are shown in Table XXXIV. The recoveries ranged from 1.2 to 4*8 g.
salicylate (mean 5*0 g.).
The urine pH remained acid throughout and over the six hour
period there was a tendency for the mean urine pH to become even
more acid.
Relationship Between Changes in ELasma Salicylate and Acid-Base
Status
The changes in arterial pH, pCOg and standard bicarbonate are
shown in Table XXXV. The mean changes in these relative to mean
changes in plasma salicylate are plotted in Pig. 30. In all the
patients there was a fall in arterial pH. The three female
patients, all became mildly acidotic. There was a tendency for
the pCOg to rise in the second 3 hours of the observation period,
but only one patient, 56, had a pCO within the normal range. There
was little change in the levels of standard bicarbonate in the four
males, but the three female patients all had increased levels at the























































































































PATIENTS pH pC02 (mm./Hg.) Bicarbonate
(m.Eq./litre)
Peak Lowest Peak Lowest Peak Lowest







M 58 7.44 7.37 16.5 13.0 19.5 12.0
A 59 7.46 7.37 22.0 15.0 20.0 16.0
L 60 7.47 7.39 24.0 21.0 22.5 13.0
E
S
54 7.43 7.41 20.0 19.0 19.5
55 7.50 7.46 22.0 21.0 20.0
56 7.52 7.46 29.0 23.0 24.0
57 7.48 7.41 22.5 20.0 21.0
Acid-Base changes during the period of observation in
7 patients treated with forced saline-laevulose diuresis
with potassium supplements.
- 181 -
Acid-Base Status of Patients in Relation to Plasma Salicylate




Changes in the mean values (- S.E.M.) of plasma salicylate
in relation to changes in the mean values (- S.E.M.) in
arterial pH, pCOg and standard bicarbonate in 7 patients
treated with forced saline-laevulose diuresis with
potassium supplements.
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bicarbonate did not change during the six hours after starting
treatment.
In general the changes in blood gases and pH were associated
with the fall in plasma salicylate.
Changes in Plasma and Urinary Potassium in Relation to the Arterial
and Urinary uH
Results are shown in Tables XXXIV and XXXVI and the mean
values are plotted in Pig. 31. There was little change in the
average levels of plasma potassium in this group of patients.
Only at the fifth hour was mild hypokalaemia found. Two
patients, 55 and 60, were significantly hypokalaemic before the
start of treatment, but with the regime of potassium supplements
the plasma levels rose in both patients and within four hours had
reached normal levels. Another two patients, 54 and 58, became
hypokalaemic at 12 hours, but in both the plasma levels had
returned to normal within 24 hours.
The hourly urinary potassium remained steady throughout the
first six hours of observation, with the exception of the
pretreatment excretion which was higher than subsequent measuremaits.
The pretreatment collection was not a measured hour's collection
and probably reflected excretion which had occurred over a longer
period of time. The arterial pH fell slightly, but the urinary
pH did not change significantly during the six hour period. The
total recoveries of potassium in the urine were not large with
the exception of patient 60, who excreted119 m.Eq.K+. The range






0 2 4 6 8 12 24
M
A 54 4.2 4.4 4.0 5.0 3.1 3.8it
T 55 3.0 3.2 3.5 3.4 3.6
Jj
T? 56 4.2 3.8 3.7 3.6 4.8£J
S 57 3.8 3.5 3.6 3.6 3.8 3.7
F
E
M 58 3.8 4.3 4.2 3.4 3.3 2.8 3.4
A 59 4.4 4.6 4.0 4.6 4.5 4.4
L 60 3.0 3.2 3.5 3.4 3.6
E
S
Changes in plasma potassium in 7 patients treated with
forced saline--laevulose diuresis with potassium supplements.
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Effects of Forced Saline-Laevulose Diuresis on Plasma
Potassium































Changes in the mean values (- S.E.M.) in plasma and
urinary potassium, arterial pH and urinary pH in
7 patients treated with forced saline-laevulose diuresis
with potassium supplements.
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Changes in Plasma Potassium. Magnesium and. Calcium in Relation to
Changes in Arterial pH and P.C.V.
The relative changes in mean values are shown in Fig. 32.
The changes in plasma magnesium and calcium and packed cell
volume are recorded in Tables XXXVII and XXXVIII and XXXIX.
Of the six patients in whom plasma magnesium was monitored, three
patients, 56, 58 and 59 developed hypomagnesaemia. The nadir
of the curve occurred between four and six hours of the diuresis
regime. In all cases the plasma magnesium was found to return
spontaneously to normal levels.
All of the six patients with the exception of patient 57
developed hypocalcaemia. This change occurred within two hours
after starting treatment in patients 58 and 59 and. was of a severe
nature in patients 54, 58, 59 and 60. As with magnesium the
lowest levels were found about the fourth hour of treatment and
spontaneous recovery of the plasma levels to normal occurred in the
patients in whom the plasma calcium was subsequently monitored.
None of the patients were given supplements of either calcium or
magnesium and no patient demonstrated any clinical abnormality
such as tetany which could have been related to these mineral
changes.
The urinary losses of potassium in the six hour period
(Table XXXIV) have been described and were not excessive.
Similarly the urinary losses of magnesium in the same time were
not great and ranged from 21 to 54 mg. (mean 39•5 mg.). Four
patients, 54, 58, 58 and 60 were found to have considerable losses
of calcium (Table XXXXV) and all of them developed hypocalcaemia.
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Effects of Forced Saline-Laevulose Diuresis with Potassium
Supplements on Plasma Potassium, Magnesium and Calcium,
Arterial pH and Packed Cell Volume ( P.C.V.)
0 12 3 4 5 6
HOURS
Figure 52.
Changes in the mean values (- S.E.M.) in plasma potassium,
magnesium and calciug arterial pH and P.C.V. in patients




PLASMA MA&NESIUM (mg. per 100 ml.)
PATIENTS Time (Hours)
Pretreatment
0 2 4 6 8 12 16 24
M
A 54 2.75 2.55 2.1 2.05 2.5 2.55 2.2
L 56 2.25 2.45 1.7 1.85




M 58 2.5 2.15 1.25 1.4 1.5 1.45 1.55 2.5
A 59 2.5 2.0 1.65 1.6 1.7 1.75 2.05 2.25
L 60 2.5 2.25 1.85 2.05 2.5
E
S
Changes in plasma magnesium in 6 patients treated with
forced saline-laevulose diuresis with potassium supplements
TABLE XXXVIII
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PLASMA CALCIUM (mg. per 100 ml.)
PATIENTS Time (Hours)
Pretreatment
0 2 4 6 8 12 16 24
M
A 54 10.2 8.7 7.4 7.5 8.1 8.6 8.9
L 56 9.2 9.8 8.0 8.0




M 58 9.9 7.3 6.2 6.6 7.0 6.9 7.2 8.0
A 59 9.3 7.2 7.3 7.6 7.7 8.1 8.1 8.6
L 60 10.3 8.8 7.3 5.8 9.1
E
S
Changes in plasma calcium in 6 patients treated with
forced saline-laevulose diuresis with potassium supplements.
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TABLE XXXIX
PACKED CELL VOLUME (P.C.V.) - per cent
PATIENTS Time (Hours)
Pretreatment
0 2 4 6 8 12
54 48 48 45 43 45
55 45 44 43 40 38
56 49 51 50 45 46
57 47 47 46 46 45 45
F
E
M 58 49 42 41 42 38 38 40 39
A 59 39 39 33 31 32 32
L 60 41 40 38 38
E
S
Changes in P.C.V. in 7 patients treated with forced
saline-laevulose diuresis with potassium supplements.
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The nadirs of the curves for plasma potassium, magnesium
and calcium all occurred at the fourth hour of treatment. The
P.C.V. was also found to fall in association with the levels of
these three cations, the lowest average levels being also at the
same time. The average percentage reduction in P.C.V. was 11 per
cent and that for plasma potassium was 13 per cent. The figure
for plasma magnesium was 29 per cent and for plasma calcium was
25 per cent.
There was no clear relation between the changes in plasma
potassium, magnesium and calcium and the alterations in arterial
pH.
Changes in Plasma and Urinary Sodium
Results are shown in Table XL. In all seven patients the
plasma level of sodium tended to fall during the first four hours
of treatment, but by six hours in most patients the plasma levels
were beginning to rise once again. Rather marked hyponatraemia
was found in patients 55» 56, 57 and 58- On the average, the
major reduction in level occurred at the same time as that for
plasma potassium, magnesium, calcium and P.C.V.
The urinary losses of sodium in the six hour period varied
considerably from patient to patient, the range being 59 to
350 m.Eq. Na+. The urinary losses in the patients who developed
severe hyponatraemia also varied considerably. Patient 55 lost
only 59 m.Eq. Na+whereas patient 58 lost 272 m.Eq. On the other
hand patient 60 excreted 350 m.Eq. Na+ in six hours and yet did not
develop a marked hyponatraemia. There was little relationship
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TABLE XL
PLASM SODIUM (m.Eq. per litre)
PATIENTS Time (Hours)
Pretreatment
0 2 4 6
54 145 141 140 142
55 134 125 130 130
56 143 13$ 130 126
57 146 128 125 128
F
E
M 58 135 131 125 122
A 59 148 137 130 139
L 60 140 136 134 134
E
S
Mean Values 141 134 130 132
Changes in plasma sodium in 7 patients treated with forced
saline-laevulose diuresis with potassium supplements.
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therefore between the urinary losses of sodium and the changes in
the blood levels of this cation.
Facilities for measuring plasma osmolality were not
available during the most of these studies. However, it was
possible to estimate this in four of the patients, 52, 54, 58 and
60, treated with forced saline-laevulose diuresis. The levels
found are recorded in Table XLI together with levels of plasma
calcium and magnesium measured at the same time. The normal
range for the method of measuring plasma osmolality was 285 to
295 m.osmol. per litre. In patients 52 and 58 the plasma calcium
and magnesium levels fell at six hours in unison with the plasma
osmolality but by 24 hours the osmolality was normal although the
plasma calcium remained low. Similar trends occurred in patients
54 but to a lesser degree. In patient 60 the plasma osmolality
actually rose considerably at times when the levels of calcium and
magnesium had fallen significantly. These results support the
findings of the P.C.V. that although haemodilution was a factor
in producing the lowered plasma cations it could not explain all
the changes which occurred, and in many patients, it was of
comparatively little importance.
Fluid Deficit
All the patients in this group were found to have
a calculated fluid deficit over the total infusion period. The
deficits ranged from 1.8 to 8.7 litres (Table XXHl). As in the
patients treated with forced saline-laevulose diuresis without
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the severity of the poisoning as judged by the peak plasma
salicylate levels.
Discussion
The effectiveness of forced saline-laevulose diuresis was
rather limited in that the plasma salicylate level fell rather
slowly, the mean half excretion time for salicylate being
intermediate between that quoted for untreated patients (Oliver
and Dyer, 1960 and Cumming et al., 1964), aikl patients treated with
forced alkaline diuresis. This was despite the fact that
a good urine flow was achieved, which was similar to that found
with the full forced alkaline diuresis therapy of Dukes et al.
(1963). In both groups of patients treated with forced saline-
laevulose diuresis, the urine remained acid throughout the period
of study despite the fact that it has been claimed that the best
way to alkalinize the urine of patients with acute salicylate
poisoning is to give adequate supplements of potassium (Robin et
al., 1959). In this study very adequate infusions of potassium
were given to seven patients during the period of diuresis but
no rise in urinary pH was demonstrated.
A further important consideration is that the relative
proportion of free salicylate, which is excreted in the presence
of an acid urine, is limited (G-hose, 19^7)• It is generally
agreed that it is the amount of circulating free salicylate which
determines the toxicity in any individual case. In keeping with
a limited elimination of active drug, the clinical features of
salicylism were not quickly relieved in either group of patients
treated with a forced saline-laevulose regime.
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Persistence of clinical features whilst using this
treatment has been noted, previously by Whitten et al (1961) but
the authors were unable to offer an explanation for this. The
reasons are certainly not clear, but it is well-known that the
effects of salicylate for example on the respiratory centre may
persist for many hours even when the plasma level is falling.
The level of C.S.F. salicylate may be more important in these
cases than the plasma level. Also, although biotransformation
occurs at a relatively slow rate, tissue levels of salicylate may
become persistently and significantly elevated with prolonged
effects on such processes as enzyme systems and metabolic
oxidation. Biotransformation becomes a more significant factor
the longer the blood salicylate levels remain elevated.
There were no marked changes in acid-base status in the
eleven patients studied. The main abnormalities found were in
keeping with mild and moderate respiratory alkalosis which was
compensated in some and not so in others. Some patients in the
group given potassium supplements became mildly acidotic. This
was a little surprising but may have been due to the development
in these patients of a degree of metabolic acidosis. Such a change
has been described by Eichenholz et al. (1963). These authors
stressed that the change may occur with great rapidity and without
there being any obvious change in the clinical state of the
patients.
Hypokalaemia was not an important complication of this
therapy, even when the patients were not given potassium
supplements. Serious hypokalaemia was not found except in one
male patient, in whom there were no clinical features of hypokal-
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aemia and. who made a full recovery without any added potassium
being administered. -An interesting observation in the patients
given potassium supplements was that, although they were given
338 m.Eq. of potassium in the course of the six hour period of
observation, the urine losses of potassium were similar to those
found in the patients, who were not given potassium supplements.
Despite this the patients on potassium supplements did not become
hyperkalaemic. Haemodilution was not a major factor and so the
most likely explanation was that the excess potassium had passed
from the extracellular to the intracellular compartment. Whatever
the explanation, no untoward effects were noted.
In most textbooks of medical treatment the highest
suggested rates of intravenous potassium infusions are 25 m.Eq.
per hour and 200 m.Eq. per day. The amounts of potassium given
during this therapy were far greater than these recommendations.
The results obtained justified the rate of administration used
and supported the views of Seftel and Kew (l966),Abramson and
Arky (1966) and Pullen, Doig and Lambie, (1967) all of whom have
reported that the treatment of patients with potassium depletion
may demand intravenous potassium administration at rates
considerably in excess of those currently recommended.
The changes in plasma magnesium and calcium are of
considerable interest, especially as none of the patients showed
any features of tetany. The urinary losses of magnesium were
not large and it is unlikely that they could have explained the
changes in blood levels found. From the associated changes in
P.C.V. and plasma osmolality haemodilution did not appear to be the
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main factor. Therefore, the fact that the blood levels of this
cation were shown to recover spontaneously and fairly quickly to
normal levels, is in favour of shifts having occurred from the
extracellular to the intracellular compartment. The distribution
of exchangeable magnesium within the body has been estimated by
radioactive magnesium studies. The results are rather inconclusive
but there seems to be three pools of exchangeable magnesium;
a fast rate, an intermediate rate and a slow rate turnover pool.
The fast is believed to be mainly extracellular magnesium; the
intermediate in the vital organs and the slow in the muscle.
Bone magnesium on the whole, does not appear to be readily
exchangeable. In order that the changes in plasma magnesium
should occur at the speed found in this study it would deem likely
that the main exchanges occurred between the extracellular
■
magnesium and that of the vital organs.
|
In the case of calcium, urinary losses during the six hour
period were of much greater significance and the greatest
urinary losses of calcium occurred in the patients, who developed
the most marked degrees of hypocalcaemia. These urinary losses,
however, were not sufficient to account for the reductions in
plasma calcium.
Comparison of the mean values of plasma potassium, calcium
and magnesium revealed an approximate correlation between the
changes in these cations. It is therefore surprising that none
of the patients developed tetany. Magnesium deficiency causes
changes in nerve conduction, transmission at themyoneural junction
and muscular contraction. With a lowered concentration of
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magnasium or calcium, the stimulation threshold of the motor
nerve is lowered. In muscle, because of actions on a number of
enzyme systems, which are interrelated, the effects of magnesium
are opposite to those of calcium. Low concentrations of
magnesium enhance contractions; low concentrations of calcium
inhibit contractions. Conditions at the myoneural junction are
most complex, for magnesium concentration affects the quantity of
acetylcholine liberated, the activity of acetylcholinesterase and
the excitability of the pre-synaptic nerve and the muscle membrane.
An increase in transmission at the motor end-plate is the overall
result of a decrease in concentration of magnesium or of calcium.
Tetany should, therefore, have been a marked feature in these
patients.
On the basis of the present data it is only possible to
speculate on the reasons why this did not occur. The amount of
ionised calcium in the blood must have remained above the critical
level for the development of tetany. The graphs of the mean
levels of plasma potassium, sodium, magnesium and calcium and
P.C.V. all showed the lowest levels at four hours after starting
treatment. This suggested that haemodilution may have been
an important factor in the reductions found in the plasma levels
of these cations. Haemodilution could not have explained all
the changes, which occurred, particularly in magnesium and calcium
levels. Another possible explanation is that salicylate is to
a considerable degree bound to the same plasma proteins as
magnesium and calcium. It is possible that there is, in the
early stages of the poisoning, a competition for the protein
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binding sites between the salicylate and these two cations. If
this is the case, the ratio of ionised calcium and magnesium to
unionised cation may have been relatively increased. Therefore,
even if there is considerable loss of mineral during the period of
diuresis, the level of ionised magnesium and calcium may not
fall below the critical level to provoke tetany. Whatever the
actual mechanism was, there was no serious change noted in the
clinical states of the patients treated and all made a full recovery
from the poisoning. Every patient with significant changes in
the levels of plasma cations returned to biochemical normality
without any specific mineral replacement other than potassium.
The changes in plasma sodium were more closely related to
haemodilution effects than was the case with the other cations
measured. No relationship was demonstrated between the amounts
of sodium excreted in the urine and corresponding plasma levels
in individual patients.
The fluid deficits on the fluid balance charts were of
considerable interest. The balances were calculated with an
allowance of 500 ml. as insensible fluid loss. In patients with
acute salicylate poisoning who have hyperpnoea and marked
sweating this is clearly an underestimate. Indeed the fluid
deficits recorded are almost certainly due to these factors as
the patients all achieved a satisfactory diuresis, which would
not have occurred in the presence of hypovolaemia. Cumming et
al. (1964) stressed the importance of extrarenal fluid losses in
the assessment of patients with acute salicylate poisoning.
For this reason also patients in this study who were given any
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forced diuresis regime were allowed to go up to two hours after
starting the infusion without passing urine, before it was
considered necessary to reassess the patient's renal function.
Conclusion
Forced saline-laevulose diuresis will effect only a moderate
removal of salicylate from the body even when the plasma salicylate
is quite high . In association with this the clinical features
of salicylate toxicity tend to persist for an unsatisfactorily
long time after starting treatment. Hypokalaemia was not
a serious problem with this therapy but significant changes in
plasma magnesium and calcium were found. The clinical
significance of these changes is obscure but none of the patients
showed any features of tetany.
?
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FORCED ALKALINE DIURESIS WITH STANDARD POTASSIUM SUPPLEMENTS
From the results obtained in the patients treated with saline-
laevulose diuresis it was apparent that 'water' diuresis in itself
failed to achieve a rapid removal rate of salicylate. The main
defect in the regime was that the urine remained strongly acid.
This could be corrected by the addition of alkali to the regime
(Cumming et al., 1964). Whitten et al. (1961) also reported
that an alkali infusion quickly relieved their patients' symptoms.
For these reasons it was decided to treat a group of patients with
forced alkaline diuresis according to the regime of Dukes et al.,
(1963)* In view of the severe hypokalaemia found in patients
treated with a similar regime early in these investigations,
standardised potassium supplements were also given to every patient.
Patients and Methods
Eleven patients were treated, 4 males and 7 females (Table
XLIl). The ages of the patients varied from 16—63 years (mean
age 33 )• -All of ^e patients had moderate or severe aspirin
poisoning, the peak plasma salicylate levels varying from 49 to 88
mg. per 100 nil. (mean 7"! mg« per 100 ml.). The average time
since ingestion of the tablets was 6.4 hours. One patient, 65,
was alkalotic and 2 patients, 69 and 70, were significantly
acidotic. The levels of pC02 and standard bicarbonate were
reduced in all patients. None of the patients had any known renal
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The forced diuresis regime given was,
0.9 per cent sodium chloride 500 ml.
5 per cent laevulose 500 ml.
1.26 per cent sodium bicarbonate 500 ml.
These solutions were given in rotation at an infusion rate
of 2 litres per hour for the first 3 hours and 1 litre thereafter
until the plasma salicylate had fallen to less than 35 nig. per
100 ml. After the fifth bottle of the regime 26 m.Eq.K. were
given in the form of 2.0 g. KC1 in every 500 ml. bottle of
solution. The reason for the delay in giving potassium was to
allow for rehydration of the patient and to allow time for a urine
flow to be established. In this way the dangers from a rapid
administration of intravenous potassium were minimised.
Measurements of plasma salicylate and potassium were made
in all the patients immediately before starting treatment and
at hourly intervals for the next six hours. In a number of
patients further measurements were made up to 24- hours after
starting treatment. The plasma magnesium was measured at the
same time intervals in 10 patients and the plasma calcium was
estimated at similar times in eight patients. Plasma sodium
levels were measured before treatment and at two hourly intervals
for the next six hours. The P.C.V. was measured at two hourly
intervals in six patients. Similar serial measurements of the
arterial pH, pCO^ and standard bicarbonate were made in all
patients. As this required frequent samples of arterial blood
an intra-arterial cannula was introduced into the brachial artery
in all the patients, using the Seldinger technique (Seldinger,1953)*
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Clotting within the catheter was avoided by filling the catheter
after each sampling with 0.9 per cent saline containing heparin
in a concentration of 10 units per ml.
Careful collections of urine were made at hourly intervals
throughout the period of observation. The volumes were noted
and the hourly excretion of salicylate and potassium was
measured. The total excretion of magnesium, calcium and sodium
over the six hour period was also measured. The urinary pH was




Ten of the eleven patients made a complete and uneventful
recovery from the poisoning. In particular there were no
features of tetany or hypokalaemia in these patients. Patient
70 died after an apparent satisfactory response to the diuresis
therapy and the case report will be discussed in some detail.
The infusion therapy was given successfully in all patients and
there were no signs of overloading of the circulation.
Changes in Plasma Salicylate Relative to the Urinary Salicylate.
pH and Urinary Volumes
Results are shown in Table XLIII and Pig. 33» The
plasma salicylate levels fell steadily in all patie nts throughout
the period of study. The calculated mean half excretion time for
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TABLE XLIII
PLASMA SALICYLATE (mg. per 100 ml.)
PATIENTS
Pretreatment
0 2 4 6 8 12 16
M
A
61 85 73 51 40 39 32
J±.
T.
62 75 52 39 16
JJ
63 71 65 65 52 39 34 25
Jh
S 64 69 60 60 39 38
F 65 88 56 35 26 22 16 13
E 66 76 46 39 34 25 17 12
M 67 76 55 40 29
A 68 68 53 40 36 32
L 69 63 59 49 38
E 70 60 45 39 34 17 10
S 71 49 44 42 42 40 27
Changes in plasma salicylate in 11 patients treated with
forced alkaline diuresis with standard potassium supplements.
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Effects of Forced Alkaline Diuresis with Standard Potassium




Changes in the mean values (- S.E.M.) in plasma salicylate
urinary salicylate, urinary pH and urine volumes in
11 patients treated with forced alkaline diuresis with
standard potassium supplements.
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salicylate in these patients was between 1+ and 5 hours. The
total recovery of salicylate ranged from 3*4 to 9.8 g. (mean 5.5 g.)
(Table XLIV).
The mean urinary excretion of salicylate increased rapidly
in the first two hours of treatment and then averaged approximately
600 mg. per hour. Associated with the increase in salicylate
excretion the urine volumes increased on average to approximately
600 ml./hr. and also the mean urinary pH rose and was maintained
above 7.0. In none of the patients did the urinary pH exceed
8.0. In Fig. 34 there is shown to be a significant relationship
between the changes in plasma salicylate and urinary salicylate
(r = -0.62; p = 0.001). There was also a significant relation¬
ship (Fig. 35) between the urinary excretion of salicylate and
urinary pH. (r = 0.63; p = 0.01).
Changes in Acid-Base Status Relative to the Plasma Salicylate
Results are shown in Table XLV and Fig. 36. During the
first six hours of the diuresis therapy the arterial pH tended
to rise. In all of the patients except 63, 69 and 71 a very
considerable degree of metabolic alkalosis was induced and in
two patients, 65 and 70, the arterial pH rose to 7.63. On the
average, Fig. 36, there was little change demonstrated in arterial
pC02 but considerable individual variations occurred. Patients
64 and 70 showed reductions in pC02 from 35«5 to 19.0 and 31.0 to
17.0 respectively. On the other hand in patients 65 and 71, rises
were noted from 14.0 to 23.0 and 13.2 to 31.8*
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Relationship between plasma salicylate levels and urinary
salicylate in 11 patients treated with forced alkaline
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Relationship between the levels of plasma salicylate
and urinary salicylate in 11 patients treated with
forced alkaline diuresis with standard potassium
supplements.
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Relationship between the levels of urinary salicylate
and urinary pH in 11 patients treated with forced alkaline




pH PC02 (mm/Hg) Bicarbonate
(mEq per litre)
Peak Lowest Peak Lowest Peak Lowest
Level Level Level Level Level Level
61 7.58 7.45 28.5 21.5 26.0 19.0
62 7.56 7.43 30.0 20.0 30.0 20.0
63 7.46 7.41 25.5 18.0 20.5 19.5
64 7.56 7.42 35.5 19.0 24.8 20.5
F 65 7.63 7.54 23.0 14.0 27.0 13.7
E 66 7.56 7.44 30.0 25.0 25.0 22.0
M 67 7.50 7.43 29.5 15.0 24.0 18.0
A 68 7.58 7.40 24.0 17.5 24.0 18.5
L 69 7.47 7.31 20.0 13.0 20.0 15.0
E 70 7.63 7.37 31.0 17.0 28.0 14.0
S 71 7.44 7.43 31.8 13.2 17.9 16.1
Acid-Base changes during the period of observation in
11 patients treated with forced alkaline diuresis with
standard potassium supplements.
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Acid-base status of Patients in Relation to Plasma Salicylate
during Forced Alkaline Diuresis with Standard Potassium
Supplements.
0 1 2 3 I 5 6
HOURS
Figure 36»
Changes in the mean values (- S.E.M.) in plasma salicylate
and the mean changes (- S.E.M.) in arterial pH, pCC>2 and
standard bicarbonate in 11 patients treated with forced
alkaline diuresis with standard potassium supplements.
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bicarbonate the levels of standard bicarbonate in general rose
and in patients 62, 65 and 70, the standard bicarbonate was
increased to normal levels.
In general therefore as the metabolic alkalosis increased
the plasma salicylate fell (lig. 36).
Changes in Plasma Potassium in Relation to Urinary Potassium and
Arterial and Urinary pH
Results are shown in Table XLVI and Pig. 37• Three
patients, 65, 70 and 71, were hypokalaemic before treatment.
Respite the infusion of 338 mEq of potassium, nine of the
11 patients became hypokalaemic during the first six hours of
treatment. In contrast one patient, 65, who was initially
severely hypokalaemic, attained normal plasma potassium levels
during the course of treatment.
The urinary excretion of potassium remained constant at
about 10 mEq per hour despite the potassium supplements given.
The total excretions of potassium are given in Table XLIV. The
range of potassium losses was 19»0 to 121 mEq with a mean loss
of 64 mEq.
The rises in arterial and urinary pH levels over the second
half of the six hour period had no apparent effect on the urinary
excretion of potassium. In Pig. 37 there appeared to be
a correlation between the rise in arterial pH and the fall in
plasma potassium. This, however, did not attain a level of
significance (r = 0.1'6; p = 0.30) (Eig. 38).
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TABLE XLVI
PLASMA POTASSIUM (mEq per litre)
PATIENTS Time (Hours)
Pretreatment
0 2 4 6 8 12 16 24
M
A
61 3.7 3.8 3.2 2.9 3.0 3.1 3.0
ii
T. 62 4.9 3.4 2.9 3.5 3.3 3.6Jj
F 63 4.3 5.5 5.0 5.2 4.2 3.2 2.8
s 64 4.3 4.0 2.6 3.0 2.9
p 65 2.6 2.8 3.4 4.7 3.7 4.2
E 66 4.0 3.2 2.9 2.4 3.0 3.5 4.0
M 67 3.6 3.0 2.9 3.0 2.8 3.4
A 68 3.5 3.7 3.1 2.6 2.3 2.6 3.2
L 69 3.7 3.8 4.0 3.0 2.8
E 70 3.3 3.0 2.9 3.0 2.8 3.4
S 71 3.4 3.6 3.1 3.2
Changes in plasma potassium in 11 patients treated with
forced alkaline diuresis with standard potassium
supplements.
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Effects of Forced Alkaline Diuresis with Standard Potassium
Supplements on Plasma Potassium, Urinary Potassium,Arterial pH,
and Urinary pH.
0 12 3 4 5 6
HOURS
Figure
Changes in the mean values (- S.E.M.) in plasma and
urinary potassium, arterial pH and urinary pH in 11
patients treated with forced alkaline diuresis with
standard potassium supplements.
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Relationship between arterial pH and plasma potassium
in 11 patients treated with forced alkaline diuresis
with standard potassium supplements.
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Relationship Between Plasma Potassium, Magnesium and Calcium and
Changes in Arterial pH and P.C.V.
Results are shown in Pig. 39 and Tables XLVI, XLVII,
XLVIII and XLIX.
All the patients had plasma magnesium levels within the
normal range before starting treatment. After the infusion
regime was started, there was a general tendency for the levels
to fall during the first three hours then to remain low till the
end of the six hour period. Subsequent levels which were done
in a few patients showed a spontaneous return towards normal.
The nadir of the curve occurred between the fourth and sixth hour
of treatment. The urinary losses of magnesium in six patients
(Table XLIV) ranged from 0.5 to 27.07 mg. (mean 12.5 mgO during
the six hour period.
Plasma calcium levels were measured in eight patients.
Before treatment the plasma calcium was normal in all patients.
As with magnesium the levels subsequently fell in every case with
again a tendency to spontaneous recovery after 24 hours. Despite
the alarming low levels of magnesium and calcium recorded, none
of the patients showed any clinical features of tetany. The
excretion of calcium in the six hour period in six of these
patients (Table XLIV) was 5*2 to 64 mg. (mean 37 nig.).
The P.C.V. was monitored in six patients (Table XLIX).
There waB an initial fall in the average levels during the first
three hours but in the second half of the six hour period the
levels rose to the pre-treatment values. As the mean values of
potassium, magnesium and calcium fell, the arterial pH rose and the
- 218 -
Effect of Forced Alkaline duiresis with standard Potassium
supplements on Plasma Potassium, Magnesium, Calcium ,
Arterial pH and Packed Cell Volume ( P.C.V)
J i : i i i i
0 1 2 3 k 5 6'
HOURS
Figure 39.
Changes in the mean values (- S.E.M.) in plasma potassium,
magnesium and calcium, arterial pH and P.C.V. in patients




PLASMA MAG-NESIUM (mg per 100 ml)
PATIENTS Time (Hours)
Pretreatment
0 2 4 6 8 12 16 24
M
A 62 2.37 1.86 1.75 1.70
L 63 1.95 2.12 2.25 1.66
E
S
64 1.75 1.46 1.21 1.16
•
F 65 1.74 1.37 0.91 1.21
E 66 2.4 2.45 1.95 1.5 1.45 1.7 1.5 2.2
M 67 2.55 2.30 2.0 1.9 2.05 2.06
A 68 1.7 1.7 1.29 1.33 1.58 1.54 1.79 1.95
L 69 1.79 1.83 1.62 1.37
E 70 2.05 2.05 2.07 2.05 1.2 1.4 1.45
S 71 2.25 2.25 1.7 2.0
Changes in plasma magnesium in 10 patients treated




PLASMA CALCIUM (mg per 100 ml)
PATIENTS Time (Hours)
Pretreatment





62 9.8 7.9 7.4 7.4 7.3
63 10.1 10.4 10.5 8.1
7.9
66 10.0 10.3 9.5 7.2 7.3 7.6 7.0 9.6
67 10.5 9.6 8.4 8.1 8.4 8.6
68 9.4 8.3 7.2 7.5 7.2 7.0 7.9 9.3
69 9.1 9.1 7.8 7.2
70 9.6 8.7 8.3 8.4 7.6 8.1 7.5
71 9.2 9.2 7.8 8.0
Changes in plasma calcium in 8 patients treated with
forced alkaline diuresis with standard potassium supplements.
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TABLE XLIX
PACKED CELL VOLUME (per cent)
PATIENTS Time (Hours)
Pretreatment
0 2 4 6 8 16
f 61 .39 33 30 42 32
2 64 55 41 42 43
S
67 43 47 43 42
69 57 56 57 54 51
70 39 37 38 43 44
71 55 56 50 52
Changes in P.C.V. in 6 patients treated with forced
alkaline diuresis with standard potassium supplements.
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metabolic alkalosis, which occurred, persisted up to the 6 hour
period. As the levels of plasma potassium, magnesium and calcium
remained low during the second half of the six hour period of the
observation whilst the P.C.V. returned to normal made it unlikely
that haemodilution was a significant factor in the causation of
low levels of the cations.
Changes in Plasma and Urinary Sodium
Results are shown in Table L.
One patient, 71> was considerably hyponatraemic before
starting treatment, but the other patients all had initially
normal plasma sodium levels. In general, there was a tendency
for the plasma sodium levels to fall as the diuresis proceeded
but only one patient, 62, developed marked hyponatraemia and this
was transient. During diuresis the hyponatraemia improved in
patient 71• Throughout the six hour period of observation there
was little change in the mean values of plasma sodium. The
total urinary excretion of sodium during the six hour period ranged
from 74 to 304 mEq (mean 177 mEq). As in the group of patients
treated with forced saline-laevulose diuresis there was no relation
between the amounts of sodium excreted in the urine and changes
in plasma levels. It is true that patient 71» who had marked
hyponatraemia, excreted rather large amounts of sodium, 247 mEq
in the six hours but patient 67, who had the greatest losses of




PLASMA SODIUM (mEq. per litre)
PATIENTS Time (Hours
0 2 4 6
m
a
*61 149 140 137 140
a
t. 62 136 135 128 131jj
E
S
*63 140 137 135 141
64 133 131 132 135
P *65 141 136 136 135
E *66 135 135 137 135
M *67 136 137 136 140
A *68 137 135 133 132
L 69 139 142 140 140
E 70 146 143 142 139
S 71 125 124 130 130
Vomited after ingestion and before admission.
Changes in plasma sodium in 11 patients treated with forced
alkaline diuresis with standard potassium supplements.
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Pluid Deficits
In keeping with the results obtained in other groups of
patients with severe acute salicylate overdosage, all of the
patients treated with forced alkaline diuresis were found to
have calculated fluid deficits (Table XLIS) ranging from 1.9 to
9.0 litres (mean 5.0 litres).
Patient 70 was the one patient who died, in the whole
series of 307 patients. She was a young girl aged 16 and had
been in excellent health prior to taking the overdosage of
aspirins apart from a tendency to be depressed from time to time.
On the night of her admission to hospital the patient had told
her boy friend that their relationship was finished and then,
whilst he was still there, took 60 aspirin tablets. She did not
vomit and was admitted to the ward just over three hours after
having taken the overdosage.
On examination she was fully conscious, warm and sweaty,
but her temperature was only 37«4°C. Tachypnoea was present
and she had a tachycardia of 116 per minute in sinus rhythm.
She was moderately deaf with tinnitus and, although she complained
of nausea, vomiting was not initially amarked feature. Routine
medical examination was otherwise entirely normal. Her initial
plasma salicylate of 60 mg. per 100 ml. confirmed that she had
severe acute salicylate poisoning. A metabolic acidosis was
present before treatment, the arterial pH being 7.37, pCOg 31 mm./
Hg. and standard bicarbonate 19 mEq. per litre. The prothrombin
ratio was normal as were the haematological indices and platelet
count. On the basis of this assessment she was treated with
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forced alkaline diuresis with standard potassium supplements, as
has been described. The levels of plasma magnesium, sodium and
calcium before treatment were normal and the plasma potassium was
only slightly low. The response to treatment is shown in
Figs. 40 and 41. A brisk diuresis was achieved and at the end
of six hours the plasma salicylate had fallen to a satisfactory-
level of 27 mg. per 100 ml. This then continued to fall until
by 20 hours it was only just detectable in the plasma. During
the main diuresis period she became mildly hypokalaemic but by
12 hours this had risen to an acceptable level and at no time
was the plasma potassium dangerously low. Also for the first
six hours after starting treatment there was no evidence of
serious hypocalcaemia, hypomagnesaemia or hyponatraemia.
In keeping with these satisfactory biochemical findings
there was considerable clinical improvement in the patient's
condition. Her symptoms of salicylism disappeared with the
exception of continuing nausea and periodic vomiting, the vomitus
being small in amount and consisting only of slightly bile-
stained fluid. Her progress was regarded as satisfactory but
because of the vomiting the intravenous fluids were continued
at an infusion rate of 500 ml. per hour for eight hours and
thereafter reduced a.s shown in Fig. 40.
About 10 hours after starting treatment she had a minor
epileptiform convulsion, which lasted for only about 30 seconds
before subsiding spontaneously. There was no other evidence of
tetany and Chvostek's and Trousseau's signs were negative. Ocular
fundal examination was normal and there were no abnormalities
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Changes in Plasma Salicylate and Potassium in patient 70
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Figure 40
Response of patient 70 to forced alkaline diuresis with
standard potassium supplements.
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Changes in Plasma Sodium, Calcium and Magnesium and in Arterial pH
found in patient 70.
HOURS
Figure 41»
Changes in plasma sodium, calcium and magnesium and
in arterial pH found in patient 70 in response to forced
alkaline diuresis with standard potassium supplements.
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elicited on neurological examination. In the course of the
next four hours she had three further episodes, all of which were
of a similar, transient nature. Eighteen hours after her
admission to hospital she was talking to a nurse, when she
suddenly collapsed became apnoeic and unconscious. Mouth-to-
mouth respiration was started immediately, despite which she
remained cyanosed, but when intubated and ventilated with 100 per
cent oxygen she became pink at once. At no time was there any
cardiac arrhythmia or arrest and an electrocardiograph, done during
the period of intensive resuscitation was entirely normal. The
pupils, however, became partially dilated and showed little, if
any, reaction to light and there was no return of spontaneous
respiration. She remained deeply unconscious but there was no
evidence of localised neurological abnormality. The plantar
responses were flexor and there was a slight withdrawal reflex.
Otherwise there was no response to stimulation. Blood gas
analysis just after the arrest showed pH 7.32, pCO^ 20.3, standard
bicarbonate 14.4 mEq per litre, pOg 410 mm./Hg. and the plasma
potassium was 3.0 mEq. per litre.
In Pig. 41 marked degrees of hyponatraemia, hypomagnesaemia
and hypoealcaemia were present from the eight hour period until
just before the respiratory arrest. Unfortunately these
measurements were not available until after the arrest had occurred
and so no specific therapy was given to correct them.
As there was no sign of recovery of spontaneous respiration,
she was mechanically ventilated using a Banaet respirator. She
was easily ventilated and the minute volume had to be reduced
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below 4 litres per minute to allow the arterial pCC^ to approach
normal.
In the course of the 12 hours after the arrest occurred she
developed polyuria and passed 8.6 litres of urine in this time
whereas the fluid administration during the same period was
approximately 2.0 litres. The polyuria continued for the next
24 hours, the urine output being 11,155 ml. and to compensate for
this loss, 10,500 ml. of fluid in the form of 0.9 per cent saline
and 5.0 per cent dextrose were given intravenously. The urine
was dilute, the specific gravity remaining consistently low,
varying between 1.004 and 1.006. It appeared that she had
developed diabetes insipidus and she was given aqueous vasopressin
0.5 ml. intramuscularly. This reduced the urine flow to 80 ml.
per hour. The patient, became temporarily oedematous but this
subsided after adjustment of the fluid balance.
She remained very deeply unconscious with no response to
painful stimulation apart from a slight withdrawal response on
plantar stimulation. A lumbar puncture was performed, which
was normal in manometries and appearance. There was no
abnormality on biochemical and bacteriological study of the
cerebrospinal fluid; in particular the C.S.F. protein was normal
at 45 mg. per 100 ml. An electroencephalograph was done, which
showed virtually no activity from the brain in any lead.
Five days after her admission to hospital, she became hypo¬
tensive with a systolic blood pressure of 80 mm./Hg. This
responded initially to 2.5 mg. metaraminol ('Aramine') intra¬




Post mortem examination was performed 10 hours after
death occurred.
The macroscopic appearances of the pleural, pericardial and
peritoneal sacs were normal. The organs of the alimentary
system were also normal and no abnormality was found in the genito¬
urinary and cardiovascular system with the exception of two diffuse
subendocardial haemorrhages in the left ventricle. In the
respiratory system both lungs were intensely congested and
oedematous with bilateral bronchopneumonia. The thyroid and
suprarenal glands were normal. There was no skull fracture and
there was no extra or subdural haemorrhage. The leptomeninges
and superficial vessels including the Circle of Willis were normal.
The brain showed marked generalised swelling and was extremely
soft. There was marked swelling, congestion and softening of
both cerebral hemispheres, the brain stem and cerebellum.
The changes were those of autolysis rather than infarction, and
in the white matter liquefaction was occurring. In the right
occipital lobe the ribbon of cortical grey matter was becoming
separated from the underlying white matter. In the right
mammillaiy body there wa3 a focus of congestion 4 mm. in diameter.
Microscopic examination was made of representative sections
from both cerebral hemispheres, including the basal ganglia, brain
stem and cerebellum. In all sections severe changes were seen in
the grey and white matter. These were of an autolytic nature and
indistinguishable from those found as the result of advanced post
mortem autolysis.
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The grey matter showed patchy pallor of staining of ground
substance and severe pericellular vacuolation; the neurones were
in the main shrunken and had lost their Nissl substance. Some
had small pyknotic nuclei, but in many the nuclei failed to
stain. In some areas the neurones had either disappeared or
merged imperceptibly into the pale eosinophilic ground substance.
The most striking feature was the virtual total absence of any
glial, mesodermal or vascular response. The neuroglia showed
similar autolytic changes.
The white matter was less affected than the grey;
vacuolation was slight but practically all the neuroglial nuclei
ws'e markedly pyknotic. The vessels throughout the pia
arachnoid were much better preserved.
Similar changes were seen in the brain stem and cerebellum.
In the brain stem the damage was particularly severe in the
tegmentum.
In the pituitary gland there was practically total necrosis
of the anterior and posterior lobes unaccompanied by any reactive
change.
Discussion
Forced alkaline diuresis achieved rapid and satisfactory
recoveries of salicylate and in this respect this regime was
clearly superior to a similar infusion rate of saline-laevulose.
As the diuresis produced by these two forms of treatment was
similar, the difference in removal of salicylate was presumably
related to the alkalinisation of the urine. The benifits of
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raising the urinary pH in promoting salicylate excretion by the
kidney has been established by numerous authors including Robin
et al. (1959), Whitten et al (1961), Oliver and Dyer (i960) and
Cumming et al. (1964J. A further important consideration in this
regard is that the amount of "free" salicylate removed is greatly
increased in the presence of an alkaline pH. It may be assumed
therefore that not only was the total recovery of salicylate
increased by this regime but that a considerable amount was
"free" salicylate. In support of this was the fact that all
patients, who had marked clinical features of the poisoning,
obtained rapid relief on this treatment.
The major criticism which has been made against the use of
alkalis in the treatment of patients with acute salicylate
poisoning has been the possibility of causing dangerous alkalosis
and possibly fatal tetany (Winters et al., 1963; McLaughlin,
1965; Done, 1965 and G-hose and Joekes, "\S66). In this group
of patients significant hypokalaemia was found in several despite
the considerable potassium supplements. Alkalosis, which in some
patients was severe, was produced and marked hypomagnesaemia and
hypocalcaemia occurred. When the blood levels of these minerals
and the associated acid-base status is considered, it was indeed
surprising that tetany wa,s not a marked feature. The urinary
losses of potassium, magnesium and calcium in this group of patients
were insufficient to explain the reductions in plasma levels and
haemodilution was not a significant factor. It is likely,
therefore, that there were considerable shifts of these cations
from extracellular to intracellular sites. Cellular uptake of
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potassium in response to alkalosis is well known (Briggs and
Findley, 19^7; Whang and Reyes, 1967, and many others), but
the participation of magnesium and calcium in the maintenance of
acid-base equilibrium is perhaps less generally recognised. The
mineral portion of the skeleton is thought to exist in the form
of a vast number of tiny, flat, hexagonal crystallites which
present an enormous total surface area. Cations such as Na+,
K+, Ca++ and Mg++appear to be loosely combined at the surface
of the crystallites, so that they can exchange with cations in
the surrounding extracellular fluid. This bone material is very
sensitive to changes in plasma pH. With an increase in H+
concentration there is a shift of the above cations out of bone
and in a state of alkalosis the opposite occurs (Robinson, 1961).
Bergstrom (1956) has described these events in some detail and
stressed that these changes may occur with great rapidity. It is,
therefore, probable that in this group of patients the reductions
in plasma sodium, potassium, magnesium and calcium were primarily
due to ion shifts in response to the alkalosis produced by the
therapy, The changes in plasma sodium and potassium were
reduced by the amounts of these cations given in the regime. In
support of ion shifts being the major factor operating was the fact
that the plasma levels of these cations tended to return to normal
spontaneously before the patients were established on diet and in
the absence of specific replacements of these minerals being given
other than sodium and potassium. The fact that tetany was not
produced, suggests that in some way the ionised calcium in the
circulation did not fall below critical levels. Competition
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between salicylate and magnesium and calcium for protein-binding
sites may have been the main factor but in the absence of specific
data regarding the relative protein binding of the salicylate and
these minerals this must remain speculative.
The absence of clinical features of hypokalaemia and of
tetany despite the changes observed in acid-base state and in
plasma potassium, magnesium and calcium levels, prompts a
consideration of how important these changes are from the practical
point of view. In many instances, the changes which occurred
were rapid in onset and of a severe nature. Such a state of
instability of H+ concentration and of important cations must be
regarded as potentially dangerous and must lend support to those,
who criticise forced alkaline diuresis on the grounds of the
i
dangerous side-effects associated with its use.
The results obtained in the girl, who died, provide a good
example of this. Despite the fact that she responded very
satisfactorily to the treatment in terms of reduction of plasma
salicylate and although hypokalaemia was not a serious problem,
she nevertheless died suddenly of acute respiratory arrest.
It is true that she was pronounced dead some five days later having
been kept alive by artificial means but the post mortem which was
done only a few hours after death was declared, showed that the
brain had undergone advanced autolysis. The findings were in
fact an example of "deanimation" or dissociated death, in which
the brain has "died" at least some few days before the body
(Kramer, 19&3). ^ is a rare but well recognised occurrence in
individuals who, because of some pre-existent brain damage, fail
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to breathe spontaneously and have to be kept alive on a mechanical
respirator. The polyuria which developed before death was
amply explained by the damage to the pituitary gland seen at
autopsy.
The crux of the problem, however, remains. Why did the
respiratory arrest occur? For a few hours before the arrest
occurred she had a number of minor convulsive episodes, which, as
was discovered later, occurred at the same time as significant
falls in the levels of plasma magnesium and calcium. Severe
bypomagnesaemia and hypocalcaemia occurred, both of which may cause
convulsions (Hanna, Harrison, Maclntyre and Eraser, 1960 and
Vallee, Wacker and Ulmer, i960). There is no proof that these
changes were the cause of her convulsions and ultimate respiratory
arrest but the circumstantial evidence in favour of this was
strong. The most common mode of death in acute salicylate poisoning
is respiratory or cardiac arrest, which often occurs without
warning. Such deaths are usually regarded in despair as "electrolyte"
deaths. Further study of the effects of changes in plasma
magnesium and calcium in this poisoning may well thro® some
light on this important problem.
Another criticism which has been made of the use of forced
alkaline diuresis is that it may cause severe hypernatraemia
(Feuerstein et al., i960). In this group of patients this
was not found. On the contrary, the plasma levels of sodium tended
to fall during the course of treatment. It would seem, therefore,
,
that hypernatraemia need not be considered to be a serious
complication of this regime.
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All the patients were found to have a calculated fluid
deficit as in previous groups of patients studied and again there
appeared to be a correlation between the magnitude of the fluid
deficit and the severity of the poisoning in terms of plasma
salicylate level.
Conclusion
Forced alkaline diuresis according to the Dukes' regime
was demonstrated to be an extremely effective means of reducing
the plasma salicylate in patients with acute overdosage of this
drug. On the other hand, severe and rapid changes occurred in
acid-base balance, plasma potassium, magnesium and calcium. One
patient died despite the fact that the plasma salicylate had been
successfully reduced to low levels. There was some evidence
that this death may have resulted from changes in the plasma
magnesium and calcium. Winter# and others were fully justified
when they expressed reservations about the use of this regime of
forced alkaline diuresis. It is likely that the metabolic changes
induced by the treatment are of considerable significance and
constitute a hazard to the patient, which may occasionally be




Although the regime of forced alkaline diuresis was very
efficient in reducing the plasma salicylate, it was not an ideal
regime in that marked changes in H+ concentration and in important
plasma cations occurred during the course of treatment. The main
abnormalities seemed to be related to the metabolic alkalosis
produced and so, rather than increase the amounts of potassium
administered, which may have been dangerous in itself, it was
decided to reduce the total amount of bicarbonate given. Also
it was thought more appropriate to give a continuous infusion
of fluid and alkali rather than the intermittent regime given in
Dukes method of forced alkaline diuresis. For this purpose
a composite infusion solution was devised, which, for simplicity,
was referred to as the 'cocktail1.
The mixture consisted of,
0.9 per cent saline 500 ml.
5.0 per cent laevulose 1000 ml.
1.26 per cent sodium bicarbonate 500 ml.
These solutions were mixed in 2 litre bottles and prepared
and sterilised by the hospital dispensary. In this way a supply
was always kept available. To each bottle was added 3*0 g.
potassium chloride, just before administration to the patient.
The rate of infusion given using the 'cocktail' was the same as
with the other regimes of forced intravenous fluids. Two litres
were administered intravenously every hour for three hours, and then
1 litre per hour until the plasma salicylate had fallen to less
than 35 nig. per 100 ml. and the patient was able to tolerate an
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adequate oral fluid intake. The fact that the mixture was set
up in 2 litre bottles simplified the regime for the nursing staff
and reduced the number of times the bottles had to be changed.
In the course of a six hour period of main diuresis 682.5 m.Eq.
of Na+ and 175 m.Eq. of K+ were administered using the forced
•cocktail* diuresis. By comparison, using forced alkaline
diuresis, 912.6 m. Sq. of Na+ and 169 m.Eq. of K+ were given.
Perhaps the major difference between the two regimes was that
with forced alkaline diuresis in six hours 37.8 g. of sodium
bicarbonate were given, whereas with the forced 'cocktail' only
28.4 g. sodium bicarbonate were infused in the same time.
Patients and Methods
Thirteen patients, 7 males and 6 females, were treated
with forced 'cocktail' diuresis (Table Li). All the patients
were suffering from moderate or severe acute salicylate overdosage
The plasma salicylate ranged from 48 to 81 mg. per 100 ml.
(mean 67 mg. per 100 ml.). All had been admitted relatively
soon after ingestion of the tablets (1-8 hours; mean 4.5 hours).
Five patients, 72, 78, 79, 82, 83 and 84, were alkalotic on admission
and one patient, 75, was acidotic. The remaining patients all
had arterial pH levels within the normal range. The pC02 and
standard bicarbonate levels were reduced in all patients except
patient 75 in whom the pC02 was slightly elevated. This was
probably a reflection of the metabolic acidosis present. The
patients were aged from 16 to 63 with a mean age of 30.
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treatment and at hourly intervals up to six hours after starting
the infusion. In a number of patients subsequent measurements
were made up to 24 hours after starting treatment. Similar
monitoring of the plasma potassium was done. Plasma magnesium
levels were estimated in eight patients at three hourly intervals
up to six hours, and at 12 hours after starting treatment.
Similar measurements were made of the plasma calcium in 12 patients
and plasma inorganic phosphorus in 7 patients. The P.C.V. was
monitored in 10 patients and serial measurements of arterial pH,
pC02 and standard bicarbonate were made on blood taken from the
brachial artery in all patients before treatment and at two, four
and six hours after starting forced diuresis. At similar time
intervals, the plasma sodium levels were measured on venous blood.
Careful measurements of the urine volume, urinary excretion
of salicylate and potassium and urinary pH were made at hourly
intervals for the first six hours of the diuresis. The total
six hour urinary excretion of sodium magnesium and calcium was
also estimated.
The usual precautions of collection and preservation of
the specimens for arterial blood acid-base measurements and urinary
pH were observed. If the specimens for plasma potasssium
sodium, magnesium, calcium and inorganic phosphorus were not
measured immediately, the plasma was separated and stored in the
deep freeze. The plasma inorganic phosphate was measured using
the Technicon autoanalyser by a modification of the method of




All the patients made a very satisfactory recovery from the
poisoning and there were no clinical complications observed.
Every patient, who had significant complaints of salicylism, was
rapidly relieved of symptoms.
Comparison Between the Changes in ELasma Salicylate. Urinary
Salicylate. Urinary pH and Urine Volumes.
Results are shown in Tables LII and LIII and in Fig. 42.
The plasma salicylate levels fell progressively during the first
6 hours of treatment and the fall was maintained up to 24 hours.
The mean level had fallen from 68 to 44 mg. per 100 ml. in four
hours and the calculated mean half excretion time for salicylate
was 6.7 hours. After an initial peak of 900 mg. per hour the
mean excretion rate of salicylate fell to approximately 550 mg.
per hour, but this was then maintained for the remainder of the
six hour period. The mean urinary pH rose to 7.0 after two hours
treatment and remained steady at this level thereafter, the highest
urinary pH reached being 7.8.
The urine flow per minute averaged 700 ml. per hour for
most of the main diuresis period, but fell to 400 ml. per hour
at the end of the six hour period.
The total urinary excretion of salicylate over the 6 hours
was 2.4 to 8.0 g. (mean 5.4 g.), which was almost five times the
excretion of salicylate before treatment (Table LIIl).
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TABLE LII
PLASM SALICYLATE (mg per 100 ml)
PATIENTS Time (Hours)
Pretreatment
0 2 4 6 8 12 16 24
72 80 45 42 14
M 73 76 73 64 52
A 74 74 62 34
L 75 65 58 50 42 22 20 7
E 76 59 56 38 30 28 5
S 77 52 48 33 28
78 48 37 23 20
79 81 78 49 40 23 14
80 78 77 46 32
81 74 58 40 31 23
82 73 44 31 26 18
83 65 57 37
84 49 36 30 7
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Effects of Forced 'Cocktail' Diuresis on Plasma Salicylate,
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Figure 4-2«
Changes in mean values S.E.M.) of plasma and urinary
salicylate, urinary pH and urine volumes in 13 patients
treated with forced "cocktail" diuresis.
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Changes in Acid-Base Status Relative to Changes in Salicylate
Results are shown in Table LIV and Rig. 43.
Of the six patients who were alkalotic before the start
of treatment, four, 72, 76, 79 and 83, had a normal arterial pH
during the course of treatment. The other two patients, 82 and
84, remained mildly alkalotic, but less so than at the start of
treatment. Patient 75, who was initially acidotic, regained
a normal pH; all the other patients continued with normal pH
levels.
In all patients there was improvement in the levels of
arterial pC02 and standard bicarbonate and in one patient 75 the
pCO^ became normal.
These improvements in acid-base status occurred as the
treatment continued and as the plasma salicylate progressively fell.
Changes in Plasma Potassium and Urinary Potassium Relative to
Changes in Arterial and Urinary pH.
Results are shown in Tables LIII and LV and in Pig. 44.
During the initial six hour period of treatment only two
patients, 72 and 83, developed mild hypokalaemia and seven patients,
73, 74, 75, 79, 80, 81 and 82, showed slight increases in the
plasma potassium. The mean values of plasma potassium plotted
in Pig. 44 remained in normal limits. It is of interest to
note that a number of the patients, who had plasma potassium levels
done subsequent to the main diuresis period, did show significant
reductions in the blood levels but with the exception of patient 72





pH pCO (mm/Hg) Bicarbonate
(mEq per litre)
Peak Lowest Peak Lowest Peak Lowest
Level Level Level Level Level Level
72 7.48 7.45 28.0 22.0 20.0 20.0
M 73 7.42 7.39 31.0 31.0 22.0 21.0
A 74 7.42 7.40 34.0 30.0 23.0 21.5
L 75 7.44 7.35 47.0 22.0 22.0 21.0
E 76 7.46 7.42 25.O 20.0 20.0 20.0
S 77 7.44 7.41 23.O 20.0 22.5 19.0
78 7.42 7.40 24.0 21.0 24.0 19.0
79 7.53 7.43 28.0 16.0 23.0 19.0
80 7.49 7.43 23.0 20.0 22.0 19.0
81 7.42 7.39 26.0 21.0 21.0 18.0
82 7.50 7.46 19.0 17.0 20.5 20.0
83 7.47 7.43 22.0 19.0 22.0 20.0
84 7.50 7.48 30.0 20.0 25.0 22.5
Acid-base changes during the period of observation
in 13 patients treated with forced "cocktail" diuresis.
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Acid-base status in patients in relation to Plasma Salicylate
during Forced 'Cocktail' Diuresis.
HOURS
HLgureJtl.
Changes in mean values (- S.E.M.) of plasma salicylate
in relation to mean values (- S.E.M.) arterial pH, pCC>2




PLASMA POTASSIUM (mEq per litre)
PATIENTS Time (Hours)
Pretreatment
0 3 6 8 12 16 24
72 3.6 3.1 3.1 2.9
M 73 4.0 4.2 5.4 3.3 4.4
A 74 3.8 4.2 4.4 3.6 3.5 3.2
L 75 4.2 3.6 4.4 3.6 3.6
E 76 4.4 4.3 4.0 3.4 4.1
S 77 4.1 4.0 4.0 4.0
78 3.9 3.5 3.7 3.3 3.2
79 3.9 3.9 4.6 3.4
80 4.3 4.4 4.4 3.2 3.3
81 4.2 4.3 4.7 3.4 ^ A'; 4.3
82 3.8 3.9 5.0 3.2
83 3.6 3.8 3.4 3.6 4.0
84 4.2 3.6 3.6 3.2 4.3
Changes in plasma potassium in 13 patients treated with
forced "cocktail" diuresis.
- 249 -
Effect of Forced 'Cocktail*on Plasma Potassium, Urinary
Potassium, Arterial pH and Urinary pH.
0 12 3 15 6
HOURS
Figure 44*
Changes in mean values S.E.M.) of plasma and urinary-
potassium, arterial pH and urinary pH in 13 patients
treated with forced "cocktail" diuresis,,
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evidence of hypokalaemia or tetany and all made an uneventful
recovery.
After an initial peak loss of 25 mEq. of potassium per hour
(Fig. 44) the mean urinary losses of this cation stabilised at
approximately 15 mEq. per hour. The total losses of potassium in
the urine are shown in Table LIII. The range was 65.0 to
161.0 mEq. with an average loss of 96.0 mEq.
Aiere was no apparent relationship between the recorded
levels of plasma and urinary potassium levels and changes in the
arterial and urinary pH, which remained relatively steady through¬
out. It is important to note that, despite the reduction in the
amount of alkali given in this regime, alkalinising effect on the
urine was demonstrated in this group of patients. The average
urinary pH remained about 7*0 and the highest level reached was
7.9.
Changes in Plasma Potassium. Magnesium. Calcium and Inorganic
Phosphate in Relation to Arterial pH and P.C.V.
Results are shown in Tables LVI, LVII, LVIII and LIX and
in Fig. 45.
The plasma magnesium tended to fall in all the eight patients
studied. In only one patient, 80, did moderate hypomagnesaemia
develop. This was transient and had spontaneously returned to
normal after a further six hours. The total urinary excretion
of magnesium over the initial six hours of treatment was small




PLASMA MAGNESIUM (mg. per 100 ml.)
PATIENTS Time (Hours)
Pretreatment
0 3 6 12
74 2.40 2.90 2.45 2.10
75 2.70 2.50 1.95 2.20
76 2.75 2.10 2.40 2.60
77 2.45 2.25 2.00 2.10
F
E
79 2.95 2.80 2.25 2.60
80 2.30 2.00 1.40 1.70
82 2.45 1.90 1.96
83 2.25 1.90 2.10 2.35




PLASMA CALCIUM (mg. per 100 ml.)
PATIENTS Time (Hours)
Pretreatment





















79 9.9 10.5 8.0 9.2
80 10.7 9.5 7.0 8.4
M
A 81 8.6 6.7 7.0 7.0 7.6Jti.
T. 82 10.5 7.7 7.7JJ
83 10.5 10.3 8.8 9.7
Hi
s 84 9.9 8.9 8.2




PLASMA INOBG-ANIC PHOSPHORUS (mg. per 100 ml.)
PATIENTS Time (Hours)
Pretreatment
0 3 6 12 24
M
A 74 3.8 3.2
L 76 3.9 3.8 2.6
E 77 3.8 2.8
S
P
79 5.8 5.5 2.8 2.9 2.2
80 2.4 3.0 1.1 1.9
82 3.5 3.0
83 3.2 3.4 2.2 2.1
S
Changes in plasma inorganic phosphorus in 7 patients
treated with forced "cocktail" diuresis.
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TABLE LIX
PACKED CELL VOLUME (%)
PATIENTS Time (Hours)
Pretreatment
0 2 4 6 12 16 24
72 46 44 42 37 42
73 54 51 44
75 45 46 44 45 42 43
76 42
77 42 37 34
78 54 47 45 43
79 41 42 45 46
80 49 41 39 39 39
83 45 42
84 46 40 40 44
Changes in PCV in 10 patients treated with forced
"cocktail" diuresis.
- 255 -
Effects of Forced 'Cocktail' Diuresis on Plasma Potassium,
Magnesium, Calcium and Inorganic Phosphorus and on Arterial pH
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Figure 45.
Changes in mean values S.E.M.) of plasma potassium,
magnesium, calcium and inorganic phosphorus, arterial
pH and P.C.V. in patients treated with forced "cocktail"
diuresis.
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In the 12 patients, in whom the plasma calcium was
monitored, eight developed hypocalcaemia within the first six hours
of treatment, but within 24 hours the plasma calcium levels had
risen spontaneously and in most cases were within the normal range.
The values for urinary excretion of calcium in the first six hours
in six patients are shown in Table LIII. As with magnesium, these
were low and ranged from 25.0 to 40.0 mg. with an average of 34.6
mg.
Measurements of plasma inorganic phosphorus were made in
six patients (Table LVIIl). Only one, patient 80, developed
significant hypophosphataemia. Within 24 hours this level had
risen considerably without any phosphate replacement.
The falls in mean values of plasma magnesium, calcium and
inorganic phosphorus (Fig. 45) all occurred during the first six
hours. Similar changes occurred in the P.C.V. (Table LIX).
The mean values are also plotted in Fig. 45. At six hours the
reduction in P.C.V. was 11 per cent, in plasma magnesium 15 per
cent, plasma calcium 20.5 per cent and inorganic phosphorus 42
per cent. No significant change was observed in arterial pH or
plasma potassium.
Changes in Plasma and Urinary Sodium
Levels of plasma sodium were measured in all the 13 patients
during the first six hours of treatment (Table LX). There were
no significant changes in the plasma levels in 11 patients. In
two, 73 and 79, who were slightly hyponatraemic before treatment,
the plasma levels rose to normal within 2-4 hours and thereafter
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TABLE LX
PLASMA. SODIUM (m.Eq. per litre)
PATIENTS Time (Hours)
0 2 4 6
72 138 136 137 138
M 73 133 132 140 146
A 74 147 145 143 145
L 75 139 140 136 138
E 76 140 142 136 137
S 77 135 138 136 140
78 137 140 137 136
79 132 142 140 138
80 141 138 136 142
81 138 136 138 138
82 140 140 136 138
83 138 139 136 136
84 142 140 140 142
Mean Values 158 139 138 140
Changes in plasma sodium in 13 patients treated with
forced "cocktail" diuresis.
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the levels were maintained. Urinary excretion of sodium during
the first six hours varied considerably in these patients ranging
from 58 to 316 mEq. (mean 162.9 mEq.).
Fluid Balance
Results are shown in Table LIII.
As in the other groups of patients treated there was
a calculated fluid deficit varying in individual cases from 3.5 to
11.1 litres (mean 5.9 litres). All of the patients achieved
a brisk diuresis and none were clinically severely dehydrated.
A number of patients, however, had marked features of sweating
and hyperpnoea and these features were particularly marked in
patients 73* 78 and 82, who were estimated to have the greatest
fluid deficits.
Discussion
Forced "cocktail" diuresis was a very effective means of
reducing the plasma salicylate. The mean half excretion rate
for salicylate was only slightly longer than that found with
forced alkaline diuresis. The urine flow per minute achieved
by forced "cocktail" diuresis was similar to that with forced
saline-laevulose and forced alkaline diureses. The increased
recovery of salicylate, therefore, compared with forced water
diuresis, was almost certainly again associated with the relative
alkalinisation of the urine which occurred. The urinary pH was
stabilised above 7.0 for most of the peak diuresis, but in none
of the patients did this rise above 8.0, which was regarded by
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Clamming et al. (1964) as a danger level and indicative of over-
enthusiastic bicarbonate administration. Also as the urine
became more alkaline so the amounts of free salicylate excreted
would be increased with more reduction in the toxic effects of
1
the overdosage.
The acid-base changes which occurred during the course of
■
I
this treatment, were very reassuring. In both the patients who
initially were alkalotic and in one who was acidotic, there was
I
fi
a general trend for the arterial pH to return to a normal value.
These trends continued throughout the period of treatment and it
would therefore seem that in this regime, the amount of bicarbonate
infused was sufficient to promote excretion of the salicylate
without producing a dangerous metabolic alkalosis. It is probable
that the improvements in arterial pH were related to the removal
of salicylate rather than any more direct effects of the
administered bicarbonate. The improvements in the arterial pCCh
and standard bicarbonate levels also were greater than with the
other regimes, which lends support to the supposition that the
improvements in arterial blood gases were related to the reduction
in plasma salicylate, particularly free salicylate.
Hypokalaemia was not found to be a problem in this group of
patients. Low levels of plasma potassium were found in a number
of patients, but these were not severe and there were no clinical
features to suggest hypokalaemia in any of the patients, for
these reasons, the changes in plasma potassium levels were not
hazardous. The results indicated, however, that hypokalaemia
may develop after the main period of diuresis has passed. It may
therefore be necessary to continue potassium supplements for up to
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24 hours after the start of diuresis therapy. In most patients
it is possible to give adequate oral potassium supplements after
about 6 hours and so any dangers, which may exist from intensive
intravenous potassium administration, can be avoided. In this
group of patients there were greater losses of potassium in the
urine than with forced alkaline diuresis. A likely explanation
is that because of the smaller amounts of bicarbonate infused and
the reduced tendency to metabolic alkalosis with forced "cocktail"
diuresis, there is a reduced cellular uptake of potassium.
Any surplus of potassium given as supplements, therefore, will be
excreted through the kidneys and, provided an adequate urine flow
has been established, there is no hazard in the treatment.
As with changes in plasma potassium, hypomagnesaemia was
not a prominent feature in these patients. As the urinary
excretion of magnesium over the initial six hours of treatment
was low, it may be assumed that no great shifts from the extra¬
cellular to the intracellular compartments were occurring with
this cation.
Hypocalcaemia, however, was found in over 60 per cent of
the patients studied. The hypocalcaemia was of a significant
degree, but less severe than with the other regimes used in this
investigation. It was a rather transient finding and within 24
hours the plasma levels had recovered spontaneously to normal
values. The urinary excretion of calcium in the first six hours
was not very great and was insufficient to explain the falls in
plasma calcium. These more probably resulted from two other
mechanismsj either as an effect of haemodilution or as a result
of cellular and bone uptake of calcium ions in response to
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alterations in acid-base state. From the changes in the packed
cell volume, there was a suggestion that haemodilution may have
been a significant factor in this group of patients. If a correc¬
tion factor is introduced for the percentage fall in packed cell
volume in the course of the six hour period the mean plasma
calcium levels remain within the normal range. It is possible,
therefore, that no true hypocalcaemia existed, but in the absence
of more detailed studies on this aspect it is perhaps more
appropriate to assume that all three factors, urinary excretion,
haemodilution and ion shift, contributed to the levels of plasma
calcium which were found.
A number of measurements were made of plasma inorganic
phosphorus during the initial six hour period. Only one patiai t
developed significant hypophosphataemia and again showed a
spontaneous recovery. The mean levels of plasma inorganic
phosphorus at no time fell below the lower limits of the normal
range. It is of interest to note that in one patient only,
patient 80, were hypomagnesaemia and hypocalcaemia and hypo¬
phosphataemia demonstrated simultaneously. The falls in these
elements seemed to be related and in this patient also there was
a considerable reduction in the packed cell volume. It is likely
'
therefore that in this patient the reduction in levels of
magnesium, calcium and inorganic phosphorus was largely due to
haemodilution.
None of the patients in this group showed any features of
tetany. This was not surprising in the light of the results
noted in the previous groups of patients. With forced "cocktail'
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diuresis there was less tendency for metabolic alkalosis and
hypomagnesaemia was not demonstrated. Marked hypocalcaemia did
occur, although in this case haemodilution may have been the
most important cause. Even if this was not so, the absence of
tetany may possibly be explained on the basis of relative increase
in ionised calcium as a result of competition between salicylate
and calcium for protein-building sites as has been discussed
previously. In alternative explanation, is suggested by the
results of the plasma inorganic phosphorus. The degree of
ionisation of calcium is influenced by plasma phosphate
concentration (Merrill, 1956). For this reason, the fall in the
level of plasma phosphate simultaneous with the development of
hypocalcaemia would tend to increase the ionised fraction of
plasma calcium and to obviate the occurrence of tetany. The
number of measurements on plasma inorganic phosphorus was limited
and so there must be reservations about any conclusion drawn from
these figures. It is interesting nevertheless, to speculate that
similar changes in plasma phosphate may have occurred in the
previous groups of patients treated with other regimes of therapy
and may, therefore, have been a factor in preventing tetany.
As in all the other groups of patients which have been
studied, considerable fluid deficits were found in these patients.
There seemed to be a relationship between the intensity of clinical
features observed, in particular sweating and hyperpnoea, and the
degree of fluid deficit found. There is little doubt that the
deficits were due to the marked increase in insensible fluid loss,
which occurs in severe acute salicylate poisoning, as all of the
patients established a good urinary flow within two hours of
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starting the diuresis therapy.
Conclusion
Forced "cocktail" diuresis produced a satisfactory reduction
of the plasma salicylate and a good urinary recovery of salicylate.
Hypokalaemia was not a serious problem. Similarly hypomagnesaemda
scarcely occurred with these patients and, although hypocalcaemia
was observed, haemodilution was perhaps an important factor and
calcium deficits may not have occurred to any significant degree.
Although there was a general trend towards reduction in plasma
inorganic phosphorus, true hypophosphata,emia was demonstrated in
only one patient and this was not sustained. Together with the
improvement in levels of plasma salicylate, the acid-base status
of all patients, irrespective of what the initial arterial pH
level was, improved and in most cases the arterial pH returned to
normal. The amount of bicarbonate infused in the therapy did
not provoke significant degrees of metabolic alkalosis.
Forced "cocktail" diuresis as described, is therefore a safe,
yet effective method of treatment for patients with severe acute
salicylate overdosage. It is a suitable regime for patients, in
whom the acid-base disturbance results in systemic alkalosis and
also for patients, who are acidotic.
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COMPARISON BETWEEN THE EFFECTS OF FORCED ORAL FLUIDS.
FORCED SALINE-LAEVULOSE DIURESIS. FORCED ALKALINE
DIURESIS AND FORCED "COCKTAIL" DIURESIS
The results for these four major regimes have been
described in detail on an individual basis, but in order to assess
the effectiveness and dangers of the different regimes, it is
necessary to compare the relative changes, which were found.
Clearance of Salicylate
The mean clearance values for salicylate during the six
hour period following the commencement of treatment was calculated
UV
from the conventional clearance formula —. The mean clearance
values of salicylate for the four different groups were
calculated from the mean urinary volume (ml. per minute), the
mean plasma salicylate (mg. per ml. plasma) and the mean urinary
salicylate (mg. per ml. urine) before treatment and at hourly
intervals up to six hours after starting treatment. The
results are plotted in Fig. 4-6. For both oral fluids and saline-
laevulose diuresis, the clearance value of salicylate fell as the
diuresis continued. In contrast, the clearance of salicylate
with forced alkaline and forced "cocktail" diuresis had a tendency
to rise as the diuresis proceeded. flhe clearance of salicylate
with forced alkaline was rather better than with forced "cocktail"
diuresis the average clearance of salicylate in the latter being
20 ml. per minute and in the former 25 ml. per minute. A similar
comparison was found for the mean half excretion times for
salicylate for the four regimes. These are shown in Table LXI.
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Comparison between the clearances of Salicylate on Oral Fluids,











Plots of the mean clearance values of salicylate with










The mean half excretion times for salicylate calculated for
the patients treated with forced oral fluids, forced saline-
laevulose diuresis, forced alkaline diuresis with standard
potassium supplements and forced "cocktail" diuresis.
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Again forced alkaline diuresis was the best method for removing
salicylate. Forced "cocktail" diuresis, however, was a close
second and both these methods were clearly superior to both oral
fluids and saline-laevulose diuresis. These results in respect
of changes in salicylate levels corresponded well to the
observations made on the clinical progress of the patients.
With forced alkaline and forced "cocktail" diureses the patients
obtained rapid relief of symptoms of salicylism, but with the
other two types of treatment symptoms tended to persist.
Clearances of Potassium
The clearance of potassium was calculated in a similar way
to the clearance of salicylate for the four different regimes.
The results are plotted during the first six hour period of
treatment in Figure 47* Before treatment for oral fluids, saline-
laevulose diuresis and forced "cocktail" diuresis the high levels
of potassium clearance almost certainly can be explained on the
basis of collections of urine not representing an acurate one
hour period. The clearance values of potassium were similar for
the four regimes of treatment. The highest clearance of potassium
was with forced "cocktail" diuresis and averaged 70 ml. per minute.
That for forced saline-laevulose diuresis was 60 ml. per minute,
for forced alkaline diuresis, 55 nil. per minute, for forced oral
fluids was 50 ml. per minute. The reason for the relatively low
clearance of potassium with forced alkaline diuresis was probably
related to the administration of large amounts of bicarbonate in
that regime, which would result in a large cellular uptake of
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Comparison between Clearances of Potassium on Oral Fluids,
Forced Saline-Laevulose Diuresis, Forced Alkaline Diuresis




















Plots of the mean clearance values of potassium with
the four main types of treatment studied.
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potassium from the extracellular fluids. The reduced clearance
of potassium with forced oral fluids can he readily explained on
the basis of a lower urine flow compared with the other three
regimes.
Changes in Plasma Potassium. Magnesium and Calcium
The changes in mean values are plotted in Figure 48. The
least change in plasma potassium in the first six hours of
treatment occurred with the forced "cocktail" diuresis and the
greatest changes were found, when using forced alkaline diuresis.
The other two regimes were intermediate in their effects on
plasma potassium. Significant and at times severe levels of
hypokalaemia were found from the third hour onwards with forced
alkaline diuresis and to a lesser extent with forced oral fluids.
In contrast, the levels of plasma potassium remained normal when
using forced "cocktail" diuresis.
Similar findings were obtained when the four regimes were
compared in respect of plasma magnesium. Forced "cocktail"
diuresis did not cause any significant hypomagnesaemia, whereas
forced alkaline diuresis was associated with marked falls in
plasma magnesium from the third hour of treatment until the end
of the six hour period. The other two regimes were again
intermediate in effect, though in this case, forced saline-laevulose
was rather similar to forced alkaline diuresis and forced oral
fluids similar to forced "cocktail" diuresis.
With all the four types of treatment the plasma calcium
levels fell during the second half of the main diuresis period.
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Comparison between the changes in Plasma Potassium, Magnesium
and Calcium on Oral Fluids, Forced Saline-Laevulose diuresis,
Forced Alkaline diuresis and Forced 'Cocktail' diuresis.
» ' Oral fluids
0 12 3 15
HOURS
Figure k8.
Comparison between the mean changes in plasma potassium,
magnesium and calcium, which occurred with the four
regimes of therapy.
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The least change was caused by forced oral fluids and forced
"cocktail" diuresis. The changes with forced alkaline and
forced saline-laevulose diuresis were more severe, but it should
be noted that at the end of the six hour period there was little
difference between the levels of plasma calcium in the three
intravenous infusion regimes. Haemodilution, however, was
probably an important factor in the hypocalcaemia with forced
"cocktail" diuresis but only to a small degree with forced saline-
laevulose and forced alkaliSe diuresis. If the plasma calcium,
in the case of forced "cocktail" diuresis, was corrected for this
degree of haemodilution, the levels were within the normal range.
Changes in Urinary Volume. Arterial pH. Urinary pH and P.C.V.
The results are plotted for the mean values over the initial
six hours of treatment in Pig. 49*
All three regimes in which similar infusion rates were
given resulted in similar urinary flows, and from this point of
view they were highly comparable. The urine flow with forced
oral fluids as had been expected was considerably less than with
the other three regimes.
In terms of arterial pH, only forced alkaline diuresis
caused a dramatic change. With this form of treatment severe
degrees of metabolic alkalosis were produced, which were perhaps
all the more important as they occurred over short periods of time.
The other three regimes caused much less changes in H+ concentration
and the pH values remained more or less within the normal range.
Regarding urinary pH, forced alkaline and forced "cocktail"
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Comparison beteen the four major regimes of therapy regarding
Urinary Volume, Arterial pH, Urinary pH, and P.C.V.
• • Forced oral fluids
HOURS
Figure 49*
Comparison between the mean changes in urinary volumes,
arterial pH and P.C.V., which occurred with the four forms
of treatment.
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diureses caused a significant degree of alkalinisation of the
urine which was rather more marked with the former. Forced
saline-laevulose and forced oral fluids failed to achieve this
beneficial effect and indeed with these two treatments the urine
tended to become more acid.
The changes in packed cell volume noted with forced "cocktail',
forced saline-laevulose and oral fluids were relatively similar.
All of them showed a reduction, the nadir of the curve occurring
approximately four hours after starting treatment. With forced
alkaline diuresis the packed cell volume fell earlier at two hours,
but thereafter it showed a steady and progressive increase to
the end of the six hour period. As the main falls in plasma
potassium, magnesium and calcium occurred between four and six
hours after starting treatment haemodilution may have been a factor
in all the regimes, with the exception of forced alkaline diuresis.
Fluid Deficit
The calculated fluid balance at the end of the total diuresis
period in all cases indicated the presence of a significant fluid
deficit. There were considerable variations in severity of this
but it was a uniform and regular finding. The causes of this f
deficit have been discussed and it would seem likely that quite
apart from any factor of initial dehydration due to factors such
as vomiting the main cause of the fluid deficit is increased
insensible water loss as a result of increased sweating and hyper¬
ventilation. Throughout the study there was impression that the
magnitude of the estimated fluid deficit was directly related to
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the severity of the poisoning. In order to test out this
suggestion the relationship between the estimated fluid deficit and
the peak plasma salicylate level in 33 consecutive severely
poisoned patients was calculated (Figure 50). A significant
relationship was found (r = 0.72; p = < .001). The state of the
fluid balance, therefore, will provide an additional means of
assessing patients with severe salicylate poisoning. It is, of
■
course, a retrospective means of assessment; but for purposes
of research studies may be of some value.
Conclusion
Experts agree that the treatment of patient® with severe
acute salicylate poisoning should be primarily directed to
increasing the removal rate of the salicylate. There is great
controversy, however, about the most appropriate method of
achieving this. The fact that all the patients studied had
significant fluid deficits makes treatment with one or other
method of forced iuresis the most rational form of treatment, in
so far as these regimes will correct the initial dehydration and
will also compensate for any continued losses of fluid as a result
of sweating and hyperventilation. It is difficult, if not
impossible, to assess these losses on a clinical basis and if such
regimes as peritoneal dialysis, exchange transfusion, ion exchange
resin or even haemodialysis are used, this factor may be over¬
looked.
Forced diuresis therapy for the treatment of patients with
acute salicylate poisoning, therefore, must remain the most
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Relationship between the estimated fluid deficit and the
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Figure 50.
Relationship between the estimated fluid deficit and
the peak plasma salicylate level in 33 patients with
severe salicylate poisoning.
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attractive form of treatment. As has been explained, the vast
majority of patients with this poisoning are in the younger age
groups and it is quite exceptional to encounter patients who have
sufficiently severe renal, cardiac or respiratoxy disorders to
prevent the safe and effective use of this treatment. No matter
how elaborate and effective the artificial means of removing
salicylate are, or how expertly they are used, none of them can
compare with healthy kidneys. The patients own normal kidneys
are also much more efficient in regulating the excretion and
conservation of fluids and electrolytes and in the maintenance
of acid-base balance.
In this series of investigations several different regimes
of forced diuresis have been studied in some detail. A method
has been developed which is a modification of that advocated by
Dukes et al. (1963). r-?his has been called, for simplicity,
forced "cocktail" diuresis. It is both effective and safe and
is, therefore, suitable not only for use in major hospitals, where
there is readily available, adequate biochemical and medical
expertise, but also in small hospitals, where facilities for close
biochemical monitoring of patients is. limited. The regime of
forced "cocktail" diuresis although marginally less effective
than forced alkaline diuresis in reducing the plasma salicylate
level has the "great advantage of causing insignificant changes in
acid-base balance and in plasma potassium andmagnesium. It is
probable also that any changes found in plasma calcium are of little
importance. This regime, therefore, may be used safely with the
minimi™ of biochemical monitoring, although clearly, where this is
available, it would be desirable that it should be done.
- 277 -
A further important advantage of the regime is that it is
effective for even very severely poisoned patients. Hence it
provides a suitable alternative form of treatment to the use of
the artificial kidney and will thereby reduce the burden on the
use of that machine. Acute salicylate poisoning is sufficiently
common for this consideration to be important. Only where there
is a direct contra-indication to the use of forced diuresis, such
as the presence of renal failure, severe cardiovascular disorder
and pulmonary oedema should there be resort to the use of the
artificial kidney or some other artificial means of removing
salicylate from the body. On rare occasions when the patient is
very severely poisoned or is not responding to forced "cocktail"
diuresis at a sufficiently satisfactory rate, the method may be
effectively combined with either peritoneal dialysis or haemo-
dialysis itself. In this way a maximum intensity treatment is
achieved.
Because of the admission arrangements to the Poisoning
Treatment Centre, Royal Infirmary, Edinburgh, the results given
in this report refer to observations made on older children and
adults. The regimen of forced "cocktail" diuresis, therefore,
applies to these groups of patients only. On the other hand, the
metabolic disturbances in infants and young children are basically
the same, although the metabolic acidosis may be more extreme and
may appear earlier. The principles of treatment are similar and
with appropriate adjustments in quantity to suit the size and
age of the patient a regime of forced "cocktail" diuresis could
also be devised for paediatric use.
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Little reference has been made to the psychiatric
management of patients with acute salicylate poisoning. In
older children above the age of 12 and in adults the great
majority of patients are suffering from intentionally self-
administered poisoning. Some of these seriously wish to die
and so are truly attempting suicide, but the great majority are
suffering from self-poisoning described by Kessel (19^5)• The
precipitating factor is usually some crisis situation, which in
expert hands, can often be relieved quickly and satisfactorily.
The various factors, which require consideration in the
psychiatric management of these patients, are complex and
beyond my scope as a physician. Suffice it to comment that any
patient, who has intentionally taken an overdosage of any toxic
substance, toust be given the benefit of expert psychiatric advice
as a matter of urgency. Failure to provide this, is failure to
manage the patient adequately.
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